data_2rue_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rue _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 m -133.14 140.66 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.03 143.38 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -138.49 97.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.72 161.5 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.836 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.31 -36.57 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -86.64 -7.5 58.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.91 -46.31 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.708 0.289 . . . . 0.0 111.572 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -44.8 -48.77 10.95 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.593 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.487 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.47 -34.23 34.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.311 . . . . 0.0 111.655 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -59.2 2.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 pt -56.03 -47.31 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 29.0 m -63.25 -38.93 83.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.63 -8.95 58.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -72.51 105.35 4.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.3 -15.58 57.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 111.076 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -142.22 150.68 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.074 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -83.67 145.04 29.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -133.85 142.29 41.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.96 103.83 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tt -100.61 116.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -106.53 129.9 54.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.143 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 28.7 m-85 -100.15 120.19 39.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.802 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CE2' ' HB1' ' A' ' 44' ' ' ALA . 31.5 p90 -142.71 176.56 8.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.62 148.16 42.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.67 -45.14 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.541 2.161 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -78.15 -3.5 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.9 t -50.2 -46.45 54.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.65 -40.42 2.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.48 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -108.65 -3.12 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.48 -19.98 13.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -49.65 -28.19 5.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 110.958 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.5 -27.8 37.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -33.26 72.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.849 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' CE2' ' A' ' 33' ' ' TYR . . . -61.98 -62.35 5.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.378 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 20.4 Cg_endo -60.9 -34.28 91.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.518 2.145 . . . . 0.0 112.272 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -29.04 68.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -78.66 -28.53 45.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.77 -35.73 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.801 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.62 -55.45 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.35 -28.68 68.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.21 -43.15 90.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.575 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.07 -30.01 62.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.118 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -55.43 5.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.413 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.81 -32.66 74.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.11 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.22 -28.91 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -173.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 43.36 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -138.68 33.63 2.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.42 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.48 16.16 16.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.82 -49.77 2.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.358 . . . . 0.0 110.916 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 54' ' ' TYR . 11.9 p -135.75 139.65 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.441 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 20.6 mm -85.86 106.23 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.977 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.77 134.39 52.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.51 153.16 30.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -168.16 150.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.36 146.13 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.592 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . . . -88.11 48.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 p -137.47 20.66 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.21 -177.72 6.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.55 160.06 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.82 41.7 31.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 p -128.78 82.8 67.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 80.3 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.713 2.275 . . . . 0.0 112.344 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -125.92 93.4 3.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.47 118.18 27.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.76 160.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.546 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -76.34 -48.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.215 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.73 141.2 14.32 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.638 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -42.75 -49.12 13.68 Favored Pre-proline 0 CA--C 1.485 -1.536 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -65.91 78.52 0.29 Allowed 'Trans proline' 0 N--CA 1.424 -2.572 0 CA-C-N 119.124 0.723 . . . . 0.0 111.176 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -101.1 143.06 31.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.089 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.46 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 3.2 mp -127.8 119.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -103.42 115.34 30.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.3 131.24 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.0 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.439 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.8 m-85 -132.7 93.48 24.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 147.98 47.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.427 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.13 115.85 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.1 -36.87 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.291 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.98 30.0 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.012 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -172.18 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.53 -15.22 46.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.591 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.7 pm0 -128.85 112.67 18.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.771 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.95 108.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.443 2.095 . . . . 0.0 112.157 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.14 105.88 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.67 126.9 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -73.26 -177.14 2.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 p -109.58 -26.96 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.7 133.52 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 169.83 9.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -175.55 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -149.25 148.38 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.01 -27.91 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.11 -35.82 72.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.938 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.57 -29.23 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.7 tp -70.63 -51.5 27.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 tt -57.39 -45.94 85.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -58.54 -50.9 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.003 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.07 -52.23 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.83 -30.86 9.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.82 -27.94 58.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.5 -38.0 22.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -92.04 -44.44 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.113 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.76 136.47 19.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.604 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -32.6 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.782 0.325 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.9 m -100.28 144.38 29.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.72 143.52 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 30' ' ' ILE . 1.5 t -118.21 100.87 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.04 163.85 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.5 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.317 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.65 -7.69 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.656 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -44.64 5.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 0.0 111.356 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.28 -49.91 63.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.357 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.9 -34.68 29.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.728 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -75.28 -59.32 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.3 pt -56.06 -46.94 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 88' ' ' TYR . 23.3 m -64.69 -37.23 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.66 -11.11 59.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.436 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.75 108.85 8.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -79.33 -12.39 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -91.69 11.27 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.539 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.49 134.43 4.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.75 139.87 32.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.656 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.9 t -133.85 141.32 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mt -124.72 103.31 8.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.692 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 32' ' ' PHE . 6.9 tt -101.67 127.72 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 14.8 tm-20 -117.64 124.3 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.22 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 30' ' ' ILE . 34.0 m-85 -95.18 118.74 32.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.833 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -139.76 174.71 10.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.004 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.77 145.36 30.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.11 -46.48 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.476 2.118 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -78.02 -3.44 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.5 t -50.58 -47.19 58.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.784 0.326 . . . . 0.0 111.318 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.22 -39.84 2.73 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.574 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -110.14 -1.93 17.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.835 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.8 m -107.19 -22.86 12.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.45 -27.22 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.37 -28.75 41.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.93 70.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -62.89 -61.99 6.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 17.8 Cg_endo -60.12 -36.68 88.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.428 2.085 . . . . 0.0 112.399 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -29.09 69.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.52 -26.4 38.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.34 -35.62 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.659 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.68 -53.76 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 tp -60.58 -27.84 68.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.69 52.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.97 65.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.266 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.35 -63.6 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -29.42 63.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.064 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.69 -34.84 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -29.13 61.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.0 -173.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -130.98 30.18 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.91 -30.28 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.55 -29.88 33.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -75.15 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.32 139.68 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.58 131.02 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 20.3 mm -81.77 120.56 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.3 126.65 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -106.13 155.8 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.688 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 p -168.12 155.36 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.11 146.22 25.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.57 46.04 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.278 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.57 20.6 2.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.52 -177.71 5.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.91 158.44 15.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.827 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t0 51.11 40.59 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.36 100.13 20.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.961 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.65 -73.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.637 2.225 . . . . 0.0 112.134 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 44.1 93.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.658 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.09 101.14 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.534 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.85 160.28 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.614 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -43.58 12.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.451 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.57 141.14 16.75 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.945 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -47.3 -46.84 57.68 Favored Pre-proline 0 CA--C 1.485 -1.522 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.22 74.07 2.56 Favored 'Trans proline' 0 N--CA 1.422 -2.699 0 CA-C-N 119.422 0.829 . . . . 0.0 110.866 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -98.88 121.2 40.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.203 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 3.0 mp -102.47 116.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -103.34 122.23 44.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 133.5 50.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.091 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 40.8 m-85 -129.76 93.38 34.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.674 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.21 140.64 41.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.841 2.361 . . . . 0.0 112.271 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.01 115.85 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.62 -34.31 5.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.64 12.29 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.643 0.259 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -168.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.63 -17.78 42.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.421 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -128.77 130.58 23.48 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.563 0.22 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.94 112.71 3.48 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.393 2.062 . . . . 0.0 112.439 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.01 105.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.948 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 119.3 30.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.453 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -66.33 -175.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -26.09 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.728 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.88 127.29 1.02 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.86 145.15 27.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -56.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 m -134.63 155.97 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -73.87 -27.02 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.331 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.23 -35.98 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.042 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.64 -31.03 57.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.68 -51.38 50.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 tt -58.98 -45.96 91.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -58.01 -33.89 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.0 56.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.5 mt -56.36 -29.15 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.6 -37.05 25.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -72.17 -29.58 64.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.22 23.07 12.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.05 144.0 15.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.56 -29.75 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 111.038 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.407 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.4 m -116.4 121.65 42.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.25 143.36 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG11 ' CD1' ' A' ' 30' ' ' ILE . 0.9 OUTLIER -129.57 97.81 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.014 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 t -99.4 162.7 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.696 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.04 -36.16 49.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.776 0.322 . . . . 0.0 111.456 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -9.19 56.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -41.13 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.556 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -39.84 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -38.81 73.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.92 -43.92 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 21' ' ' VAL . 20.9 pt -66.8 -45.44 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 19.4 m -70.03 -36.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.3 mt -76.83 -14.74 59.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 110.15 1.04 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.24 -12.29 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.405 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -106.62 14.91 26.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 141.85 19.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.69 127.5 44.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.91 147.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 111.438 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.84 114.73 16.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.764 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' A' ' 32' ' ' PHE . 8.3 tt -105.03 118.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.203 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.9 tm-20 -109.31 131.54 54.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CE2' HD13 ' A' ' 30' ' ' ILE . 28.2 m-85 -103.36 126.1 50.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 111.364 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 44' ' ' ALA . 32.8 p90 -152.84 171.17 18.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.59 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 155.63 59.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 27.2 Cg_endo -63.35 -56.88 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.55 2.167 . . . . 0.0 112.103 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p90 -61.91 -18.46 60.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.701 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 t -42.87 -39.97 2.74 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.563 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.72 -64.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.27 -69.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.3 p -67.15 -13.64 62.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.446 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -51.3 -27.38 9.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.896 0.379 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.36 63.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -22.33 64.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . . . -66.73 -63.13 3.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.549 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 12.0 Cg_endo -56.24 -35.7 95.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -25.8 63.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -77.42 -29.03 52.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.234 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 49' ' ' GLU . 1.6 pt-20 -77.29 -31.15 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.33 -51.36 37.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.5 tp -70.25 -30.52 67.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.5 -50.66 63.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.313 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.82 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.946 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -60.34 3.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' CD1' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.55 -27.6 58.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.15 -33.06 33.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -77.18 -30.71 55.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 m -58.91 176.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.73 -10.84 60.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -95.96 38.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -30.35 65.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -105.71 16.22 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -116.48 -41.24 3.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 14.3 p -126.55 150.23 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.88 122.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 111.28 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 15.1 mm -87.86 110.41 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.799 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.43 128.44 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 144.31 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.561 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.38 156.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.256 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -94.79 146.23 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.59 51.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.41 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -137.75 19.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.923 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -177.78 6.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 111.407 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.39 153.15 34.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.834 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 58.02 47.0 15.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 7.5 p -133.18 89.57 32.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.549 2.166 . . . . 0.0 112.077 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -112.22 84.91 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.06 109.72 20.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.413 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.77 160.17 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.597 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.29 -43.3 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.31 141.34 16.5 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.896 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -45.09 -45.96 28.97 Favored Pre-proline 0 CA--C 1.487 -1.472 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 37.3 Cg_endo -67.75 80.35 0.48 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 CA-C-N 119.548 0.874 . . . . 0.0 111.435 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -86.09 137.28 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.134 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 28.6 mt -130.93 109.53 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.774 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -103.38 119.36 38.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.06 128.1 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 11.3 m-85 -132.74 93.4 24.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.43 154.17 21.17 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.595 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.16 117.66 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.05 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.98 -38.0 3.35 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.46 11.26 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.658 0.266 . . . . 0.0 111.486 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -173.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.2 -17.84 43.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.367 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.82 121.93 21.21 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.519 0.2 . . . . 0.0 110.636 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . 55.7 Cg_endo -70.17 107.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.324 2.016 . . . . 0.0 112.176 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.1 105.83 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.7 p -93.09 128.9 39.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.4 m-85 -69.54 176.82 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.6 -24.88 12.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.82 117.04 0.62 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.7 p -76.65 145.86 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.921 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -148.19 -72.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -132.35 165.18 24.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.82 -29.06 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.43 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -57.06 -31.36 65.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.04 -30.28 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tp -72.02 -49.99 32.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.42 HG13 ' CE2' ' A' ' 54' ' ' TYR . 4.5 tt -57.22 -46.38 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -63.13 -37.36 86.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.66 51.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.11 -29.83 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.42 63.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.59 -26.43 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -116.14 23.0 12.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.148 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.53 138.8 10.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.519 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -6.29 58.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.584 0.231 . . . . 0.0 111.366 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.629 0.252 . . . . 0.0 111.323 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.9 m -111.01 127.65 55.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.66 143.39 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.25 97.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.26 167.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.23 60.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.552 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -86.73 -7.65 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.934 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.54 -52.67 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.492 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -49.23 -55.7 11.72 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.41 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -46.2 -34.95 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -73.66 -59.35 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 pt -55.9 -49.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.852 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 33.1 m -56.53 -43.05 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.22 -12.63 60.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -58.75 96.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.862 0.363 . . . . 0.0 110.804 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.1 -19.25 64.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.371 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.74 27.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.645 0.26 . . . . 0.0 111.279 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -176.94 145.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.585 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.85 146.44 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.871 0.367 . . . . 0.0 111.467 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.9 mt -136.67 101.21 4.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.72 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tt -102.36 119.11 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.201 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.19 131.33 54.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.05 123.78 45.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.801 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -146.73 174.47 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.76 147.68 39.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.31 -42.11 4.18 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.622 2.215 . . . . 0.0 112.333 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -78.21 -3.44 42.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.392 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.2 t -51.43 -49.58 61.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -39.73 2.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.473 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -108.79 -3.2 17.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.623 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.4 m -107.22 -20.78 13.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -49.55 -27.88 4.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.78 41.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.823 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -31.71 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.78 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.42 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -60.3 -62.32 6.16 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.447 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 19.7 Cg_endo -60.8 -37.32 79.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.466 2.111 . . . . 0.0 112.314 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -64.04 -29.2 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.78 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.51 -24.34 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.948 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -71.06 -35.63 72.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -52.99 9.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.36 -29.12 68.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.21 -44.91 58.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.03 65.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.59 -57.56 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.9 83.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.013 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.35 71.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.38 38.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.9 m -129.22 177.78 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.42 -21.31 64.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -95.29 38.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -74.8 -39.81 61.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.07 16.11 15.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.88 -51.56 2.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.806 0.336 . . . . 0.0 110.797 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.94 149.72 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.31 120.97 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.74 106.18 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.17 127.84 55.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 140.51 46.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.657 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 p -157.11 153.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -95.5 146.2 24.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.3 55.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 111.345 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -137.65 20.52 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.3 -177.77 5.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 111.339 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.52 154.66 30.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.09 62.08 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.057 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -154.47 104.03 2.37 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.035 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 78.59 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.491 2.127 . . . . 0.0 112.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -104.38 74.2 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -93.54 98.51 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.435 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.19 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.726 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -48.5 16.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.087 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.13 16.7 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.628 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.8 OUTLIER -45.94 -44.91 36.86 Favored Pre-proline 0 CA--C 1.486 -1.49 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 7.6 Cg_exo -66.6 80.97 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.57 0 CA-C-N 119.239 0.764 . . . . 0.0 111.327 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -102.95 142.92 33.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.211 -178.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.417 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 4.1 mp -126.36 117.95 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.802 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -103.28 112.11 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.62 131.48 43.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.174 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 34.4 m-85 -132.87 93.23 24.05 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.2 145.19 17.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.672 2.248 . . . . 0.0 112.664 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.78 124.04 27.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.64 -23.9 31.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.53 29.65 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -165.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.24 -18.09 42.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.23 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.7 pm0 -129.19 119.96 19.89 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.449 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.35 111.26 2.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.243 1.962 . . . . 0.0 112.058 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.01 105.84 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.38 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.4 p -96.55 123.18 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.6 m-85 -74.14 178.75 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -118.41 15.83 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.08 123.0 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 t -100.96 155.29 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.925 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -139.72 -47.05 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.9 m -143.87 152.26 40.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.35 -27.05 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.4 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.05 -34.2 68.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.097 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.53 -30.68 59.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.992 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -70.7 -53.74 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tt -55.81 -45.49 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -58.11 -39.83 79.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.011 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -48.57 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.18 -23.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.289 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.43 33.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.56 -29.2 19.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.52 -30.99 14.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.22 136.14 20.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.51 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.43 -7.75 57.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.579 0.228 . . . . 0.0 111.355 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 111.279 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.793 0.33 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -136.94 142.92 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.36 143.43 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 17' ' ' TYR . 15.7 t -135.6 97.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.2 161.66 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.776 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.9 -35.59 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -86.61 -7.48 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.29 -47.6 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.622 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -44.08 -49.06 8.98 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.473 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.11 -32.08 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -79.37 -59.39 2.78 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.3 pt -54.97 -38.36 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 29.1 m -74.52 -37.99 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.698 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.06 -6.39 52.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.546 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.42 105.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.927 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -79.39 -12.39 59.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.418 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 28.05 8.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.205 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.88 131.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 137.41 33.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.82 147.45 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.45 104.92 6.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.693 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 32' ' ' PHE . 9.1 tt -100.65 129.29 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.55 126.37 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CE2' HD12 ' A' ' 30' ' ' ILE . 38.6 m-85 -97.1 117.91 32.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE1' ' HD2' ' A' ' 67' ' ' LYS . 11.9 p90 -134.91 174.33 10.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.71 145.76 32.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -46.67 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.536 2.158 . . . . 0.0 112.329 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -78.91 -3.41 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.6 t -48.63 -46.78 40.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.306 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.6 -36.92 3.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.595 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -114.83 -2.76 12.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.791 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.6 m -105.06 -22.3 13.13 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.063 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -49.52 -27.99 4.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.045 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.51 -28.09 37.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.6 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.409 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -62.62 -62.68 5.27 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 18.5 Cg_endo -60.19 -36.55 88.0 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.436 2.09 . . . . 0.0 112.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -29.23 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.24 -24.25 37.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.56 -33.27 66.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.619 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.71 -54.15 7.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 tp -60.58 -31.52 70.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.733 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.46 -42.47 81.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.35 63.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 -59.58 2.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -39.53 78.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.61 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 t -113.1 -173.85 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.52 -18.22 58.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.271 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.13 35.8 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.989 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -29.24 70.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.157 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -103.14 16.25 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.373 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -116.9 -74.64 0.6 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.32 141.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.41 128.26 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.448 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 23.4 mm -83.47 111.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.51 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.169 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -106.8 151.95 24.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -168.14 156.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.62 146.13 29.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.23 51.69 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.864 0.364 . . . . 0.0 111.21 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 p -137.63 20.61 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.4 -177.74 4.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 111.201 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 164.05 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.66 31.58 17.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.991 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.13 101.95 14.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.82 -68.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.463 2.109 . . . . 0.0 112.206 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 42.12 83.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.715 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.12 102.84 15.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.43 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.22 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.581 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.44 -46.05 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.38 141.24 16.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.951 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -47.44 -46.23 58.07 Favored Pre-proline 0 CA--C 1.485 -1.521 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.18 71.59 3.59 Favored 'Trans proline' 0 N--CA 1.423 -2.672 0 CA-C-N 119.469 0.846 . . . . 0.0 110.973 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.43 ' OG1' ' CG2' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -92.13 142.87 27.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.181 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 7.9 mt -123.21 116.53 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.97 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -103.54 116.85 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.08 130.87 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.174 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.464 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 3.5 m-85 -132.82 93.36 23.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.708 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.21 142.96 19.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.653 2.235 . . . . 0.0 112.478 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.93 131.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.98 -36.56 3.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.265 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.65 2.78 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.69 -17.78 41.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.489 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.76 118.94 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.597 0.237 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.33 111.01 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.36 2.04 . . . . 0.0 112.267 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -80.13 105.78 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.69 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.16 124.09 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.02 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 2.8 m-85 -81.08 -176.86 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.028 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.4 m -102.54 -25.5 13.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.685 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.07 140.24 2.88 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 t -95.21 145.11 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.963 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -145.22 -66.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -121.22 160.3 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.3 m -76.95 -28.58 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.284 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.68 -33.43 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.57 -35.28 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.71 -46.69 52.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.16 -38.91 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.58 -49.81 71.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.47 -46.98 85.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mt -51.46 -41.03 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.176 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.06 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -75.05 -51.6 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.68 -43.9 58.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 138.57 49.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.58 -38.7 28.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.03 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.1 m -129.42 135.73 49.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.2 139.15 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.984 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 17' ' ' TYR . 7.1 t -123.99 97.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.54 166.46 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.679 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.15 -39.05 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.82 -9.99 54.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.76 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -47.19 4.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -46.97 -50.56 18.86 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.395 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.67 -32.84 31.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.25 -59.25 2.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.948 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -56.37 -47.62 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD2' ' A' ' 88' ' ' TYR . 28.0 m -62.74 -38.27 81.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.652 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.32 -10.47 59.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.51 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.88 104.31 0.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.35 -20.08 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.379 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -95.48 22.12 7.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.303 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.03 137.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.381 . . . . 0.0 111.048 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -83.78 140.01 32.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.79 141.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 111.462 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.25 118.94 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.711 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 tt -111.66 123.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.159 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -111.84 132.46 54.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -101.98 129.5 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.11 173.36 15.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.7 145.93 32.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 44.5 Cg_endo -68.59 -42.08 5.43 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.45 2.1 . . . . 0.0 112.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 25.8 p90 -79.44 -3.47 46.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.7 t -53.8 -48.57 69.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.27 -42.2 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.415 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.68 -1.93 25.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.715 0.293 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.3 m -110.06 -22.48 11.79 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -27.34 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.246 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.47 -29.28 52.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.027 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -30.9 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -59.6 -62.0 6.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 27.4 Cg_endo -62.45 -36.78 63.98 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -63.9 -29.16 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.428 ' CE2' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -82.16 -25.4 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.35 -36.31 66.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -73.52 -56.79 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.39 -28.93 68.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.809 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.66 -50.62 53.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.09 -30.14 67.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mt -70.63 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.403 ' CZ ' HG13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -57.84 -31.04 66.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.02 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.93 72.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.33 35.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -118.21 -176.35 3.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.35 -28.67 68.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -96.63 38.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -70.94 -37.47 72.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.18 16.25 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HB3' ' CG ' ' A' ' 118' ' ' TYR . 5.9 mtt180 -110.77 -31.72 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.08 155.72 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.28 123.18 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.259 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 65' ' ' ILE . 19.8 mm -84.55 106.16 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.74 126.62 53.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.53 150.4 27.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -164.28 154.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.219 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -95.23 146.15 24.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.47 56.83 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 111.252 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -137.63 20.63 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.0 -177.72 6.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.254 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.65 157.2 25.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.52 48.49 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.82 93.19 28.26 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.006 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 79.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.592 2.195 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -114.02 117.61 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -119.62 107.44 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.417 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.8 160.06 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.26 -36.55 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.28 141.31 12.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.509 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -40.69 -44.28 4.84 Favored Pre-proline 0 CA--C 1.487 -1.455 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 15.8 Cg_exo -63.98 81.21 0.15 Allowed 'Trans proline' 0 N--CA 1.427 -2.399 0 CA-C-N 119.318 0.792 . . . . 0.0 111.382 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -91.17 142.32 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.388 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 6.9 mt -132.87 107.81 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -103.86 129.99 51.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.915 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.62 132.06 55.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 39.2 m-85 -130.26 93.42 33.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.5 142.2 36.2 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.542 2.161 . . . . 0.0 112.436 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 93' ' ' LYS . . . -77.21 115.92 17.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.65 -21.6 27.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.6 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.44 47.47 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 111.512 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.433 ' NZ ' ' HA ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -89.39 -164.12 1.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.32 -17.95 42.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.557 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -129.01 112.42 18.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.675 0.274 . . . . 0.0 110.621 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 110.91 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.349 2.033 . . . . 0.0 112.106 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.0 t -80.01 105.76 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.05 130.95 40.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.2 m-85 -75.62 -178.06 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.023 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -106.69 -26.78 11.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.29 127.17 1.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.564 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 t -89.41 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -147.37 -77.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -115.46 155.89 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -69.24 -26.84 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.326 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.45 -35.33 70.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.3 -29.17 61.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.8 tp -72.63 -51.05 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.096 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.403 HG13 ' CZ ' ' A' ' 54' ' ' TYR . 4.2 tt -56.04 -45.62 80.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -57.03 -48.97 77.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.04 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -52.24 66.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.3 mt -48.57 -34.52 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.79 -30.43 62.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.822 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -80.54 -46.29 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -81.25 -33.95 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.993 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.93 23.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.646 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -26.73 37.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.778 0.323 . . . . 0.0 110.963 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 62' ' ' ARG . 18.3 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -119.86 129.64 54.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.75 143.36 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.65 97.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.0 160.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.82 -34.4 5.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -86.79 -7.43 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.55 -51.61 2.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -45.16 -51.29 10.65 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.56 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -48.14 -34.43 9.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -75.79 -59.2 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 pt -54.69 -47.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 22.9 m -62.0 -44.96 99.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.493 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.06 -12.41 61.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.369 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -72.13 103.15 3.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.33 -12.36 59.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 t -68.66 -28.81 67.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.45 159.4 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.798 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -133.88 141.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.53 142.38 51.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 tt -139.73 122.02 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -110.94 143.94 40.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -113.47 113.85 25.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 45.1 p90 -135.75 171.5 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.69 147.97 41.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.23 -43.83 2.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.494 2.129 . . . . 0.0 112.386 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -78.77 -3.39 44.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.477 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.2 t -50.21 -48.67 54.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.807 0.337 . . . . 0.0 111.312 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.3 -36.26 4.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.495 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -114.69 -4.59 12.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.686 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 22.5 m -104.08 -19.91 14.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -49.47 -28.05 4.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.045 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.41 44.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -30.72 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -61.77 -62.8 5.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 19.8 Cg_endo -60.69 -35.32 89.89 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 112.149 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -65.75 -28.98 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.802 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -79.23 -27.77 42.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -72.22 -31.46 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -75.49 -60.2 2.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.4 tp -58.82 -30.42 67.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.06 -41.94 79.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.68 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -57.15 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -29.93 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.98 -30.12 58.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -74.26 -31.31 62.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -59.71 -173.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.16 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 29.9 m-85 -119.48 37.08 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.1 -46.87 87.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.15 16.21 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -110.77 -53.55 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.89 152.27 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.21 126.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 mm -82.97 113.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.6 126.72 55.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.237 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 7.6 ptmt -109.42 134.56 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.734 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.6 158.2 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -100.98 146.3 27.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.502 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.09 47.65 1.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.283 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -137.68 20.61 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.92 -177.76 5.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.302 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.16 157.13 19.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.11 40.18 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.17 78.12 59.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 79.02 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.578 2.185 . . . . 0.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -127.44 88.93 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.089 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.16 118.95 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.431 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.54 160.06 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.467 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -44.34 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.773 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.96 141.3 13.39 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.952 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -46.44 -45.96 45.84 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.46 72.06 3.02 Favored 'Trans proline' 0 N--CA 1.424 -2.602 0 CA-C-N 119.444 0.837 . . . . 0.0 111.152 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -87.0 142.97 27.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.249 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 10.0 mt -126.58 111.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -103.45 127.29 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.38 136.52 48.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 27.8 m-85 -132.67 93.56 24.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.09 144.96 38.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 112.436 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.89 118.87 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -36.1 4.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.377 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -124.12 16.67 9.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -173.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.77 47.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.543 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -128.44 112.95 19.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.593 0.235 . . . . 0.0 110.681 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.23 118.56 5.67 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.377 2.051 . . . . 0.0 112.356 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.13 105.99 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 109.47 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.1 m-85 -64.43 -176.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.034 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -116.43 15.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.931 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.42 131.53 3.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.4 t -89.93 162.93 15.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -159.78 -67.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 m -131.34 156.55 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -68.41 -30.63 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.255 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -59.82 -34.19 72.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.63 -29.3 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -50.25 27.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tt -58.94 -45.89 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.32 -41.43 84.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.98 -46.93 76.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.05 -30.14 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.85 -30.6 40.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -80.03 -28.72 39.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.77 22.2 13.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.025 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -108.42 147.96 16.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -80.54 -31.97 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.846 0.355 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -118.56 144.24 46.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 143.36 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.12 97.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -103.37 161.01 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.649 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.32 -33.56 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.67 -7.59 58.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.73 -46.26 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 111.627 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -43.59 -47.93 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.674 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.03 -33.1 23.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.727 0.299 . . . . 0.0 111.769 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -59.24 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 pt -56.1 -46.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 22.4 m -65.08 -38.72 83.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.662 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.94 -9.67 58.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.431 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.49 104.32 2.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.27 -12.37 59.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.4 p -68.75 -44.27 74.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.773 0.32 . . . . 0.0 111.08 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -127.73 166.13 18.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.44 148.21 22.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.84 145.92 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 mt -130.5 98.17 4.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' CG1' ' CG1' ' A' ' 68' ' ' VAL . 8.1 tt -102.34 117.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -107.93 127.25 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -93.45 119.83 33.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CZ ' ' HD2' ' A' ' 67' ' ' LYS . 15.0 p90 -136.96 174.17 10.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 144.42 26.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.26 -45.03 2.04 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.422 2.082 . . . . 0.0 112.124 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -3.88 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.5 t -52.38 -49.97 63.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.45 -39.52 2.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.312 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -108.03 -2.29 19.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 18.1 m -108.93 -21.17 12.77 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.265 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -27.18 6.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.53 -22.98 43.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.22 -29.43 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.3 -62.71 4.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.483 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 19.3 Cg_endo -59.01 -26.56 82.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.571 2.181 . . . . 0.0 112.356 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.56 -28.94 46.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.1 OUTLIER -79.26 -30.03 42.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.161 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.98 -38.28 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.531 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.05 -53.66 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.8 -32.92 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.15 97.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.6 65.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.43 -57.63 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.79 69.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.45 -24.23 57.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.24 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -95.48 37.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 m -126.48 -173.73 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.789 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 37.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.964 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -138.68 30.02 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.28 72.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -94.05 16.28 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.232 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -113.29 -63.87 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.7 155.84 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.046 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.37 128.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.162 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 24.2 mm -83.96 118.59 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.93 132.42 46.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -102.32 160.65 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' A' ' 30' ' ' ILE . 14.4 p -167.98 158.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -105.58 146.14 30.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.553 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.48 44.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.21 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.6 20.76 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.93 -177.73 6.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 111.2 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.54 142.65 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.748 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 63.37 51.52 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.03 86.25 18.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.42 79.89 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -110.31 105.69 14.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 105.06 14.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -136.75 160.08 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.612 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -69.43 -57.89 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.24 16.77 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.562 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -43.19 -48.14 15.8 Favored Pre-proline 0 CA--C 1.484 -1.577 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -68.39 76.44 0.71 Allowed 'Trans proline' 0 N--CA 1.423 -2.652 0 CA-C-N 119.282 0.779 . . . . 0.0 110.785 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -97.39 139.88 32.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.24 -178.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.468 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 6.8 mt -115.5 120.02 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -105.34 112.86 26.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.998 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.431 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 49.1 m-85 -132.71 93.5 24.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.45 133.37 20.62 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.605 2.204 . . . . 0.0 112.454 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.27 117.32 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -35.72 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.32 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.38 17.61 11.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 0.0 111.302 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -170.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.84 41.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.97 112.45 18.62 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.71 0.29 . . . . 0.0 110.636 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.84 117.39 4.86 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.442 2.095 . . . . 0.0 112.29 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.3 t -80.15 105.81 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.64 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.3 112.16 23.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.468 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.3 m-85 -66.32 -178.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -109.42 -24.99 10.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.839 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.01 132.02 1.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.276 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.3 161.74 38.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 0.0 111.15 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.36 26.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.14 146.87 14.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.9 m -77.8 -30.85 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.171 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.1 -36.78 78.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.12 -30.07 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -53.54 19.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 tt -56.33 -45.83 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -58.03 -44.42 87.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -43.91 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 mt -56.35 -31.18 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.097 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.74 -30.4 51.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.99 -28.15 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 25.89 9.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.22 142.96 16.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -80.54 -28.17 37.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.357 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.799 0.333 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -135.59 138.1 42.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.33 143.46 11.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 17' ' ' TYR . 3.4 t -135.36 109.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.79 166.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.14 -38.65 3.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -86.63 -7.5 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.41 -52.64 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.588 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -47.09 -52.55 14.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.437 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.23 -35.7 27.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 111.795 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -75.87 -59.28 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.3 pt -54.7 -47.0 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 23.6 m -64.59 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.626 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.34 -9.74 58.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.407 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -69.78 103.45 2.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.28 -12.47 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.5 p -94.53 19.65 9.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.659 0.266 . . . . 0.0 111.337 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -173.49 143.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.78 140.16 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.43 137.6 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.37 104.66 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' A' ' 32' ' ' PHE . 5.2 tt -105.23 130.38 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 10.6 tm-20 -122.55 118.23 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CE2' HD12 ' A' ' 30' ' ' ILE . 41.4 m-85 -88.25 125.44 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.632 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 44' ' ' ALA . 33.4 p90 -143.26 164.46 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.2 148.5 57.4 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 -37.81 11.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.512 2.141 . . . . 0.0 112.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -3.47 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 41.0 t -52.46 -46.6 66.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.88 -37.07 3.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.671 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -116.07 -6.51 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 110.94 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 34.9 m -98.12 -20.38 17.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.951 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -49.48 -28.29 5.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.57 -26.8 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . . . -63.33 -62.76 4.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 18.3 Cg_endo -59.62 -31.6 94.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 0.0 112.225 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.11 -29.19 64.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.755 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.19 -25.85 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -71.37 -38.87 71.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -70.08 -50.63 39.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.31 -35.22 75.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.617 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.02 -39.12 96.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.324 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.57 75.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -52.81 14.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.737 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.06 -29.43 67.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.23 -27.02 32.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.38 32.56 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 -173.64 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.756 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 22.68 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -138.77 28.44 2.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.837 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -34.42 77.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -79.87 -29.39 39.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -56.38 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 21.2 t -116.46 148.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.48 122.1 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 mm -81.86 124.73 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 126.75 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 139.79 44.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.775 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.26 151.73 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.23 146.26 26.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.409 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.59 51.2 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.417 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -137.76 20.56 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.15 -178.08 2.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.936 0.398 . . . . 0.0 111.369 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.04 151.17 42.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.921 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.51 57.47 6.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.1 t -144.44 93.89 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.995 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.71 78.29 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.527 2.151 . . . . 0.0 112.228 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -108.03 82.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 112.89 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.04 160.21 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.537 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.77 -29.47 22.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 83' ' ' PRO . . . -132.29 141.63 13.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.763 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -42.17 -45.41 9.62 Favored Pre-proline 0 CA--C 1.488 -1.408 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 36.0 Cg_endo -66.38 75.9 0.36 Allowed 'Trans proline' 0 N--CA 1.427 -2.393 0 CA-C-N 119.759 0.95 . . . . 0.0 111.605 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.1 m -77.69 136.07 38.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.25 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 6.3 mt -132.7 107.99 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttm -104.04 121.31 42.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.68 133.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m-85 -132.75 93.35 24.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.802 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.85 145.45 19.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.574 2.182 . . . . 0.0 112.414 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.94 143.16 39.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.9 -37.34 3.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.349 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.27 13.24 7.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.622 0.249 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CE ' ' N ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -55.36 -173.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.44 -17.28 43.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -120.5 116.07 32.21 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.575 0.226 . . . . 0.0 110.622 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.5 114.95 3.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.366 2.044 . . . . 0.0 112.355 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.07 105.88 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.15 109.3 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.4 m-85 -68.55 -178.36 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.6 t -110.04 -28.9 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.36 143.51 4.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.35 -177.75 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.006 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 179.6 -35.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 m -148.64 148.6 30.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.1 -27.01 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.317 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -59.49 -35.19 73.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.967 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.34 -30.71 57.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.74 -51.75 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.1 tt -57.95 -45.96 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.223 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -58.1 -37.68 74.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.186 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -42.54 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.068 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.87 -28.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.95 -28.76 27.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -28.13 42.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 23.61 11.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.24 124.32 5.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.57 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -67.5 -32.38 73.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.4 m -126.47 144.33 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 143.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 t -143.91 97.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.26 162.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.77 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.79 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -86.65 -7.54 58.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -47.22 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 111.639 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -45.45 -48.59 13.8 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.518 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.98 -34.3 28.41 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.78 -59.31 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 21' ' ' VAL . 16.3 pt -55.26 -46.43 78.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 21.9 m -66.16 -38.27 81.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.631 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.74 -10.35 59.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.39 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.7 105.06 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.911 0.386 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -79.29 -12.45 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.371 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.0 p -112.13 23.17 14.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.642 0.258 . . . . 0.0 111.291 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -167.13 130.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.66 136.23 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.84 146.31 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.94 107.65 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 tt -107.76 115.94 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.18 122.12 47.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 35.3 m-85 -88.39 132.21 34.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -153.61 168.15 27.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.971 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.89 147.66 52.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 -45.13 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -75.53 -5.06 43.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.9 t -50.09 -49.15 52.49 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.813 0.339 . . . . 0.0 111.365 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.8 -35.49 4.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.662 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.23 -3.93 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.743 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.6 m -103.12 -20.24 14.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.47 -27.05 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.39 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.942 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -27.83 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -63.53 -62.89 4.67 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.507 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 19.1 Cg_endo -59.38 -39.99 71.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.431 2.087 . . . . 0.0 112.204 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.98 69.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.723 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.462 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.86 -24.59 35.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -34.83 60.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -76.48 -62.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 tp -59.68 -29.17 67.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.79 -46.16 69.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.09 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 111.196 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.21 -61.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.59 -29.46 64.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.5 -26.86 51.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -96.29 38.18 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -127.5 -176.2 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.94 -3.85 46.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -72.6 -42.74 64.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -93.87 16.18 14.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.31 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 34.9 mtt180 -120.5 -55.73 2.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 54' ' ' TYR . 8.9 p -128.96 132.48 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.74 136.06 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.373 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.462 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 12.5 mm -89.29 117.23 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.87 130.57 50.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.001 0.429 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 160.71 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -168.12 149.73 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.32 145.33 37.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . . . -79.54 51.62 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -137.67 15.13 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.61 -177.74 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -127.27 165.7 19.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.839 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.88 35.23 23.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.194 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 t -131.48 94.03 27.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.15 79.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.318 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.08 106.39 15.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -108.41 113.81 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.443 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.82 160.12 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.6 -45.21 54.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.85 141.57 14.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.337 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.5 OUTLIER -37.3 -45.09 1.59 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 20.6 Cg_exo -62.53 78.49 0.1 Allowed 'Trans proline' 0 N--CA 1.429 -2.315 0 CA-C-N 119.292 0.783 . . . . 0.0 111.442 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -81.21 142.11 33.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.381 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 1.8 mp -132.91 107.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.358 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -103.38 124.48 48.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -110.1 130.14 55.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.861 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.434 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 47.9 m-85 -132.81 93.56 23.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.33 147.98 23.44 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.577 2.185 . . . . 0.0 112.482 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.14 139.08 39.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.07 -38.04 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.173 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.59 57.98 1.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.0 0.429 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 -172.59 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.55 -10.04 45.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.9 pm0 -128.72 112.76 19.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.711 0.291 . . . . 0.0 110.704 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.28 111.14 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.443 2.095 . . . . 0.0 112.318 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 31.5 t -80.14 105.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 123.96 39.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.041 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.1 m-85 -69.35 -176.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.0 m -122.5 15.74 10.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.55 123.93 2.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.553 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.11 167.57 11.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.891 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.51 -66.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 m -128.6 154.37 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 m -65.53 -28.67 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.314 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -58.03 -38.81 76.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -72.89 -38.54 66.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.43 -58.81 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.43 -45.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.298 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -57.5 -30.82 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -31.15 40.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 mt -67.72 -28.89 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.65 -37.31 21.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -28.89 62.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.88 23.72 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.48 146.48 18.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -31.2 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 62' ' ' ARG . 5.5 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.24 -62.58 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.536 2.157 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.95 29.43 16.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.046 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.26 -27.88 1.83 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.546 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -22.31 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -76.16 -29.86 57.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.062 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 134.77 -43.03 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.319 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 98.9 Cg_exo -43.9 -62.26 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.632 2.221 . . . . 0.0 112.921 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.9 t -85.19 126.15 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 m -133.14 140.66 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.03 143.38 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.6 t -138.49 97.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.7 p -105.72 161.5 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.836 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.31 -36.57 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -86.64 -7.5 58.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.91 -46.31 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.708 0.289 . . . . 0.0 111.572 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -44.8 -48.77 10.95 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.593 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.487 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.47 -34.23 34.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.311 . . . . 0.0 111.655 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -59.2 2.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.9 pt -56.03 -47.31 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 29.0 m -63.25 -38.93 83.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.63 -8.95 58.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -72.51 105.35 4.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -79.3 -15.58 57.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.393 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 111.076 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -142.22 150.68 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.074 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -83.67 145.04 29.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.771 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 t -133.85 142.29 41.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.258 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mt -125.96 103.83 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.8 tt -100.61 116.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -106.53 129.9 54.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.143 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 28.7 m-85 -100.15 120.19 39.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.802 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.423 ' CE2' ' HB1' ' A' ' 44' ' ' ALA . 31.5 p90 -142.71 176.56 8.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.62 148.16 42.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.092 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.67 -45.14 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.541 2.161 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -78.15 -3.5 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 17.9 t -50.2 -46.45 54.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.65 -40.42 2.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.48 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -108.65 -3.12 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.4 m -108.48 -19.98 13.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -49.65 -28.19 5.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 110.958 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.5 -27.8 37.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -33.26 72.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.849 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB1' ' CE2' ' A' ' 33' ' ' TYR . . . -61.98 -62.35 5.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.378 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 20.4 Cg_endo -60.9 -34.28 91.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.518 2.145 . . . . 0.0 112.272 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -29.04 68.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -78.66 -28.53 45.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.77 -35.73 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.801 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.62 -55.45 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.0 tp -60.35 -28.68 68.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.21 -43.15 90.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.575 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.07 -30.01 62.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.118 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -55.43 5.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.413 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.81 -32.66 74.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.11 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.22 -28.91 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -173.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 43.36 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -138.68 33.63 2.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.42 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.48 16.16 16.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.82 -49.77 2.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.358 . . . . 0.0 110.916 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 54' ' ' TYR . 11.9 p -135.75 139.65 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.1 p -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.441 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 20.6 mm -85.86 106.23 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.977 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.77 134.39 52.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.51 153.16 30.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -168.16 150.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.36 146.13 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.592 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . . . -88.11 48.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 p -137.47 20.66 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.21 -177.72 6.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.55 160.06 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.82 41.7 31.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.0 p -128.78 82.8 67.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 80.3 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.713 2.275 . . . . 0.0 112.344 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -125.92 93.4 3.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.47 118.18 27.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.76 160.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.546 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -76.34 -48.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.215 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.73 141.2 14.32 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.638 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.518 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -42.75 -49.12 13.68 Favored Pre-proline 0 CA--C 1.485 -1.536 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -65.91 78.52 0.29 Allowed 'Trans proline' 0 N--CA 1.424 -2.572 0 CA-C-N 119.124 0.723 . . . . 0.0 111.176 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -101.1 143.06 31.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.089 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.46 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 3.2 mp -127.8 119.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -103.42 115.34 30.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.3 131.24 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.0 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.439 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.8 m-85 -132.7 93.48 24.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 147.98 47.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.427 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.13 115.85 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.1 -36.87 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.291 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.98 30.0 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.012 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -172.18 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.53 -15.22 46.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.591 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.7 pm0 -128.85 112.67 18.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.771 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.95 108.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.443 2.095 . . . . 0.0 112.157 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.14 105.88 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.67 126.9 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -73.26 -177.14 2.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 p -109.58 -26.96 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.7 133.52 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 169.83 9.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -175.55 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 19.8 m -149.25 148.38 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.01 -27.91 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.11 -35.82 72.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.938 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.57 -29.23 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.7 tp -70.63 -51.5 27.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.3 tt -57.39 -45.94 85.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -58.54 -50.9 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.003 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.07 -52.23 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 17.7 mt -50.83 -30.86 9.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.82 -27.94 58.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.5 -38.0 22.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -92.04 -44.44 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.113 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.76 136.47 19.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.604 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -32.6 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.98 -31.19 72.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.13 29.63 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -137.22 151.98 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.161 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.12 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.19 -45.92 36.08 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.564 2.176 . . . . 0.0 112.311 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 pp -108.35 107.73 18.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.16 87.41 1.78 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -77.82 -39.26 44.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.06 20.08 17.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.44 164.58 12.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -51.87 -26.62 24.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.578 2.186 . . . . 0.0 112.376 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.82 147.8 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.9 m -100.28 144.38 29.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.72 143.52 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG11 ' CD1' ' A' ' 30' ' ' ILE . 1.5 t -118.21 100.87 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.04 163.85 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.33 -39.5 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.317 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.65 -7.69 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.656 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -44.64 5.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 0.0 111.356 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -52.28 -49.91 63.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.357 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.9 -34.68 29.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.728 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -75.28 -59.32 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.3 pt -56.06 -46.94 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 88' ' ' TYR . 23.3 m -64.69 -37.23 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.66 -11.11 59.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.436 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.75 108.85 8.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -79.33 -12.39 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -91.69 11.27 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.539 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.49 134.43 4.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.75 139.87 32.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.656 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.9 t -133.85 141.32 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mt -124.72 103.31 8.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.692 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 32' ' ' PHE . 6.9 tt -101.67 127.72 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 14.8 tm-20 -117.64 124.3 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.22 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 30' ' ' ILE . 34.0 m-85 -95.18 118.74 32.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.833 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -139.76 174.71 10.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.004 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.77 145.36 30.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.11 -46.48 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.476 2.118 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -78.02 -3.44 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 19.5 t -50.58 -47.19 58.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.784 0.326 . . . . 0.0 111.318 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.22 -39.84 2.73 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.574 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -110.14 -1.93 17.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.835 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 20.8 m -107.19 -22.86 12.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.45 -27.22 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.37 -28.75 41.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.93 70.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -62.89 -61.99 6.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 17.8 Cg_endo -60.12 -36.68 88.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.428 2.085 . . . . 0.0 112.399 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -29.09 69.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.52 -26.4 38.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.34 -35.62 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.659 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.68 -53.76 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.4 tp -60.58 -27.84 68.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.69 52.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.97 65.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.266 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.35 -63.6 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -29.42 63.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.064 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.69 -34.84 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -29.13 61.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.0 -173.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -130.98 30.18 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.91 -30.28 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.55 -29.88 33.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -75.15 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.32 139.68 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.58 131.02 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 20.3 mm -81.77 120.56 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.3 126.65 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -106.13 155.8 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.688 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 p -168.12 155.36 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.11 146.22 25.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.57 46.04 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.278 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.57 20.6 2.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.52 -177.71 5.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.91 158.44 15.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.827 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t0 51.11 40.59 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.2 p -129.36 100.13 20.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.961 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.65 -73.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.637 2.225 . . . . 0.0 112.134 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 44.1 93.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.658 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.09 101.14 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.534 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.85 160.28 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.614 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -43.58 12.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.451 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.57 141.14 16.75 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.945 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -47.3 -46.84 57.68 Favored Pre-proline 0 CA--C 1.485 -1.522 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.22 74.07 2.56 Favored 'Trans proline' 0 N--CA 1.422 -2.699 0 CA-C-N 119.422 0.829 . . . . 0.0 110.866 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -98.88 121.2 40.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.203 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 3.0 mp -102.47 116.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -103.34 122.23 44.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.8 133.5 50.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.091 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 40.8 m-85 -129.76 93.38 34.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.674 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.21 140.64 41.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.841 2.361 . . . . 0.0 112.271 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.01 115.85 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.62 -34.31 5.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.64 12.29 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.643 0.259 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -168.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.63 -17.78 42.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.421 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -128.77 130.58 23.48 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.563 0.22 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.94 112.71 3.48 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.393 2.062 . . . . 0.0 112.439 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -80.01 105.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.948 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 119.3 30.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.453 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -66.33 -175.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -26.09 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.728 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.88 127.29 1.02 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.86 145.15 27.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -56.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 m -134.63 155.97 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -73.87 -27.02 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.331 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.23 -35.98 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.042 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.64 -31.03 57.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.68 -51.38 50.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 tt -58.98 -45.96 91.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.206 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt -58.01 -33.89 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.0 56.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.5 mt -56.36 -29.15 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.6 -37.05 25.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -72.17 -29.58 64.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.22 23.07 12.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.05 144.0 15.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.56 -29.75 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 111.038 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.29 17.21 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.407 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.1 29.55 5.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.88 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.32 119.94 39.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.034 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.24 172.69 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.577 2.185 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.87 -36.62 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 -30.84 9.37 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -61.26 -31.14 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -105.16 -29.86 10.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -141.5 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.18 98.09 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.875 2.383 . . . . 0.0 111.977 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.8 t -144.58 141.51 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.4 m -116.4 121.65 42.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.25 143.36 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG11 ' CD1' ' A' ' 30' ' ' ILE . 0.9 OUTLIER -129.57 97.81 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.014 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.6 t -99.4 162.7 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.696 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.04 -36.16 49.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.776 0.322 . . . . 0.0 111.456 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -9.19 56.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -41.13 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.556 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -39.84 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -38.81 73.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.92 -43.92 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 21' ' ' VAL . 20.9 pt -66.8 -45.44 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 19.4 m -70.03 -36.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.3 mt -76.83 -14.74 59.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 110.15 1.04 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.24 -12.29 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.405 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -106.62 14.91 26.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 141.85 19.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.69 127.5 44.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.692 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.91 147.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 111.438 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.84 114.73 16.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.764 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' A' ' 32' ' ' PHE . 8.3 tt -105.03 118.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.203 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.9 tm-20 -109.31 131.54 54.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CE2' HD13 ' A' ' 30' ' ' ILE . 28.2 m-85 -103.36 126.1 50.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 111.364 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 44' ' ' ALA . 32.8 p90 -152.84 171.17 18.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.59 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 155.63 59.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.41 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 27.2 Cg_endo -63.35 -56.88 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.55 2.167 . . . . 0.0 112.103 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.41 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p90 -61.91 -18.46 60.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.701 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 t -42.87 -39.97 2.74 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.563 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.72 -64.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.27 -69.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 7.3 p -67.15 -13.64 62.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.446 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -51.3 -27.38 9.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.896 0.379 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.36 63.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -22.33 64.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . . . -66.73 -63.13 3.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.549 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.412 ' HA ' ' HG2' ' A' ' 48' ' ' GLU . 12.0 Cg_endo -56.24 -35.7 95.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.09 -25.8 63.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -77.42 -29.03 52.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.234 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 49' ' ' GLU . 1.6 pt-20 -77.29 -31.15 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.33 -51.36 37.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.5 tp -70.25 -30.52 67.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.5 -50.66 63.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.313 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.82 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.946 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -60.34 3.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.43 ' CD1' ' CG1' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.55 -27.6 58.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.15 -33.06 33.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -77.18 -30.71 55.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 m -58.91 176.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.73 -10.84 60.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -95.96 38.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -30.35 65.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -105.71 16.22 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -116.48 -41.24 3.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.43 ' CG1' ' CD1' ' A' ' 54' ' ' TYR . 14.3 p -126.55 150.23 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.88 122.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 111.28 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 15.1 mm -87.86 110.41 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.799 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.43 128.44 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 144.31 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.561 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.38 156.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.256 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -94.79 146.23 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.59 51.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.41 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -137.75 19.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.923 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -177.78 6.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 111.407 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.39 153.15 34.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.834 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 58.02 47.0 15.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 7.5 p -133.18 89.57 32.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.549 2.166 . . . . 0.0 112.077 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -112.22 84.91 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.06 109.72 20.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.413 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.77 160.17 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.597 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.29 -43.3 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.31 141.34 16.5 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.896 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -45.09 -45.96 28.97 Favored Pre-proline 0 CA--C 1.487 -1.472 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 37.3 Cg_endo -67.75 80.35 0.48 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 CA-C-N 119.548 0.874 . . . . 0.0 111.435 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -86.09 137.28 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.134 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 28.6 mt -130.93 109.53 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.774 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -103.38 119.36 38.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.06 128.1 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 11.3 m-85 -132.74 93.4 24.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.43 154.17 21.17 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.595 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.16 117.66 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.05 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.98 -38.0 3.35 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.46 11.26 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.658 0.266 . . . . 0.0 111.486 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -173.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.2 -17.84 43.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.367 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.82 121.93 21.21 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.519 0.2 . . . . 0.0 110.636 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 88' ' ' TYR . 55.7 Cg_endo -70.17 107.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.324 2.016 . . . . 0.0 112.176 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.1 105.83 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.7 p -93.09 128.9 39.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.4 m-85 -69.54 176.82 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.6 -24.88 12.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.82 117.04 0.62 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.7 p -76.65 145.86 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.921 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -148.19 -72.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.8 m -132.35 165.18 24.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.82 -29.06 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.43 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -57.06 -31.36 65.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.951 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.04 -30.28 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tp -72.02 -49.99 32.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.42 HG13 ' CE2' ' A' ' 54' ' ' TYR . 4.5 tt -57.22 -46.38 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -63.13 -37.36 86.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.66 51.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.11 -29.83 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.42 63.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.59 -26.43 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -116.14 23.0 12.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.148 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.53 138.8 10.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.519 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -6.29 58.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.584 0.231 . . . . 0.0 111.366 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.35 22.06 5.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.629 0.252 . . . . 0.0 111.323 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -22.97 22.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.049 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 61.83 90.35 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.114 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.93 155.55 65.1 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.599 2.199 . . . . 0.0 112.292 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -31.14 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.97 89.48 1.54 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -82.65 -59.68 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -76.49 -29.82 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.85 65.47 2.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.34 -27.84 40.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.582 2.188 . . . . 0.0 112.253 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -91.65 130.32 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.9 m -111.01 127.65 55.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.66 143.39 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.25 97.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.5 t -105.26 167.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.54 -41.23 60.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.552 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -86.73 -7.65 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.934 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.54 -52.67 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.492 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -49.23 -55.7 11.72 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.41 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -46.2 -34.95 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -73.66 -59.35 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 pt -55.9 -49.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.852 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 33.1 m -56.53 -43.05 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.22 -12.63 60.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.413 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -58.75 96.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.862 0.363 . . . . 0.0 110.804 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.1 -19.25 64.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.371 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.74 27.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.645 0.26 . . . . 0.0 111.279 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -176.94 145.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.585 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.8 t -133.85 146.44 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.871 0.367 . . . . 0.0 111.467 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.9 mt -136.67 101.21 4.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.72 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 tt -102.36 119.11 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.201 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.19 131.33 54.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -101.05 123.78 45.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.801 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -146.73 174.47 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.76 147.68 39.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.31 -42.11 4.18 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.622 2.215 . . . . 0.0 112.333 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -78.21 -3.44 42.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.392 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.2 t -51.43 -49.58 61.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -39.73 2.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.473 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -108.79 -3.2 17.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.623 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.4 m -107.22 -20.78 13.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -49.55 -27.88 4.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.78 41.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.823 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.97 -31.71 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.78 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.42 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -60.3 -62.32 6.16 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.447 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 19.7 Cg_endo -60.8 -37.32 79.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.466 2.111 . . . . 0.0 112.314 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -64.04 -29.2 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.78 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.51 -24.34 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.948 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -71.06 -35.63 72.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -52.99 9.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.36 -29.12 68.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.21 -44.91 58.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.03 65.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.59 -57.56 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -45.9 83.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.013 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.35 71.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.38 38.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.9 m -129.22 177.78 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.42 -21.31 64.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -95.29 38.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -74.8 -39.81 61.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.07 16.11 15.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.88 -51.56 2.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.806 0.336 . . . . 0.0 110.797 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.94 149.72 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.31 120.97 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.9 mm -83.74 106.18 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.17 127.84 55.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 140.51 46.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.657 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 p -157.11 153.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.31 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -95.5 146.2 24.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.3 55.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 111.345 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -137.65 20.52 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.3 -177.77 5.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 111.339 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.52 154.66 30.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.09 62.08 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.057 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.5 t -154.47 104.03 2.37 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.035 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 78.59 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.491 2.127 . . . . 0.0 112.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -104.38 74.2 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -93.54 98.51 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.435 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.19 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.726 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -48.5 16.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.087 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.13 16.7 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.628 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.8 OUTLIER -45.94 -44.91 36.86 Favored Pre-proline 0 CA--C 1.486 -1.49 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 7.6 Cg_exo -66.6 80.97 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.57 0 CA-C-N 119.239 0.764 . . . . 0.0 111.327 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -102.95 142.92 33.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.211 -178.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.417 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 4.1 mp -126.36 117.95 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.802 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -103.28 112.11 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.62 131.48 43.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.174 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 34.4 m-85 -132.87 93.23 24.05 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.2 145.19 17.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.672 2.248 . . . . 0.0 112.664 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.78 124.04 27.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.64 -23.9 31.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.53 29.65 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -165.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.24 -18.09 42.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.23 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.7 pm0 -129.19 119.96 19.89 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.449 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.35 111.26 2.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.243 1.962 . . . . 0.0 112.058 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.01 105.84 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.38 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.4 p -96.55 123.18 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.6 m-85 -74.14 178.75 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -118.41 15.83 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.08 123.0 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 t -100.96 155.29 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.925 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -139.72 -47.05 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.9 m -143.87 152.26 40.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.35 -27.05 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.4 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -57.05 -34.2 68.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.097 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.53 -30.68 59.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.992 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -70.7 -53.74 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tt -55.81 -45.49 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -58.11 -39.83 79.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.011 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.4 -48.57 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.18 -23.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.289 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.43 33.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.56 -29.2 19.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.52 -30.99 14.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.22 136.14 20.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.51 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.43 -7.75 57.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.579 0.228 . . . . 0.0 111.355 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -93.42 22.13 5.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 7.57 26.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.458 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 61.63 115.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 111.168 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.064 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.46 -49.23 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.531 2.154 . . . . 0.0 112.257 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 57.37 173.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.67 -31.09 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -72.33 -13.08 61.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.641 0.258 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -93.77 20.17 7.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.659 0.266 . . . . 0.0 111.263 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.407 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -49.69 -60.87 6.06 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.81 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 7' ' ' GLY . 24.7 Cg_endo -61.95 -27.2 79.54 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.265 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.88 143.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -136.94 142.92 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.36 143.43 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' CG1' ' HB2' ' A' ' 17' ' ' TYR . 15.7 t -135.6 97.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -105.2 161.66 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.776 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.9 -35.59 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -86.61 -7.48 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.29 -47.6 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.622 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -44.08 -49.06 8.98 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.473 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.11 -32.08 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -79.37 -59.39 2.78 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.3 pt -54.97 -38.36 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 29.1 m -74.52 -37.99 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.698 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.06 -6.39 52.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.546 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.42 105.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.927 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -79.39 -12.39 59.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.418 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 28.05 8.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.205 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.88 131.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 137.41 33.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.82 147.45 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.397 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.45 104.92 6.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.693 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 32' ' ' PHE . 9.1 tt -100.65 129.29 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.55 126.37 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CE2' HD12 ' A' ' 30' ' ' ILE . 38.6 m-85 -97.1 117.91 32.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CE1' ' HD2' ' A' ' 67' ' ' LYS . 11.9 p90 -134.91 174.33 10.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.71 145.76 32.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -46.67 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.536 2.158 . . . . 0.0 112.329 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -78.91 -3.41 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 29.6 t -48.63 -46.78 40.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.306 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.6 -36.92 3.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.595 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -114.83 -2.76 12.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.791 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.6 m -105.06 -22.3 13.13 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.063 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -49.52 -27.99 4.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.045 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.51 -28.09 37.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.77 -31.6 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.778 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.409 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -62.62 -62.68 5.27 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 18.5 Cg_endo -60.19 -36.55 88.0 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.436 2.09 . . . . 0.0 112.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 -29.23 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.24 -24.25 37.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.56 -33.27 66.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.619 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.71 -54.15 7.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.2 tp -60.58 -31.52 70.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.733 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.46 -42.47 81.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.35 63.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 -59.58 2.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -39.53 78.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.61 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 t -113.1 -173.85 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.52 -18.22 58.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.271 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.13 35.8 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.989 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -29.24 70.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.157 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -103.14 16.25 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.373 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -116.9 -74.64 0.6 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.4 t -97.32 141.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.41 128.26 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.448 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 23.4 mm -83.47 111.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.51 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.169 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -106.8 151.95 24.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 p -168.14 156.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -103.62 146.13 29.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.23 51.69 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.864 0.364 . . . . 0.0 111.21 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 p -137.63 20.61 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.4 -177.74 4.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 111.201 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 164.05 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.66 31.58 17.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.991 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.3 p -132.13 101.95 14.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.82 -68.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.463 2.109 . . . . 0.0 112.206 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 42.12 83.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.715 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.12 102.84 15.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.43 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.22 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.581 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.44 -46.05 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.38 141.24 16.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.951 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -47.44 -46.23 58.07 Favored Pre-proline 0 CA--C 1.485 -1.521 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.18 71.59 3.59 Favored 'Trans proline' 0 N--CA 1.423 -2.672 0 CA-C-N 119.469 0.846 . . . . 0.0 110.973 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.43 ' OG1' ' CG2' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -92.13 142.87 27.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.181 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 7.9 mt -123.21 116.53 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.97 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -103.54 116.85 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.08 130.87 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.174 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.464 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 3.5 m-85 -132.82 93.36 23.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.708 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.21 142.96 19.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.653 2.235 . . . . 0.0 112.478 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.93 131.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.98 -36.56 3.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.265 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.65 2.78 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.69 -17.78 41.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.489 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.76 118.94 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.597 0.237 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -62.33 111.01 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.36 2.04 . . . . 0.0 112.267 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.8 t -80.13 105.78 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.69 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.16 124.09 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.02 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.444 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 2.8 m-85 -81.08 -176.86 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.028 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.4 m -102.54 -25.5 13.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.685 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.07 140.24 2.88 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 t -95.21 145.11 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.963 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -145.22 -66.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -121.22 160.3 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.3 m -76.95 -28.58 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.284 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.68 -33.43 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.57 -35.28 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.71 -46.69 52.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -57.16 -38.91 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.58 -49.81 71.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.47 -46.98 85.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 18.8 mt -51.46 -41.03 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.176 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.06 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -75.05 -51.6 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.68 -43.9 58.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 138.57 49.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.58 -38.7 28.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -57.5 -29.58 64.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.14 -22.99 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.01 -170.1 1.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.09 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.9 144.26 52.7 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.589 2.193 . . . . 0.0 112.376 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.01 -51.74 62.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.33 125.5 2.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.6 p -68.06 -30.36 69.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -97.79 20.13 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.38 -118.72 4.39 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.461 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.26 -56.69 2.65 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.419 2.079 . . . . 0.0 112.304 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.23 126.4 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.1 m -129.42 135.73 49.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.2 139.15 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.984 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' CG1' ' HB2' ' A' ' 17' ' ' TYR . 7.1 t -123.99 97.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.54 166.46 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.679 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.15 -39.05 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.82 -9.99 54.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.76 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -47.19 4.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -46.97 -50.56 18.86 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.395 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.67 -32.84 31.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.25 -59.25 2.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.948 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 pt -56.37 -47.62 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.457 ' CG1' ' CD2' ' A' ' 88' ' ' TYR . 28.0 m -62.74 -38.27 81.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.652 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 71.2 mt -77.32 -10.47 59.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.51 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.88 104.31 0.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.35 -20.08 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.379 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -95.48 22.12 7.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.303 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -177.03 137.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.381 . . . . 0.0 111.048 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -83.78 140.01 32.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.0 t -133.79 141.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 111.462 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.25 118.94 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.711 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 tt -111.66 123.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.159 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -111.84 132.46 54.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -101.98 129.5 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.11 173.36 15.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.7 145.93 32.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.42 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 44.5 Cg_endo -68.59 -42.08 5.43 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.45 2.1 . . . . 0.0 112.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 25.8 p90 -79.44 -3.47 46.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.7 t -53.8 -48.57 69.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.27 -42.2 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.415 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.68 -1.93 25.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.715 0.293 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.3 m -110.06 -22.48 11.79 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -27.34 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.246 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.47 -29.28 52.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.027 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.3 -30.9 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -59.6 -62.0 6.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 27.4 Cg_endo -62.45 -36.78 63.98 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -63.9 -29.16 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.428 ' CE2' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -82.16 -25.4 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.35 -36.31 66.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -73.52 -56.79 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.39 -28.93 68.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.809 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.66 -50.62 53.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.09 -30.14 67.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mt -70.63 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.403 ' CZ ' HG13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -57.84 -31.04 66.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.02 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.93 72.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.33 35.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -118.21 -176.35 3.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.35 -28.67 68.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -96.63 38.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -70.94 -37.47 72.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.18 16.25 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HB3' ' CG ' ' A' ' 118' ' ' TYR . 5.9 mtt180 -110.77 -31.72 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.08 155.72 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.28 123.18 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.259 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 65' ' ' ILE . 19.8 mm -84.55 106.16 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.74 126.62 53.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.53 150.4 27.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -164.28 154.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.219 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -95.23 146.15 24.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.47 56.83 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 111.252 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -137.63 20.63 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.0 -177.72 6.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.254 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -116.65 157.2 25.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.52 48.49 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.82 93.19 28.26 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.006 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 79.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.592 2.195 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -114.02 117.61 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -119.62 107.44 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.417 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.8 160.06 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.26 -36.55 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.28 141.31 12.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.509 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -40.69 -44.28 4.84 Favored Pre-proline 0 CA--C 1.487 -1.455 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 15.8 Cg_exo -63.98 81.21 0.15 Allowed 'Trans proline' 0 N--CA 1.427 -2.399 0 CA-C-N 119.318 0.792 . . . . 0.0 111.382 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -91.17 142.32 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.388 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.407 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 6.9 mt -132.87 107.81 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -103.86 129.99 51.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.915 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.62 132.06 55.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 39.2 m-85 -130.26 93.42 33.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.5 142.2 36.2 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.542 2.161 . . . . 0.0 112.436 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 93' ' ' LYS . . . -77.21 115.92 17.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.65 -21.6 27.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.6 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.44 47.47 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 111.512 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.433 ' NZ ' ' HA ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -89.39 -164.12 1.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.32 -17.95 42.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.557 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -129.01 112.42 18.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.675 0.274 . . . . 0.0 110.621 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 110.91 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.349 2.033 . . . . 0.0 112.106 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.0 t -80.01 105.76 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.05 130.95 40.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.407 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.2 m-85 -75.62 -178.06 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.023 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -106.69 -26.78 11.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.29 127.17 1.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.564 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 4.6 t -89.41 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.892 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -147.37 -77.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.6 m -115.46 155.89 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -69.24 -26.84 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.326 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -57.45 -35.33 70.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.3 -29.17 61.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.8 tp -72.63 -51.05 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.096 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.403 HG13 ' CZ ' ' A' ' 54' ' ' TYR . 4.2 tt -56.04 -45.62 80.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -57.03 -48.97 77.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.04 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -52.24 66.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.3 mt -48.57 -34.52 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.79 -30.43 62.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.822 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -80.54 -46.29 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -81.25 -33.95 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.993 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.93 23.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.646 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -26.73 37.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.778 0.323 . . . . 0.0 110.963 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.425 ' CG ' ' HB3' ' A' ' 62' ' ' ARG . 18.3 m-85 -54.58 -29.09 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -92.61 -22.97 19.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.09 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.42 100.57 6.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.085 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.22 132.77 45.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mp -130.7 -59.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.32 -135.65 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.506 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -65.18 -46.64 79.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -65.26 -29.52 70.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.56 119.96 18.93 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.67 -51.28 11.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.426 2.084 . . . . 0.0 112.316 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.0 m -66.49 121.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -119.86 129.64 54.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.75 143.36 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.65 97.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.0 160.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.82 -34.4 5.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -86.79 -7.43 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.55 -51.61 2.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -45.16 -51.29 10.65 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.56 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.493 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -48.14 -34.43 9.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -75.79 -59.2 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.7 pt -54.69 -47.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 22.9 m -62.0 -44.96 99.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.493 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.8 mt -69.06 -12.41 61.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.369 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -72.13 103.15 3.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -79.33 -12.36 59.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.461 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.3 t -68.66 -28.81 67.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.45 159.4 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.061 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.798 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -133.88 141.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.53 142.38 51.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.4 tt -139.73 122.02 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -110.94 143.94 40.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -113.47 113.85 25.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 45.1 p90 -135.75 171.5 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.69 147.97 41.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.23 -43.83 2.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.494 2.129 . . . . 0.0 112.386 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -78.77 -3.39 44.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.477 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.2 t -50.21 -48.67 54.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.807 0.337 . . . . 0.0 111.312 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.3 -36.26 4.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.495 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -114.69 -4.59 12.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.686 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 22.5 m -104.08 -19.91 14.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -49.47 -28.05 4.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.045 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.41 44.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -30.72 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -61.77 -62.8 5.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 19.8 Cg_endo -60.69 -35.32 89.89 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 112.149 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -65.75 -28.98 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.802 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -79.23 -27.77 42.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -72.22 -31.46 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -75.49 -60.2 2.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.4 tp -58.82 -30.42 67.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.06 -41.94 79.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.68 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -57.15 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -29.93 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.98 -30.12 58.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -74.26 -31.31 62.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -59.71 -173.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.16 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 29.9 m-85 -119.48 37.08 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.1 -46.87 87.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.15 16.21 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -110.77 -53.55 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.89 152.27 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.21 126.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.0 mm -82.97 113.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.6 126.72 55.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.237 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 7.6 ptmt -109.42 134.56 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.734 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.6 158.2 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.271 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -100.98 146.3 27.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.502 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.09 47.65 1.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.283 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -137.68 20.61 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.92 -177.76 5.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.302 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.16 157.13 19.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.11 40.18 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.17 78.12 59.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 79.02 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.578 2.185 . . . . 0.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -127.44 88.93 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.089 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.16 118.95 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.431 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.54 160.06 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.467 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -44.34 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.773 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.96 141.3 13.39 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.952 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -46.44 -45.96 45.84 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.46 72.06 3.02 Favored 'Trans proline' 0 N--CA 1.424 -2.602 0 CA-C-N 119.444 0.837 . . . . 0.0 111.152 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER -87.0 142.97 27.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.249 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.464 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 10.0 mt -126.58 111.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -103.45 127.29 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.38 136.52 48.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 27.8 m-85 -132.67 93.56 24.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.09 144.96 38.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 112.436 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.89 118.87 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -36.1 4.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.377 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -124.12 16.67 9.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -173.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.77 47.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.543 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -128.44 112.95 19.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.593 0.235 . . . . 0.0 110.681 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.23 118.56 5.67 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.377 2.051 . . . . 0.0 112.356 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.13 105.99 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 109.47 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.464 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.1 m-85 -64.43 -176.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.034 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -116.43 15.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.931 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.42 131.53 3.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.4 t -89.93 162.93 15.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -159.78 -67.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 m -131.34 156.55 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.5 m -68.41 -30.63 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.255 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -59.82 -34.19 72.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.63 -29.3 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.45 -50.25 27.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.8 tt -58.94 -45.89 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -58.32 -41.43 84.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.98 -46.93 76.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.05 -30.14 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.85 -30.6 40.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -80.03 -28.72 39.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.77 22.2 13.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.025 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -108.42 147.96 16.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -80.54 -31.97 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -76.47 -32.36 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -92.99 -23.05 18.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.38 39.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.123 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.114 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.31 -177.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.194 . . . . 0.0 112.255 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.5 tp -94.34 -50.71 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.21 -43.39 1.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 m -76.41 -31.25 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.907 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -95.24 -29.77 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.86 91.05 0.78 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.55 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.91 -25.34 28.03 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.536 2.157 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.6 m -57.36 144.6 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.19 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -118.56 144.24 46.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 143.36 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -144.12 97.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.255 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -103.37 161.01 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.649 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.32 -33.56 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.67 -7.59 58.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.73 -46.26 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 111.627 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -43.59 -47.93 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.674 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.03 -33.1 23.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.727 0.299 . . . . 0.0 111.769 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -59.24 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 pt -56.1 -46.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 22.4 m -65.08 -38.72 83.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.662 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.94 -9.67 58.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.431 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.49 104.32 2.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.27 -12.37 59.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.4 p -68.75 -44.27 74.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.773 0.32 . . . . 0.0 111.08 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -127.73 166.13 18.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.068 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.44 148.21 22.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.754 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.84 145.92 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.6 mt -130.5 98.17 4.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' CG1' ' CG1' ' A' ' 68' ' ' VAL . 8.1 tt -102.34 117.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -107.93 127.25 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -93.45 119.83 33.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CZ ' ' HD2' ' A' ' 67' ' ' LYS . 15.0 p90 -136.96 174.17 10.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 144.42 26.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.26 -45.03 2.04 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.422 2.082 . . . . 0.0 112.124 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -3.88 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.5 t -52.38 -49.97 63.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.45 -39.52 2.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.312 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -108.03 -2.29 19.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 18.1 m -108.93 -21.17 12.77 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.265 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -27.18 6.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.53 -22.98 43.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.22 -29.43 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 45' ' ' PRO . . . -65.3 -62.71 4.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.483 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 44' ' ' ALA . 19.3 Cg_endo -59.01 -26.56 82.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.571 2.181 . . . . 0.0 112.356 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.56 -28.94 46.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.445 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.1 OUTLIER -79.26 -30.03 42.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.161 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -74.98 -38.28 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.531 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.05 -53.66 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.0 tp -64.8 -32.92 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.655 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.15 97.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.6 65.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.43 -57.63 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.79 69.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.45 -24.23 57.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.24 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -95.48 37.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 m -126.48 -173.73 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.789 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 37.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.964 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -138.68 30.02 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.28 72.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -94.05 16.28 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.232 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -113.29 -63.87 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.7 155.84 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.046 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.8 p -141.37 128.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.162 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.445 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 24.2 mm -83.96 118.59 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.93 132.42 46.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.361 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -102.32 160.65 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' A' ' 30' ' ' ILE . 14.4 p -167.98 158.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -105.58 146.14 30.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.553 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.48 44.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.21 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.6 20.76 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.93 -177.73 6.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 111.2 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.54 142.65 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.748 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 63.37 51.52 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.03 86.25 18.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.42 79.89 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -110.31 105.69 14.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 105.06 14.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -136.75 160.08 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.612 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -69.43 -57.89 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.24 16.77 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.562 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -43.19 -48.14 15.8 Favored Pre-proline 0 CA--C 1.484 -1.577 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -68.39 76.44 0.71 Allowed 'Trans proline' 0 N--CA 1.423 -2.652 0 CA-C-N 119.282 0.779 . . . . 0.0 110.785 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -97.39 139.88 32.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.24 -178.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.468 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 6.8 mt -115.5 120.02 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -105.34 112.86 26.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.998 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.431 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 49.1 m-85 -132.71 93.5 24.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.45 133.37 20.62 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.605 2.204 . . . . 0.0 112.454 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.27 117.32 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -35.72 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.32 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.38 17.61 11.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 0.0 111.302 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -170.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.84 41.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.97 112.45 18.62 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.71 0.29 . . . . 0.0 110.636 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.84 117.39 4.86 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.442 2.095 . . . . 0.0 112.29 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.3 t -80.15 105.81 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.64 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.3 112.16 23.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.468 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.3 m-85 -66.32 -178.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -109.42 -24.99 10.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.839 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.01 132.02 1.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.276 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.3 161.74 38.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 0.0 111.15 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.36 26.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.14 146.87 14.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.9 m -77.8 -30.85 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.171 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.1 -36.78 78.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.12 -30.07 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.27 -53.54 19.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.0 tt -56.33 -45.83 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -58.03 -44.42 87.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -43.91 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 mt -56.35 -31.18 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.097 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.74 -30.4 51.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.99 -28.15 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 25.89 9.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.22 142.96 16.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -80.54 -28.17 37.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -93.3 19.79 7.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.357 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 28.4 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.754 0.311 . . . . 0.0 111.023 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 57.31 92.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.27 -42.33 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mp 60.53 31.05 20.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 23.01 9.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.562 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 t -86.51 -50.67 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -100.02 20.12 15.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.75 -61.7 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.588 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.15 -30.14 20.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.578 2.185 . . . . 0.0 112.343 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.8 t -66.72 139.05 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -135.59 138.1 42.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.33 143.46 11.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 17' ' ' TYR . 3.4 t -135.36 109.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p -124.79 166.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.14 -38.65 3.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -86.63 -7.5 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.41 -52.64 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.588 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -47.09 -52.55 14.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.437 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.23 -35.7 27.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 111.795 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -75.87 -59.28 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.3 pt -54.7 -47.0 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HB ' ' CG ' ' A' ' 88' ' ' TYR . 23.6 m -64.59 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.626 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.34 -9.74 58.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.407 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -69.78 103.45 2.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -79.28 -12.47 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.5 p -94.53 19.65 9.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.659 0.266 . . . . 0.0 111.337 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -173.49 143.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.78 140.16 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.2 t -133.43 137.6 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.37 104.66 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 HD12 ' CE2' ' A' ' 32' ' ' PHE . 5.2 tt -105.23 130.38 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 10.6 tm-20 -122.55 118.23 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CE2' HD12 ' A' ' 30' ' ' ILE . 41.4 m-85 -88.25 125.44 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.632 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 44' ' ' ALA . 33.4 p90 -143.26 164.46 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.2 148.5 57.4 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 -37.81 11.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.512 2.141 . . . . 0.0 112.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -3.47 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 40' ' ' CYS . 41.0 t -52.46 -46.6 66.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.88 -37.07 3.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.671 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -116.07 -6.51 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 110.94 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 37' ' ' CYS . 34.9 m -98.12 -20.38 17.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.951 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -49.48 -28.29 5.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.57 -26.8 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . . . -63.33 -62.76 4.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 18.3 Cg_endo -59.62 -31.6 94.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 0.0 112.225 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.11 -29.19 64.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.755 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.403 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.19 -25.85 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -71.37 -38.87 71.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -70.08 -50.63 39.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.31 -35.22 75.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.617 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.02 -39.12 96.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.324 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.57 75.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -52.81 14.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.737 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.06 -29.43 67.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.23 -27.02 32.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.38 32.56 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 -173.64 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.756 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 22.68 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -138.77 28.44 2.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.837 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -34.42 77.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -79.87 -29.39 39.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -56.38 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 21.2 t -116.46 148.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -134.48 122.1 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 mm -81.86 124.73 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 126.75 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.56 139.79 44.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.775 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.26 151.73 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.23 146.26 26.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.409 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.59 51.2 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.417 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -137.76 20.56 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.15 -178.08 2.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.936 0.398 . . . . 0.0 111.369 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.04 151.17 42.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.921 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.51 57.47 6.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 36.1 t -144.44 93.89 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.995 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.71 78.29 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.527 2.151 . . . . 0.0 112.228 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -108.03 82.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 112.89 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.04 160.21 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.537 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.77 -29.47 22.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 83' ' ' PRO . . . -132.29 141.63 13.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.763 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -42.17 -45.41 9.62 Favored Pre-proline 0 CA--C 1.488 -1.408 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 36.0 Cg_endo -66.38 75.9 0.36 Allowed 'Trans proline' 0 N--CA 1.427 -2.393 0 CA-C-N 119.759 0.95 . . . . 0.0 111.605 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' PHE . 1.1 m -77.69 136.07 38.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.25 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 6.3 mt -132.7 107.99 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.8 mttm -104.04 121.31 42.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.68 133.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.437 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m-85 -132.75 93.35 24.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.802 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.85 145.45 19.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.574 2.182 . . . . 0.0 112.414 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.94 143.16 39.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.06 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.9 -37.34 3.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.349 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.27 13.24 7.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.622 0.249 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CE ' ' N ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -55.36 -173.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.44 -17.28 43.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -120.5 116.07 32.21 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.575 0.226 . . . . 0.0 110.622 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.5 114.95 3.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.366 2.044 . . . . 0.0 112.355 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.07 105.88 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.15 109.3 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.432 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.4 m-85 -68.55 -178.36 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.6 t -110.04 -28.9 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.36 143.51 4.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.35 -177.75 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.006 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 179.6 -35.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 m -148.64 148.6 30.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.1 -27.01 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.317 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -59.49 -35.19 73.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.967 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.34 -30.71 57.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.74 -51.75 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.1 tt -57.95 -45.96 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.223 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -58.1 -37.68 74.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.186 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -42.54 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.068 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 mt -57.87 -28.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.95 -28.76 27.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -28.13 42.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 23.61 11.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.24 124.32 5.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.57 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -67.5 -32.38 73.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.99 -29.55 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmpp? -88.66 -22.97 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 60.59 87.3 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.111 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.092 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.15 -38.63 71.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.24 103.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.97 -93.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.577 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 m -79.46 -30.6 42.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -97.88 20.17 12.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.63 -99.05 0.88 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.666 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.72 -62.77 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.12 . . . . 0.0 112.455 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m -75.9 147.59 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.4 m -126.47 144.33 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 143.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.6 t -143.91 97.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.26 162.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.77 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.81 -35.79 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -86.65 -7.54 58.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -111.8 -47.22 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 111.639 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' CG ' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -45.45 -48.59 13.8 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.518 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.98 -34.3 28.41 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.78 -59.31 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 21' ' ' VAL . 16.3 pt -55.26 -46.43 78.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 21.9 m -66.16 -38.27 81.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.631 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.74 -10.35 59.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.39 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.7 105.06 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.911 0.386 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -79.29 -12.45 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.371 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.0 p -112.13 23.17 14.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.642 0.258 . . . . 0.0 111.291 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -167.13 130.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.66 136.23 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.84 146.31 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.94 107.65 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 tt -107.76 115.94 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.18 122.12 47.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 35.3 m-85 -88.39 132.21 34.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -153.61 168.15 27.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.971 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.89 147.66 52.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 -45.13 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -75.53 -5.06 43.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.9 t -50.09 -49.15 52.49 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.813 0.339 . . . . 0.0 111.365 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.8 -35.49 4.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.662 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.23 -3.93 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.743 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 28.6 m -103.12 -20.24 14.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.47 -27.05 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.39 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.942 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -27.83 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . . . -63.53 -62.89 4.67 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.507 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' CD ' ' CB ' ' A' ' 44' ' ' ALA . 19.1 Cg_endo -59.38 -39.99 71.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.431 2.087 . . . . 0.0 112.204 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -28.98 69.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.723 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.462 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.86 -24.59 35.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -34.83 60.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -76.48 -62.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.9 tp -59.68 -29.17 67.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.79 -46.16 69.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.09 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 111.196 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.21 -61.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' CD2' HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.59 -29.46 64.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.5 -26.86 51.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -96.29 38.18 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -127.5 -176.2 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.94 -3.85 46.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -72.6 -42.74 64.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -93.87 16.18 14.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.31 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 34.9 mtt180 -120.5 -55.73 2.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 54' ' ' TYR . 8.9 p -128.96 132.48 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.74 136.06 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.373 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.462 ' CG2' ' CE2' ' A' ' 47' ' ' TYR . 12.5 mm -89.29 117.23 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.87 130.57 50.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.001 0.429 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 160.71 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -168.12 149.73 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.32 145.33 37.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 32' ' ' PHE . . . -79.54 51.62 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -137.67 15.13 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.61 -177.74 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -127.27 165.7 19.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.839 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.88 35.23 23.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.194 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 t -131.48 94.03 27.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.15 79.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.318 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.08 106.39 15.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -108.41 113.81 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.443 ' CG2' ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.82 160.12 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.6 -45.21 54.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.85 141.57 14.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.337 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.5 OUTLIER -37.3 -45.09 1.59 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 20.6 Cg_exo -62.53 78.49 0.1 Allowed 'Trans proline' 0 N--CA 1.429 -2.315 0 CA-C-N 119.292 0.783 . . . . 0.0 111.442 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -81.21 142.11 33.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.381 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.428 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 1.8 mp -132.91 107.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.358 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -103.38 124.48 48.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -110.1 130.14 55.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.861 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.434 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 47.9 m-85 -132.81 93.56 23.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.33 147.98 23.44 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.577 2.185 . . . . 0.0 112.482 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.14 139.08 39.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.07 -38.04 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.173 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.59 57.98 1.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.0 0.429 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 -172.59 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.55 -10.04 45.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.9 pm0 -128.72 112.76 19.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.711 0.291 . . . . 0.0 110.704 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.28 111.14 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.443 2.095 . . . . 0.0 112.318 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.405 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 31.5 t -80.14 105.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.26 123.96 39.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.041 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.1 m-85 -69.35 -176.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.0 m -122.5 15.74 10.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.55 123.93 2.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.553 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.11 167.57 11.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.891 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.51 -66.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 m -128.6 154.37 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.3 m -65.53 -28.67 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.314 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -58.03 -38.81 76.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -72.89 -38.54 66.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.43 -58.81 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.43 -45.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.298 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -57.5 -30.82 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -31.15 40.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 mt -67.72 -28.89 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.65 -37.31 21.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -28.89 62.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.88 23.72 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.48 146.48 18.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -31.2 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 62' ' ' ARG . 5.5 m-85 -71.25 -28.17 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -93.35 -23.07 18.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -106.95 159.97 15.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.124 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.126 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.839 HG13 ' HD3' ' A' ' 67' ' ' LYS . 25.9 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 m -133.14 140.66 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.03 143.38 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 30' ' ' ILE . 17.6 t -138.49 97.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.613 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.7 p -105.72 161.5 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.31 -36.57 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HG3' HG13 ' A' ' 13' ' ' VAL . 4.7 pttt -86.64 -7.5 58.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -111.91 -46.31 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.708 0.289 . . . . 0.0 111.572 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.788 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.8 -48.77 10.95 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.593 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.547 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.1 p-10 -51.47 -34.23 34.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.311 . . . . 0.0 111.655 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -59.2 2.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 12' ' ' VAL . 12.9 pt -56.03 -47.31 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.0 m -63.25 -38.93 83.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 18' ' ' ASN . 81.7 mt -77.63 -8.95 58.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -72.51 105.35 4.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.874 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.1 p30 -79.3 -15.58 57.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.393 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 111.076 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.558 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 25.3 tttt -142.22 150.68 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.074 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 64' ' ' VAL . 19.5 t0 -83.67 145.04 29.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.1 t -133.85 142.29 41.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.258 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.717 HD12 HD13 ' A' ' 65' ' ' ILE . 3.2 mt -125.96 103.83 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.82 HD12 HG11 ' A' ' 12' ' ' VAL . 8.8 tt -100.61 116.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.708 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -106.53 129.9 54.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.143 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 28.7 m-85 -100.15 120.19 39.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.802 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.71 176.56 8.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.62 148.16 42.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.092 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.67 -45.14 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.541 2.161 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -78.15 -3.5 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 17.9 t -50.2 -46.45 54.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.65 -40.42 2.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.48 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -108.65 -3.12 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 12.4 m -108.48 -19.98 13.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -49.65 -28.19 5.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 110.958 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.5 -27.8 37.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -33.26 72.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.849 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.98 -62.35 5.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.378 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.624 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 20.4 Cg_endo -60.9 -34.28 91.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.518 2.145 . . . . 0.0 112.272 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -29.04 68.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -78.66 -28.53 45.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.77 -35.73 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.801 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.62 -55.45 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.582 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.0 tp -60.35 -28.68 68.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.21 -43.15 90.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.575 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.07 -30.01 62.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.118 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -55.43 5.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.81 -32.66 74.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.11 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.22 -28.91 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -173.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 43.36 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -138.68 33.63 2.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.42 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.48 16.16 16.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.82 -49.77 2.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.358 . . . . 0.0 110.916 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 54' ' ' TYR . 11.9 p -135.75 139.65 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.1 p -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.717 HD13 HD12 ' A' ' 29' ' ' LEU . 20.6 mm -85.86 106.23 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.977 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.77 134.39 52.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.839 ' HD3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.51 153.16 30.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.748 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -168.16 150.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.36 146.13 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.592 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -88.11 48.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 p -137.47 20.66 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.21 -177.72 6.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.611 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -106.55 160.06 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.82 41.7 31.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.0 p -128.78 82.8 67.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 80.3 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.713 2.275 . . . . 0.0 112.344 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -125.92 93.4 3.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.47 118.18 27.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.744 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.76 160.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.546 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -76.34 -48.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.215 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.73 141.2 14.32 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.638 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -42.75 -49.12 13.68 Favored Pre-proline 0 CA--C 1.485 -1.536 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -65.91 78.52 0.29 Allowed 'Trans proline' 0 N--CA 1.424 -2.572 0 CA-C-N 119.124 0.723 . . . . 0.0 111.176 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.744 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -101.1 143.06 31.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.089 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 ' OE1' ' A' ' 31' ' ' GLU . 3.2 mp -127.8 119.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -103.42 115.34 30.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -97.3 131.24 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.0 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.446 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.8 m-85 -132.7 93.48 24.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 147.98 47.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.427 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.874 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.13 115.85 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.1 -36.87 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.291 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.98 30.0 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.012 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -172.18 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.53 -15.22 46.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.591 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -128.85 112.67 18.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.771 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.95 108.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.443 2.095 . . . . 0.0 112.157 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 21.5 t -80.14 105.88 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.67 126.9 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -73.26 -177.14 2.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 p -109.58 -26.96 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.7 133.52 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 169.83 9.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -175.55 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 106' ' ' GLU . 19.8 m -149.25 148.38 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HB ' HD22 ' A' ' 50' ' ' LEU . 4.0 m -62.01 -27.91 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 104' ' ' THR . 18.7 pt-20 -58.11 -35.82 72.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.938 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.57 -29.23 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 112' ' ' ILE . 60.7 tp -70.63 -51.5 27.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.52 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.3 tt -57.39 -45.94 85.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.497 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.5 tttp -58.54 -50.9 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.003 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.07 -52.23 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.647 HG12 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -50.83 -30.86 9.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.82 -27.94 58.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.5 -38.0 22.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -92.04 -44.44 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.113 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.76 136.47 19.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.604 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -32.6 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG11 ' HG2' ' A' ' 67' ' ' LYS . 4.3 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.782 0.325 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.9 m -100.28 144.38 29.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.72 143.52 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.794 HG13 HD11 ' A' ' 20' ' ' ILE . 1.5 t -118.21 100.87 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 14' ' ' ALA . 4.6 t -94.04 163.85 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -56.33 -39.5 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.317 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.65 -7.69 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.656 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -44.64 5.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 0.0 111.356 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.28 -49.91 63.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.357 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.9 p-10 -50.9 -34.68 29.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -75.28 -59.32 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG13 ' A' ' 12' ' ' VAL . 13.3 pt -56.06 -46.94 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.3 m -64.69 -37.23 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.66 -11.11 59.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.436 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.75 108.85 8.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.814 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 19.0 p-10 -79.33 -12.39 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -91.69 11.27 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.539 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -163.49 134.43 4.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.75 139.87 32.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.656 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 20' ' ' ILE . 20.9 t -133.85 141.32 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.385 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.867 HD12 HD13 ' A' ' 65' ' ' ILE . 1.7 mt -124.72 103.31 8.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.692 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.769 HD11 HG11 ' A' ' 68' ' ' VAL . 6.9 tt -101.67 127.72 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 14.8 tm-20 -117.64 124.3 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.22 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.638 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-85 -95.18 118.74 32.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.833 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 13.4 p90 -139.76 174.71 10.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.77 145.36 30.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.11 -46.48 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.476 2.118 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -78.02 -3.44 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 19.5 t -50.58 -47.19 58.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.784 0.326 . . . . 0.0 111.318 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.22 -39.84 2.73 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.574 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -110.14 -1.93 17.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.835 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 20.8 m -107.19 -22.86 12.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.45 -27.22 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.37 -28.75 41.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.758 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -62.59 -29.93 70.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.89 -61.99 6.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.615 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 17.8 Cg_endo -60.12 -36.68 88.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.428 2.085 . . . . 0.0 112.399 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -65.45 -29.09 69.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -80.52 -26.4 38.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.34 -35.62 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.659 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.68 -53.76 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.4 tp -60.58 -27.84 68.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.69 52.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.97 65.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.266 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.35 -63.6 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -29.42 63.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.064 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.69 -34.84 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -29.13 61.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.0 -173.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -130.98 30.18 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.91 -30.28 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.55 -29.88 33.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -75.15 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.32 139.68 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.58 131.02 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.867 HD13 HD12 ' A' ' 29' ' ' LEU . 20.3 mm -81.77 120.56 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -129.3 126.65 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG2' HG11 ' A' ' 9' ' ' VAL . 3.8 pttp -106.13 155.8 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 30' ' ' ILE . 12.0 p -168.12 155.36 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -98.11 146.22 25.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -85.57 46.04 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.57 20.6 2.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.52 -177.71 5.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -95.91 158.44 15.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.827 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.4 t0 51.11 40.59 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 75' ' ' VAL . 9.2 p -129.36 100.13 20.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.65 -73.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.637 2.225 . . . . 0.0 112.134 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 44.1 93.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.658 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.09 101.14 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.534 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.85 160.28 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.614 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -43.58 12.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.451 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.57 141.14 16.75 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.945 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.616 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -47.3 -46.84 57.68 Favored Pre-proline 0 CA--C 1.485 -1.522 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.22 74.07 2.56 Favored 'Trans proline' 0 N--CA 1.422 -2.699 0 CA-C-N 119.422 0.829 . . . . 0.0 110.866 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.624 ' CG2' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -98.88 121.2 40.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.203 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.574 HD11 ' CB ' ' A' ' 102' ' ' SER . 3.0 mp -102.47 116.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' NZ ' HG23 ' A' ' 98' ' ' THR . 4.6 tptt -103.34 122.23 44.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -105.8 133.5 50.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.091 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 40.8 m-85 -129.76 93.38 34.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.674 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.21 140.64 41.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.841 2.361 . . . . 0.0 112.271 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.01 115.85 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.62 -34.31 5.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.64 12.29 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.643 0.259 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -168.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.63 -17.78 42.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.421 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 130.58 23.48 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.563 0.22 . . . . 0.0 110.555 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.94 112.71 3.48 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.393 2.062 . . . . 0.0 112.439 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.2 t -80.01 105.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.948 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -90.59 119.3 30.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -66.33 -175.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -26.09 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.728 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.88 127.29 1.02 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.758 ' OG ' HD21 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.86 145.15 27.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -56.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 m -134.63 155.97 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -73.87 -27.02 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.331 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.23 -35.98 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.042 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.64 -31.03 57.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.748 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.1 tt -67.68 -51.38 50.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.933 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -58.98 -45.96 91.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.206 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 109' ' ' ILE . 13.3 ttmt -58.01 -33.89 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.0 56.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.5 mt -56.36 -29.15 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.6 -37.05 25.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -72.17 -29.58 64.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.22 23.07 12.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.05 144.0 15.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.56 -29.75 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 111.038 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.407 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.766 HG13 ' HG2' ' A' ' 67' ' ' LYS . 28.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.4 m -116.4 121.65 42.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.25 143.36 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -129.57 97.81 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.014 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 14' ' ' ALA . 6.6 t -99.4 162.7 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.696 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -52.04 -36.16 49.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.776 0.322 . . . . 0.0 111.456 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -9.19 56.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -41.13 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.556 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -58.47 -39.84 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.4 p-10 -56.82 -38.81 73.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.92 -43.92 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 12' ' ' VAL . 20.9 pt -66.8 -45.44 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 19.4 m -70.03 -36.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 18' ' ' ASN . 85.3 mt -76.83 -14.74 59.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 110.15 1.04 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.77 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 12.2 t70 -79.24 -12.29 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.405 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -106.62 14.91 26.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 141.85 19.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -98.69 127.5 44.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.692 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 64' ' ' VAL . 38.4 t -133.91 147.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 111.438 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -128.84 114.73 16.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.764 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.765 HD11 HG11 ' A' ' 68' ' ' VAL . 8.3 tt -105.03 118.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.203 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.9 tm-20 -109.31 131.54 54.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 75' ' ' VAL . 28.2 m-85 -103.36 126.1 50.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 111.364 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 44' ' ' ALA . 32.8 p90 -152.84 171.17 18.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.59 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 155.63 59.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 27.2 Cg_endo -63.35 -56.88 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.55 2.167 . . . . 0.0 112.103 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p90 -61.91 -18.46 60.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.701 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 t -42.87 -39.97 2.74 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.563 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.72 -64.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.27 -69.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 7.3 p -67.15 -13.64 62.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.446 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -51.3 -27.38 9.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.896 0.379 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.36 63.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -61.05 -22.33 64.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . . . -66.73 -63.13 3.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.549 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 12.0 Cg_endo -56.24 -35.7 95.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -70.09 -25.8 63.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -77.42 -29.03 52.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.234 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 1.6 pt-20 -77.29 -31.15 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.33 -51.36 37.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' HB ' ' A' ' 105' ' ' VAL . 30.5 tp -70.25 -30.52 67.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.5 -50.66 63.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.313 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.82 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.946 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -60.34 3.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.797 ' CE1' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.55 -27.6 58.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.15 -33.06 33.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -77.18 -30.71 55.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 m -58.91 176.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.73 -10.84 60.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -95.96 38.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -30.35 65.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -105.71 16.22 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -116.48 -41.24 3.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.797 HG11 ' CE1' ' A' ' 54' ' ' TYR . 14.3 p -126.55 150.23 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.735 ' CG1' HG22 ' A' ' 28' ' ' VAL . 11.7 p -138.88 122.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.608 HG22 ' CE2' ' A' ' 47' ' ' TYR . 15.1 mm -87.86 110.41 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.799 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -113.43 128.44 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.93 144.31 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.561 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.765 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -151.38 156.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.256 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.458 ' N ' HG22 ' A' ' 68' ' ' VAL . 20.8 m-20 -94.79 146.23 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.59 51.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.41 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -137.75 19.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.923 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -177.78 6.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 111.407 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.6 m120 -118.39 153.15 34.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.834 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 58.02 47.0 15.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.5 p -133.18 89.57 32.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.549 2.166 . . . . 0.0 112.077 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -112.22 84.91 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.06 109.72 20.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.864 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.77 160.17 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.597 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.29 -43.3 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.31 141.34 16.5 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.896 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -45.09 -45.96 28.97 Favored Pre-proline 0 CA--C 1.487 -1.472 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 37.3 Cg_endo -67.75 80.35 0.48 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 CA-C-N 119.548 0.874 . . . . 0.0 111.435 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.864 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -86.09 137.28 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.134 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 28.6 mt -130.93 109.53 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.774 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 30' ' ' ILE . 10.1 mptt -103.38 119.36 38.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.06 128.1 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 11.3 m-85 -132.74 93.4 24.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.43 154.17 21.17 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.595 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.16 117.66 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.05 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.98 -38.0 3.35 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.46 11.26 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.658 0.266 . . . . 0.0 111.486 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -173.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.2 -17.84 43.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.367 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.82 121.93 21.21 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.519 0.2 . . . . 0.0 110.636 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.17 107.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.324 2.016 . . . . 0.0 112.176 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.1 105.83 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.7 p -93.09 128.9 39.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.4 m-85 -69.54 176.82 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.6 -24.88 12.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.82 117.04 0.62 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 43' ' ' LEU . 25.7 p -76.65 145.86 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -148.19 -72.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.465 HG21 ' OE2' ' A' ' 106' ' ' GLU . 3.8 m -132.35 165.18 24.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.766 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -72.82 -29.06 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.43 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.465 ' OE2' HG21 ' A' ' 104' ' ' THR . 8.4 pt-20 -57.06 -31.36 65.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.951 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.04 -30.28 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tp -72.02 -49.99 32.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.5 tt -57.22 -46.38 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' N ' HG23 ' A' ' 109' ' ' ILE . 14.3 ttpt -63.13 -37.36 86.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.66 51.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 109' ' ' ILE . 3.8 mt -55.11 -29.83 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.42 63.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.59 -26.43 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -116.14 23.0 12.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.148 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.53 138.8 10.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.519 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -6.29 58.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.584 0.231 . . . . 0.0 111.366 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 3.2 m-85 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.629 0.252 . . . . 0.0 111.323 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 67' ' ' LYS . 23.3 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.9 m -111.01 127.65 55.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.66 143.39 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -133.25 97.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.5 t -105.26 167.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -51.54 -41.23 60.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.552 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -86.73 -7.65 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.934 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.54 -52.67 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.492 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -49.23 -55.7 11.72 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.41 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 8.0 p-10 -46.2 -34.95 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -73.66 -59.35 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.7 HD11 HG13 ' A' ' 12' ' ' VAL . 9.0 pt -55.9 -49.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.852 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' TYR . 33.1 m -56.53 -43.05 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.474 ' N ' HG23 ' A' ' 21' ' ' VAL . 85.0 mt -73.22 -12.63 60.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.413 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -58.75 96.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.862 0.363 . . . . 0.0 110.804 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.772 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.2 m-20 -68.1 -19.25 64.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.371 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.74 27.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.645 0.26 . . . . 0.0 111.279 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -176.94 145.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.585 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 20' ' ' ILE . 5.8 t -133.85 146.44 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.871 0.367 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.802 HD12 HD13 ' A' ' 65' ' ' ILE . 1.9 mt -136.67 101.21 4.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.773 HD11 HG11 ' A' ' 68' ' ' VAL . 7.9 tt -102.36 119.11 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.201 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.691 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -108.19 131.33 54.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 25.5 m-85 -101.05 123.78 45.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.801 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 35.1 p90 -146.73 174.47 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.76 147.68 39.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.31 -42.11 4.18 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.622 2.215 . . . . 0.0 112.333 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -78.21 -3.44 42.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.392 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.2 t -51.43 -49.58 61.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -39.73 2.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.473 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -108.79 -3.2 17.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.623 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 16.4 m -107.22 -20.78 13.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -49.55 -27.88 4.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.78 41.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.823 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -62.97 -31.71 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.78 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -60.3 -62.32 6.16 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.447 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.7 Cg_endo -60.8 -37.32 79.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.466 2.111 . . . . 0.0 112.314 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -64.04 -29.2 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.78 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.51 -24.34 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.948 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -71.06 -35.63 72.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -52.99 9.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.0 tp -60.36 -29.12 68.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.21 -44.91 58.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.03 65.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.59 -57.56 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.13 -45.9 83.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.013 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.35 71.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.38 38.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.9 m -129.22 177.78 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.42 -21.31 64.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -95.29 38.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -74.8 -39.81 61.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.07 16.11 15.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.88 -51.56 2.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.806 0.336 . . . . 0.0 110.797 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.94 149.72 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.31 120.97 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 29' ' ' LEU . 20.9 mm -83.74 106.18 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -110.17 127.84 55.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.07 140.51 46.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.657 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 30' ' ' ILE . 12.1 p -157.11 153.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.31 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -95.5 146.2 24.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -76.3 55.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 111.345 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -137.65 20.52 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.3 -177.77 5.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 111.339 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.5 m120 -116.52 154.66 30.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.09 62.08 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.057 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 32' ' ' PHE . 42.5 t -154.47 104.03 2.37 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 78.59 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.491 2.127 . . . . 0.0 112.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -104.38 74.2 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -93.54 98.51 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.823 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.19 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.726 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -48.5 16.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.087 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.13 16.7 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.628 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -45.94 -44.91 36.86 Favored Pre-proline 0 CA--C 1.486 -1.49 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 7.6 Cg_exo -66.6 80.97 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.57 0 CA-C-N 119.239 0.764 . . . . 0.0 111.327 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.823 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -102.95 142.92 33.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.211 -178.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 102' ' ' SER . 4.1 mp -126.36 117.95 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.802 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HB2' HG23 ' A' ' 30' ' ' ILE . 6.2 mmtt -103.28 112.11 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.62 131.48 43.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.174 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.468 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 34.4 m-85 -132.87 93.23 24.05 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.2 145.19 17.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.672 2.248 . . . . 0.0 112.664 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.78 124.04 27.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.64 -23.9 31.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.53 29.65 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -165.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.24 -18.09 42.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.23 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -129.19 119.96 19.89 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.449 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.35 111.26 2.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.243 1.962 . . . . 0.0 112.058 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.01 105.84 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.38 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.4 p -96.55 123.18 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.481 ' CB ' HD13 ' A' ' 85' ' ' ILE . 3.6 m-85 -74.14 178.75 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -118.41 15.83 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.08 123.0 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 85' ' ' ILE . 5.8 t -100.96 155.29 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.925 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -139.72 -47.05 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.635 HG21 ' OE1' ' A' ' 106' ' ' GLU . 3.9 m -143.87 152.26 40.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.889 ' HB ' HD22 ' A' ' 50' ' ' LEU . 19.2 m -62.35 -27.05 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.4 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.635 ' OE1' HG21 ' A' ' 104' ' ' THR . 3.4 pt-20 -57.05 -34.2 68.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.097 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.53 -30.68 59.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.992 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.595 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -70.7 -53.74 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.617 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -55.81 -45.49 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.8 mtmt -58.11 -39.83 79.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.011 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CB ' ' HH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -66.4 -48.57 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -58.18 -23.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.289 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.43 33.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.56 -29.2 19.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.52 -30.99 14.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.22 136.14 20.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.51 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.43 -7.75 57.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.579 0.228 . . . . 0.0 111.355 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 111.279 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.793 0.33 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -136.94 142.92 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.36 143.43 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.025 HG11 HD12 ' A' ' 30' ' ' ILE . 15.7 t -135.6 97.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.6 p -105.2 161.66 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.776 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.9 -35.59 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -86.61 -7.48 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -112.29 -47.6 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.622 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.08 -49.06 8.98 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.473 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.5 p-10 -51.11 -32.08 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -79.37 -59.39 2.78 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.843 HD11 HG13 ' A' ' 12' ' ' VAL . 20.3 pt -54.97 -38.36 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.1 m -74.52 -37.99 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.698 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.06 -6.39 52.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.546 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.42 105.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.927 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 11.5 p-10 -79.39 -12.39 59.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.418 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 28.05 8.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.205 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.88 131.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 137.41 33.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.7 t -133.82 147.45 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.397 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -133.45 104.92 6.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.693 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.025 HD12 HG11 ' A' ' 12' ' ' VAL . 9.1 tt -100.65 129.29 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -118.55 126.37 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 38.6 m-85 -97.1 117.91 32.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE1' ' HD2' ' A' ' 67' ' ' LYS . 11.9 p90 -134.91 174.33 10.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.71 145.76 32.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -46.67 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.536 2.158 . . . . 0.0 112.329 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -78.91 -3.41 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 29.6 t -48.63 -46.78 40.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.6 -36.92 3.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.595 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -114.83 -2.76 12.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.791 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.6 m -105.06 -22.3 13.13 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.063 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -49.52 -27.99 4.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.045 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.51 -28.09 37.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -60.77 -31.6 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.778 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.62 -62.68 5.27 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.629 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.5 Cg_endo -60.19 -36.55 88.0 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.436 2.09 . . . . 0.0 112.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.55 -29.23 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.45 ' CD2' ' HG3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -81.24 -24.25 37.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.56 -33.27 66.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.619 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.71 -54.15 7.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.2 tp -60.58 -31.52 70.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.733 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.46 -42.47 81.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.35 63.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 -59.58 2.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.408 ' CE1' HG13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -57.88 -39.53 78.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.61 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 t -113.1 -173.85 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.52 -18.22 58.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.271 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.13 35.8 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.989 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -29.24 70.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.157 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -103.14 16.25 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.373 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -116.9 -74.64 0.6 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 29' ' ' LEU . 21.4 t -97.32 141.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.41 128.26 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.794 HD13 HD12 ' A' ' 29' ' ' LEU . 23.4 mm -83.47 111.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -113.51 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.169 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -106.8 151.95 24.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.808 HG11 HD11 ' A' ' 30' ' ' ILE . 11.4 p -168.14 156.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 m-20 -103.62 146.13 29.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -84.23 51.69 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.864 0.364 . . . . 0.0 111.21 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 p -137.63 20.61 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.4 -177.74 4.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 111.201 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -107.63 164.05 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.66 31.58 17.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.991 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.68 HG22 ' OD1' ' A' ' 77' ' ' ASP . 8.3 p -132.13 101.95 14.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.82 -68.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.463 2.109 . . . . 0.0 112.206 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.68 ' OD1' HG22 ' A' ' 75' ' ' VAL . 5.9 p-10 42.12 83.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.715 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.12 102.84 15.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.669 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.79 160.22 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.581 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.44 -46.05 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.38 141.24 16.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.951 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -47.44 -46.23 58.07 Favored Pre-proline 0 CA--C 1.485 -1.521 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.18 71.59 3.59 Favored 'Trans proline' 0 N--CA 1.423 -2.672 0 CA-C-N 119.469 0.846 . . . . 0.0 110.973 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -92.13 142.87 27.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.181 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' CD2' ' A' ' 99' ' ' TYR . 7.9 mt -123.21 116.53 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.97 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -103.54 116.85 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.567 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -101.08 130.87 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.174 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.47 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 3.5 m-85 -132.82 93.36 23.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.708 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.21 142.96 19.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.653 2.235 . . . . 0.0 112.478 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -72.93 131.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.98 -36.56 3.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.265 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.65 2.78 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.69 -17.78 41.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.489 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -128.76 118.94 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.597 0.237 . . . . 0.0 110.644 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLN . 25.4 Cg_exo -62.33 111.01 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.36 2.04 . . . . 0.0 112.267 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 87' ' ' LEU . 25.8 t -80.13 105.78 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.69 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.16 124.09 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.02 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 85' ' ' ILE . 2.8 m-85 -81.08 -176.86 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.028 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.4 m -102.54 -25.5 13.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.685 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.07 140.24 2.88 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.544 ' OG ' HD21 ' A' ' 43' ' ' LEU . 6.0 t -95.21 145.11 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -145.22 -66.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -121.22 160.3 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.647 HG11 ' O ' ' A' ' 46' ' ' LYS . 10.3 m -76.95 -28.58 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.284 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.68 -33.43 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.57 -35.28 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 112' ' ' ILE . 53.0 tp -72.71 -46.69 52.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -57.16 -38.91 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.58 -49.81 71.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.47 -46.98 85.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 109' ' ' ILE . 18.8 mt -51.46 -41.03 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.176 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.06 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -75.05 -51.6 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.68 -43.9 58.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 138.57 49.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.58 -38.7 28.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.03 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.1 m -129.42 135.73 49.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.2 139.15 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.984 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 30' ' ' ILE . 7.1 t -123.99 97.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.8 t -96.54 166.46 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.679 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -53.15 -39.05 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 111.31 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.82 -9.99 54.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.76 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -47.19 4.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.777 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -46.97 -50.56 18.86 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.395 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.9 p-10 -51.67 -32.84 31.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.25 -59.25 2.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.948 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.851 HD11 HG13 ' A' ' 12' ' ' VAL . 11.0 pt -56.37 -47.62 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 17' ' ' TYR . 28.0 m -62.74 -38.27 81.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.652 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 71.2 mt -77.32 -10.47 59.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.51 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.88 104.31 0.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 5.8 m-20 -79.35 -20.08 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -95.48 22.12 7.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.303 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -177.03 137.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.381 . . . . 0.0 111.048 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 t0 -83.78 140.01 32.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.701 HG11 ' HB ' ' A' ' 20' ' ' ILE . 16.0 t -133.79 141.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 111.462 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -128.25 118.94 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.711 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -111.66 123.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.765 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -111.84 132.46 54.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.2 m-85 -101.98 129.5 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 41.5 p90 -152.11 173.36 15.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.7 145.93 32.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 44.5 Cg_endo -68.59 -42.08 5.43 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.45 2.1 . . . . 0.0 112.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 25.8 p90 -79.44 -3.47 46.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.7 t -53.8 -48.57 69.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.27 -42.2 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.415 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.68 -1.93 25.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.715 0.293 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 13.3 m -110.06 -22.48 11.79 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -27.34 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.246 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.47 -29.28 52.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.027 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.838 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -64.3 -30.9 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -59.6 -62.0 6.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 27.4 Cg_endo -62.45 -36.78 63.98 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.9 mttp -63.9 -29.16 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -82.16 -25.4 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.35 -36.31 66.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' HD12 ' A' ' 53' ' ' LEU . 17.2 tt0 -73.52 -56.79 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.7 tp -60.39 -28.93 68.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.66 -50.62 53.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.09 -30.14 67.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.454 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.2 mt -70.63 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.565 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.84 -31.04 66.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.02 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.93 72.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.33 35.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -118.21 -176.35 3.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.35 -28.67 68.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -96.63 38.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -70.94 -37.47 72.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.18 16.25 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 118' ' ' TYR . 5.9 mtt180 -110.77 -31.72 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 54' ' ' TYR . 9.9 p -144.08 155.72 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 64' ' ' VAL . 12.1 p -135.28 123.18 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.259 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.499 HD13 HD12 ' A' ' 29' ' ' LEU . 19.8 mm -84.55 106.16 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.74 126.62 53.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.53 150.4 27.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 30' ' ' ILE . 11.5 p -164.28 154.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.219 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 68' ' ' VAL . 44.1 m-20 -95.23 146.15 24.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -77.47 56.83 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 111.252 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -137.63 20.63 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.0 -177.72 6.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.254 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.4 m120 -116.65 157.2 25.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.52 48.49 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -131.82 93.19 28.26 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.006 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 79.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.592 2.195 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -114.02 117.61 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -119.62 107.44 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.804 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.8 160.06 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.26 -36.55 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.28 141.31 12.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.509 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -40.69 -44.28 4.84 Favored Pre-proline 0 CA--C 1.487 -1.455 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 15.8 Cg_exo -63.98 81.21 0.15 Allowed 'Trans proline' 0 N--CA 1.427 -2.399 0 CA-C-N 119.318 0.792 . . . . 0.0 111.382 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.804 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -91.17 142.32 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.388 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.765 HG23 ' OE1' ' A' ' 31' ' ' GLU . 6.9 mt -132.87 107.81 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 30' ' ' ILE . 4.4 mtpt -103.86 129.99 51.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.915 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -113.62 132.06 55.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 39.2 m-85 -130.26 93.42 33.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.5 142.2 36.2 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.542 2.161 . . . . 0.0 112.436 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.21 115.92 17.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.65 -21.6 27.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.6 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.44 47.47 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 111.512 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -89.39 -164.12 1.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.32 -17.95 42.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.557 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -129.01 112.42 18.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.675 0.274 . . . . 0.0 110.621 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 110.91 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.349 2.033 . . . . 0.0 112.106 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.0 t -80.01 105.76 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.05 130.95 40.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' A' ' 85' ' ' ILE . 4.2 m-85 -75.62 -178.06 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.023 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -106.69 -26.78 11.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.29 127.17 1.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.564 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.838 ' OG ' HD21 ' A' ' 43' ' ' LEU . 4.6 t -89.41 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -147.37 -77.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.47 HG21 ' OE1' ' A' ' 106' ' ' GLU . 5.6 m -115.46 155.89 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' A' ' 50' ' ' LEU . 7.0 m -69.24 -26.84 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.326 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' OE1' HG21 ' A' ' 104' ' ' THR . 4.6 pt-20 -57.45 -35.33 70.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.3 -29.17 61.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.67 ' HG ' HD11 ' A' ' 112' ' ' ILE . 19.8 tp -72.63 -51.05 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.096 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.2 tt -56.04 -45.62 80.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.482 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.7 tttt -57.03 -48.97 77.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.04 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -52.24 66.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.67 HD11 ' HG ' ' A' ' 108' ' ' LEU . 15.3 mt -48.57 -34.52 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.79 -30.43 62.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.822 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -80.54 -46.29 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -81.25 -33.95 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.993 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.93 23.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.646 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -26.73 37.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.778 0.323 . . . . 0.0 110.963 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' A' ' 62' ' ' ARG . 18.3 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG12 ' HD3' ' A' ' 67' ' ' LYS . 6.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -119.86 129.64 54.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.75 143.36 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.59 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -134.65 97.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 16' ' ' ASN . 10.9 p -114.0 160.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -46.82 -34.4 5.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.051 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -86.79 -7.43 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -115.55 -51.61 2.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.16 -51.29 10.65 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.56 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.6 p-10 -48.14 -34.43 9.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -75.79 -59.2 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG21 ' A' ' 28' ' ' VAL . 9.7 pt -54.69 -47.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.9 m -62.0 -44.96 99.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.493 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' ASN . 84.8 mt -69.06 -12.41 61.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.369 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' HG22 ' A' ' 25' ' ' THR . 1.1 t0 -72.13 103.15 3.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.786 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.8 p30 -79.33 -12.36 59.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.461 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.611 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.3 t -68.66 -28.81 67.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.722 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -143.45 159.4 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.798 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.7 t -133.88 141.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.4 mt -127.53 142.38 51.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 68' ' ' VAL . 11.4 tt -139.73 122.02 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 43' ' ' LEU . 1.2 tp10 -110.94 143.94 40.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.8 m-85 -113.47 113.85 25.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 45.1 p90 -135.75 171.5 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.69 147.97 41.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.23 -43.83 2.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.494 2.129 . . . . 0.0 112.386 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -78.77 -3.39 44.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.477 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.2 t -50.21 -48.67 54.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.807 0.337 . . . . 0.0 111.312 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.3 -36.26 4.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.495 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -114.69 -4.59 12.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.686 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 22.5 m -104.08 -19.91 14.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -49.47 -28.05 4.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.045 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.41 44.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.575 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -61.4 -30.72 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.77 -62.8 5.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.8 Cg_endo -60.69 -35.32 89.89 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 112.149 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 105' ' ' VAL . 18.1 mmtm -65.75 -28.98 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.802 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -79.23 -27.77 42.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -72.22 -31.46 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -75.49 -60.2 2.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD22 ' HB ' ' A' ' 105' ' ' VAL . 32.4 tp -58.82 -30.42 67.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.06 -41.94 79.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.68 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -57.15 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -29.93 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.98 -30.12 58.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -74.26 -31.31 62.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -59.71 -173.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.16 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 29.9 m-85 -119.48 37.08 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.1 -46.87 87.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.15 16.21 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -110.77 -53.55 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.89 152.27 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.21 126.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.535 HG22 ' CE2' ' A' ' 47' ' ' TYR . 14.0 mm -82.97 113.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 29' ' ' LEU . . . -113.6 126.72 55.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HD3' HG12 ' A' ' 9' ' ' VAL . 7.6 ptmt -109.42 134.56 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.734 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 30' ' ' ILE . 10.0 p -144.6 158.2 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.271 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 p30 -100.98 146.3 27.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.502 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -83.09 47.65 1.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.283 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -137.68 20.61 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.92 -177.76 5.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.302 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -110.16 157.13 19.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.11 40.18 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.9 p -124.17 78.12 59.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 79.02 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.578 2.185 . . . . 0.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -127.44 88.93 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.089 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.16 118.95 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.783 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.54 160.06 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.467 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -44.34 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.773 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.96 141.3 13.39 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.952 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -46.44 -45.96 45.84 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.46 72.06 3.02 Favored 'Trans proline' 0 N--CA 1.424 -2.602 0 CA-C-N 119.444 0.837 . . . . 0.0 111.152 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.783 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -87.0 142.97 27.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.249 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 99' ' ' TYR . 10.0 mt -126.58 111.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 30' ' ' ILE . 31.4 mttp -103.45 127.29 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -109.38 136.52 48.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.455 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 27.8 m-85 -132.67 93.56 24.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.09 144.96 38.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 112.436 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.89 118.87 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -36.1 4.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.377 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -124.12 16.67 9.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -173.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.77 47.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.543 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 112.95 19.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.593 0.235 . . . . 0.0 110.681 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.23 118.56 5.67 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.377 2.051 . . . . 0.0 112.356 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.13 105.99 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 109.47 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.1 m-85 -64.43 -176.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.034 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -116.43 15.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.931 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.42 131.53 3.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.575 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.4 t -89.93 162.93 15.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -159.78 -67.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 m -131.34 156.55 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 46' ' ' LYS . 31.5 m -68.41 -30.63 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.255 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -59.82 -34.19 72.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.63 -29.3 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.844 HD23 HD11 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -72.45 -50.25 27.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -58.94 -45.89 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' N ' HG23 ' A' ' 109' ' ' ILE . 6.8 ttpt -58.32 -41.43 84.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.98 -46.93 76.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.844 HD11 HD23 ' A' ' 108' ' ' LEU . 14.2 mt -54.05 -30.14 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.85 -30.6 40.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -80.03 -28.72 39.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -114.77 22.2 13.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.025 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -108.42 147.96 16.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -80.54 -31.97 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.846 0.355 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -118.56 144.24 46.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 143.36 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.853 HG11 HD12 ' A' ' 30' ' ' ILE . 21.8 t -144.12 97.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.255 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 16' ' ' ASN . 9.9 p -103.37 161.01 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.649 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.514 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -47.32 -33.56 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.67 -7.59 58.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.573 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -113.73 -46.26 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 111.627 -179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.787 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -43.59 -47.93 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.674 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 p-10 -51.03 -33.1 23.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.727 0.299 . . . . 0.0 111.769 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -59.24 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 12' ' ' VAL . 11.4 pt -56.1 -46.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.4 m -65.08 -38.72 83.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.662 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.94 -9.67 58.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.431 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.49 104.32 2.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.785 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.5 p-10 -79.27 -12.37 59.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.4 p -68.75 -44.27 74.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.773 0.32 . . . . 0.0 111.08 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.734 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 27.3 mttm -127.73 166.13 18.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.068 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -91.44 148.21 22.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.754 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.2 t -133.84 145.92 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.248 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 65' ' ' ILE . 6.6 mt -130.5 98.17 4.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.853 HD12 HG11 ' A' ' 12' ' ' VAL . 8.1 tt -102.34 117.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.755 ' OE1' HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -107.93 127.25 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 29.0 m-85 -93.45 119.83 33.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.611 ' HB3' HD13 ' A' ' 43' ' ' LEU . 15.0 p90 -136.96 174.17 10.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.85 144.42 26.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.26 -45.03 2.04 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.422 2.082 . . . . 0.0 112.124 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -3.88 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 32.5 t -52.38 -49.97 63.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.45 -39.52 2.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.312 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -108.03 -2.29 19.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 18.1 m -108.93 -21.17 12.77 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.265 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -27.18 6.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.53 -22.98 43.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -59.22 -29.43 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -65.3 -62.71 4.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.483 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.3 Cg_endo -59.01 -26.56 82.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.571 2.181 . . . . 0.0 112.356 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.591 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -78.56 -28.94 46.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -79.26 -30.03 42.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.161 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 10.9 pt-20 -74.98 -38.28 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.05 -53.66 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' A' ' 105' ' ' VAL . 24.0 tp -64.8 -32.92 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.655 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.15 97.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.6 65.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.43 -57.63 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.79 69.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.45 -24.23 57.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.24 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -95.48 37.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 m -126.48 -173.73 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.789 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 37.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.964 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -138.68 30.02 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.28 72.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -94.05 16.28 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.232 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -113.29 -63.87 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 29' ' ' LEU . 19.7 t -122.7 155.84 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 63' ' ' VAL . 11.8 p -141.37 128.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.162 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.958 HD13 HD12 ' A' ' 29' ' ' LEU . 24.2 mm -83.96 118.59 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -129.93 132.42 46.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.361 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -102.32 160.65 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 30' ' ' ILE . 14.4 p -167.98 158.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 m-20 -105.58 146.14 30.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.553 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -90.48 44.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.6 20.76 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.93 -177.73 6.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 111.2 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.54 142.65 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.748 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 63.37 51.52 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -138.03 86.25 18.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.42 79.89 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -110.31 105.69 14.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 105.06 14.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.67 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.1 OUTLIER -136.75 160.08 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.612 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -69.43 -57.89 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.24 16.77 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.562 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.585 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -43.19 -48.14 15.8 Favored Pre-proline 0 CA--C 1.484 -1.577 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -68.39 76.44 0.71 Allowed 'Trans proline' 0 N--CA 1.423 -2.652 0 CA-C-N 119.282 0.779 . . . . 0.0 110.785 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.67 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -97.39 139.88 32.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.24 -178.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 99' ' ' TYR . 6.8 mt -115.5 120.02 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.6 ' HB2' HG23 ' A' ' 30' ' ' ILE . 7.7 mttp -105.34 112.86 26.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.486 HD21 HG12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.998 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.431 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 49.1 m-85 -132.71 93.5 24.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.45 133.37 20.62 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.605 2.204 . . . . 0.0 112.454 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -71.27 117.32 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -35.72 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.32 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.38 17.61 11.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 0.0 111.302 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -170.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.84 41.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -128.97 112.45 18.62 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.71 0.29 . . . . 0.0 110.636 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.84 117.39 4.86 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.442 2.095 . . . . 0.0 112.29 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.3 t -80.15 105.81 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.64 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.3 112.16 23.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.3 m-85 -66.32 -178.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -109.42 -24.99 10.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.839 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.01 132.02 1.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.276 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.54 ' CB ' HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -145.3 161.74 38.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.36 26.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.14 146.87 14.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' A' ' 50' ' ' LEU . 11.9 m -77.8 -30.85 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.1 -36.78 78.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.12 -30.07 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.755 HD11 ' OE1' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -69.27 -53.54 19.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.901 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -56.33 -45.83 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' N ' HG23 ' A' ' 109' ' ' ILE . 5.1 mttm -58.03 -44.42 87.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -43.91 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.901 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.7 mt -56.35 -31.18 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.097 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.74 -30.4 51.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.99 -28.15 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 25.89 9.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.22 142.96 16.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -80.54 -28.17 37.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.357 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.525 HG13 ' HG2' ' A' ' 67' ' ' LYS . 34.8 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.799 0.333 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -135.59 138.1 42.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.33 143.46 11.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.096 HG11 HD12 ' A' ' 30' ' ' ILE . 3.4 t -135.36 109.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.9 p -124.79 166.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -44.14 -38.65 3.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.8 ptpt -86.63 -7.5 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -111.41 -52.64 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.588 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.792 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -47.09 -52.55 14.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.437 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 7.4 p-10 -50.23 -35.7 27.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 111.795 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -75.87 -59.28 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.741 ' O ' HG21 ' A' ' 28' ' ' VAL . 13.3 pt -54.7 -47.0 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.6 m -64.59 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.626 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.34 -9.74 58.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.407 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -69.78 103.45 2.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.868 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.1 p30 -79.28 -12.47 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.5 p -94.53 19.65 9.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.659 0.266 . . . . 0.0 111.337 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -173.49 143.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.641 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -83.78 140.16 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 20' ' ' ILE . 16.2 t -133.43 137.6 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -130.37 104.66 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.096 HD12 HG11 ' A' ' 12' ' ' VAL . 5.2 tt -105.23 130.38 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 10.6 tm-20 -122.55 118.23 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HG13 ' A' ' 68' ' ' VAL . 41.4 m-85 -88.25 125.44 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.632 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -143.26 164.46 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.2 148.5 57.4 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 -37.81 11.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.512 2.141 . . . . 0.0 112.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -3.47 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.0 t -52.46 -46.6 66.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.88 -37.07 3.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.671 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -116.07 -6.51 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 110.94 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.9 m -98.12 -20.38 17.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.951 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -49.48 -28.29 5.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.57 -26.8 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 102' ' ' SER . 0.2 OUTLIER -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.631 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.33 -62.76 4.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.631 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.3 Cg_endo -59.62 -31.6 94.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 0.0 112.225 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -71.11 -29.19 64.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.755 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.19 -25.85 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -71.37 -38.87 71.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -70.08 -50.63 39.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.622 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.4 tp -60.31 -35.22 75.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.617 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.02 -39.12 96.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.324 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.57 75.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -52.81 14.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.737 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' HD2' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.06 -29.43 67.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.23 -27.02 32.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.38 32.56 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 -173.64 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.756 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 22.68 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -138.77 28.44 2.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.837 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -34.42 77.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -79.87 -29.39 39.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -56.38 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 29' ' ' LEU . 21.2 t -116.46 148.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.5 p -134.48 122.1 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.834 HD13 HD12 ' A' ' 29' ' ' LEU . 22.9 mm -81.86 124.73 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.62 126.75 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.56 139.79 44.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.775 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.858 HG11 HD11 ' A' ' 30' ' ' ILE . 11.1 p -154.26 151.73 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.23 146.26 26.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.409 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -74.59 51.2 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.417 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -137.76 20.56 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.15 -178.08 2.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.936 0.398 . . . . 0.0 111.369 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -123.04 151.17 42.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.921 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.51 57.47 6.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 73' ' ' ASN . 36.1 t -144.44 93.89 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.995 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.71 78.29 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.527 2.151 . . . . 0.0 112.228 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -108.03 82.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 112.89 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.632 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -137.04 160.21 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.537 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.77 -29.47 22.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 83' ' ' PRO . . . -132.29 141.63 13.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.763 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -42.17 -45.41 9.62 Favored Pre-proline 0 CA--C 1.488 -1.408 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 36.0 Cg_endo -66.38 75.9 0.36 Allowed 'Trans proline' 0 N--CA 1.427 -2.393 0 CA-C-N 119.759 0.95 . . . . 0.0 111.605 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 1.1 m -77.69 136.07 38.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.25 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 102' ' ' SER . 6.3 mt -132.7 107.99 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' HG23 ' A' ' 30' ' ' ILE . 13.8 mttm -104.04 121.31 42.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -105.68 133.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.445 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m-85 -132.75 93.35 24.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.802 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.85 145.45 19.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.574 2.182 . . . . 0.0 112.414 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.868 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.94 143.16 39.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.9 -37.34 3.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.349 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.27 13.24 7.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.622 0.249 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' N ' ' CE ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -55.36 -173.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.44 -17.28 43.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.5 116.07 32.21 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.575 0.226 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.5 114.95 3.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.366 2.044 . . . . 0.0 112.355 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -80.07 105.88 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -89.15 109.3 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.4 m-85 -68.55 -178.36 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.6 t -110.04 -28.9 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.36 143.51 4.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -108.35 -177.75 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.006 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 179.6 -35.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 106' ' ' GLU . 5.2 m -148.64 148.6 30.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.622 ' HB ' HD22 ' A' ' 50' ' ' LEU . 10.5 m -67.1 -27.01 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.317 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 104' ' ' THR . 18.1 pt-20 -59.49 -35.19 73.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.967 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.34 -30.71 57.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -69.74 -51.75 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.916 ' HA ' HD12 ' A' ' 112' ' ' ILE . 5.1 tt -57.95 -45.96 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.223 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 109' ' ' ILE . 58.9 tttt -58.1 -37.68 74.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.186 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -42.54 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.068 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.4 mt -57.87 -28.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.95 -28.76 27.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -28.13 42.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 23.61 11.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.24 124.32 5.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.57 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -67.5 -32.38 73.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.4 m -126.47 144.33 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 143.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.908 HG11 HD12 ' A' ' 30' ' ' ILE . 15.6 t -143.91 97.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.3 p -105.26 162.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.77 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.81 -35.79 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -86.65 -7.54 58.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.601 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -111.8 -47.22 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 111.639 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.45 -48.59 13.8 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.518 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.3 p-10 -50.98 -34.3 28.41 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.78 -59.31 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.753 HD11 HG13 ' A' ' 12' ' ' VAL . 16.3 pt -55.26 -46.43 78.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 21.9 m -66.16 -38.27 81.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.631 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.74 -10.35 59.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.39 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.7 105.06 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.911 0.386 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 25' ' ' THR . 25.5 p30 -79.29 -12.45 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 24' ' ' ASP . 67.0 p -112.13 23.17 14.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.642 0.258 . . . . 0.0 111.291 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -167.13 130.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.66 136.23 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.84 146.31 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -126.94 107.65 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.908 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -107.76 115.94 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.703 ' OE2' HD21 ' A' ' 43' ' ' LEU . 3.0 tt0 -111.18 122.12 47.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 35.3 m-85 -88.39 132.21 34.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 43' ' ' LEU . 32.9 p90 -153.61 168.15 27.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.89 147.66 52.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 -45.13 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -75.53 -5.06 43.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.9 t -50.09 -49.15 52.49 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.813 0.339 . . . . 0.0 111.365 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.8 -35.49 4.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.662 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.23 -3.93 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.743 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 28.6 m -103.12 -20.24 14.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.47 -27.05 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.39 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.942 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.703 HD21 ' OE2' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -61.02 -27.83 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.53 -62.89 4.67 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.507 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.1 Cg_endo -59.38 -39.99 71.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.431 2.087 . . . . 0.0 112.204 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.676 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -60.69 -28.98 69.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.86 -24.59 35.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -34.83 60.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -76.48 -62.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.639 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.9 tp -59.68 -29.17 67.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.79 -46.16 69.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.09 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 111.196 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.21 -61.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.674 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.59 -29.46 64.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.5 -26.86 51.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -96.29 38.18 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -127.5 -176.2 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.94 -3.85 46.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' ' 63' ' ' VAL . 22.8 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -72.6 -42.74 64.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -93.87 16.18 14.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.31 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 34.9 mtt180 -120.5 -55.73 2.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 54' ' ' TYR . 8.9 p -128.96 132.48 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.74 136.06 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.373 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.762 HG22 ' CE2' ' A' ' 47' ' ' TYR . 12.5 mm -89.29 117.23 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.87 130.57 50.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.001 0.429 . . . . 0.0 111.508 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 160.71 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 30' ' ' ILE . 9.1 p -168.12 149.73 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.32 145.33 37.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -79.54 51.62 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -137.67 15.13 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.61 -177.74 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.3 m-80 -127.27 165.7 19.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.88 35.23 23.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.194 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ASN . 27.4 t -131.48 94.03 27.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.15 79.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.318 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.08 106.39 15.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -108.41 113.81 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.82 160.12 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.6 -45.21 54.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.85 141.57 14.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.337 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.5 OUTLIER -37.3 -45.09 1.59 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 20.6 Cg_exo -62.53 78.49 0.1 Allowed 'Trans proline' 0 N--CA 1.429 -2.315 0 CA-C-N 119.292 0.783 . . . . 0.0 111.442 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.687 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -81.21 142.11 33.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.381 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 1.8 mp -132.91 107.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.358 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 30' ' ' ILE . 25.5 mmtt -103.38 124.48 48.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.414 ' CB ' ' HB ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -110.1 130.14 55.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.861 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 47.9 m-85 -132.81 93.56 23.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.33 147.98 23.44 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.577 2.185 . . . . 0.0 112.482 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.14 139.08 39.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.07 -38.04 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.173 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.59 57.98 1.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.0 0.429 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 -172.59 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.55 -10.04 45.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.9 pm0 -128.72 112.76 19.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.711 0.291 . . . . 0.0 110.704 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.28 111.14 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.443 2.095 . . . . 0.0 112.318 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 31.5 t -80.14 105.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -95.26 123.96 39.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.041 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.473 ' OH ' HD12 ' A' ' 108' ' ' LEU . 3.1 m-85 -69.35 -176.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.0 m -122.5 15.74 10.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.55 123.93 2.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.553 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.11 167.57 11.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.891 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.51 -66.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.509 HG21 ' OE1' ' A' ' 106' ' ' GLU . 11.2 m -128.6 154.37 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 46' ' ' LYS . 30.3 m -65.53 -28.67 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.314 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.509 ' OE1' HG21 ' A' ' 104' ' ' THR . 5.5 pt-20 -58.03 -38.81 76.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.977 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -72.89 -38.54 66.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.473 HD12 ' OH ' ' A' ' 99' ' ' TYR . 62.0 tp -60.43 -58.81 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.868 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.1 tt -51.43 -45.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.5 ' N ' HG23 ' A' ' 109' ' ' ILE . 3.2 tttt -57.5 -30.82 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -31.15 40.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 109' ' ' ILE . 27.0 mt -67.72 -28.89 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.65 -37.31 21.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -28.89 62.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.88 23.72 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.48 146.48 18.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -31.2 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 62' ' ' ARG . 5.5 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.24 -62.58 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.536 2.157 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.95 29.43 16.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.046 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.406 ' CA ' ' HB ' ' A' ' 9' ' ' VAL . . . 145.26 -27.88 1.83 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.546 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -22.31 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 2.2 tt0 -76.16 -29.86 57.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.062 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 134.77 -43.03 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.319 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 98.9 Cg_exo -43.9 -62.26 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.632 2.221 . . . . 0.0 112.921 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.839 HG13 ' HD3' ' A' ' 67' ' ' LYS . 25.9 t -85.19 126.15 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 m -133.14 140.66 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.03 143.38 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 30' ' ' ILE . 17.6 t -138.49 97.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.613 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.7 p -105.72 161.5 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.31 -36.57 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HG3' HG13 ' A' ' 13' ' ' VAL . 4.7 pttt -86.64 -7.5 58.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -111.91 -46.31 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.708 0.289 . . . . 0.0 111.572 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.788 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.8 -48.77 10.95 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.593 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.547 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.1 p-10 -51.47 -34.23 34.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.311 . . . . 0.0 111.655 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -59.2 2.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 12' ' ' VAL . 12.9 pt -56.03 -47.31 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.0 m -63.25 -38.93 83.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 18' ' ' ASN . 81.7 mt -77.63 -8.95 58.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -72.51 105.35 4.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.874 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.1 p30 -79.3 -15.58 57.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.393 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 111.076 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.558 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 25.3 tttt -142.22 150.68 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.074 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 64' ' ' VAL . 19.5 t0 -83.67 145.04 29.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.1 t -133.85 142.29 41.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.258 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.717 HD12 HD13 ' A' ' 65' ' ' ILE . 3.2 mt -125.96 103.83 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.82 HD12 HG11 ' A' ' 12' ' ' VAL . 8.8 tt -100.61 116.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.708 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -106.53 129.9 54.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.143 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 28.7 m-85 -100.15 120.19 39.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.802 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.71 176.56 8.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.62 148.16 42.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.092 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.67 -45.14 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.541 2.161 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -78.15 -3.5 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 17.9 t -50.2 -46.45 54.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.65 -40.42 2.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.48 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -108.65 -3.12 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 12.4 m -108.48 -19.98 13.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -49.65 -28.19 5.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 110.958 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.5 -27.8 37.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -33.26 72.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.849 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.98 -62.35 5.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.378 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.624 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 20.4 Cg_endo -60.9 -34.28 91.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.518 2.145 . . . . 0.0 112.272 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -29.04 68.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -78.66 -28.53 45.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.77 -35.73 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.801 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.62 -55.45 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.582 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.0 tp -60.35 -28.68 68.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.21 -43.15 90.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.575 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.07 -30.01 62.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.118 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -55.43 5.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.81 -32.66 74.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.11 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.22 -28.91 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -173.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 43.36 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -138.68 33.63 2.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.42 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.48 16.16 16.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.82 -49.77 2.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.358 . . . . 0.0 110.916 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 54' ' ' TYR . 11.9 p -135.75 139.65 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.1 p -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.717 HD13 HD12 ' A' ' 29' ' ' LEU . 20.6 mm -85.86 106.23 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.977 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.77 134.39 52.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.839 ' HD3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.51 153.16 30.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.748 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -168.16 150.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.36 146.13 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.592 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -88.11 48.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 p -137.47 20.66 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.21 -177.72 6.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.611 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -106.55 160.06 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.82 41.7 31.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.0 p -128.78 82.8 67.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 80.3 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.713 2.275 . . . . 0.0 112.344 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -125.92 93.4 3.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.47 118.18 27.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.744 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.76 160.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.546 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -76.34 -48.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.215 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.73 141.2 14.32 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.638 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -42.75 -49.12 13.68 Favored Pre-proline 0 CA--C 1.485 -1.536 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -65.91 78.52 0.29 Allowed 'Trans proline' 0 N--CA 1.424 -2.572 0 CA-C-N 119.124 0.723 . . . . 0.0 111.176 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.744 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -101.1 143.06 31.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.089 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 ' OE1' ' A' ' 31' ' ' GLU . 3.2 mp -127.8 119.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -103.42 115.34 30.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -97.3 131.24 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.0 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.446 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.8 m-85 -132.7 93.48 24.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 147.98 47.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.427 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.874 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.13 115.85 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.1 -36.87 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.291 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.98 30.0 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.012 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -172.18 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.53 -15.22 46.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.591 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -128.85 112.67 18.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.771 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.95 108.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.443 2.095 . . . . 0.0 112.157 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 21.5 t -80.14 105.88 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.67 126.9 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -73.26 -177.14 2.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 p -109.58 -26.96 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.7 133.52 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 169.83 9.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -175.55 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 106' ' ' GLU . 19.8 m -149.25 148.38 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HB ' HD22 ' A' ' 50' ' ' LEU . 4.0 m -62.01 -27.91 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 104' ' ' THR . 18.7 pt-20 -58.11 -35.82 72.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.938 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.57 -29.23 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 112' ' ' ILE . 60.7 tp -70.63 -51.5 27.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.52 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.3 tt -57.39 -45.94 85.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.497 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.5 tttp -58.54 -50.9 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.003 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.07 -52.23 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.647 HG12 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -50.83 -30.86 9.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -75.82 -27.94 58.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.5 -38.0 22.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -92.04 -44.44 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.113 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.76 136.47 19.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.604 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -32.6 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.98 -31.19 72.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.13 29.63 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 113' ' ' ALA . . . -137.22 151.98 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.161 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.12 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.19 -45.92 36.08 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.564 2.176 . . . . 0.0 112.311 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 3' ' ' LEU . 1.5 pp -108.35 107.73 18.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.16 87.41 1.78 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -77.82 -39.26 44.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.06 20.08 17.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.44 164.58 12.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 58.3 Cg_exo -51.87 -26.62 24.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.578 2.186 . . . . 0.0 112.376 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG11 ' HG2' ' A' ' 67' ' ' LYS . 4.3 t -62.82 147.8 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.9 m -100.28 144.38 29.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.72 143.52 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.794 HG13 HD11 ' A' ' 20' ' ' ILE . 1.5 t -118.21 100.87 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 14' ' ' ALA . 4.6 t -94.04 163.85 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -56.33 -39.5 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.317 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.65 -7.69 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.656 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -44.64 5.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 0.0 111.356 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.28 -49.91 63.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.357 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.9 p-10 -50.9 -34.68 29.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.728 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -75.28 -59.32 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG13 ' A' ' 12' ' ' VAL . 13.3 pt -56.06 -46.94 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.3 m -64.69 -37.23 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.66 -11.11 59.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.436 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.75 108.85 8.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.814 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 19.0 p-10 -79.33 -12.39 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -91.69 11.27 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.539 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -163.49 134.43 4.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.75 139.87 32.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.656 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 20' ' ' ILE . 20.9 t -133.85 141.32 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.385 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.867 HD12 HD13 ' A' ' 65' ' ' ILE . 1.7 mt -124.72 103.31 8.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.692 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.769 HD11 HG11 ' A' ' 68' ' ' VAL . 6.9 tt -101.67 127.72 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 14.8 tm-20 -117.64 124.3 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.22 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.638 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-85 -95.18 118.74 32.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.833 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 13.4 p90 -139.76 174.71 10.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.77 145.36 30.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.11 -46.48 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.476 2.118 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -78.02 -3.44 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 19.5 t -50.58 -47.19 58.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.784 0.326 . . . . 0.0 111.318 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.22 -39.84 2.73 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.574 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -110.14 -1.93 17.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.835 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 20.8 m -107.19 -22.86 12.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.45 -27.22 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.37 -28.75 41.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.758 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -62.59 -29.93 70.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.89 -61.99 6.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 17.8 Cg_endo -60.12 -36.68 88.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.428 2.085 . . . . 0.0 112.399 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -65.45 -29.09 69.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -80.52 -26.4 38.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.34 -35.62 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.659 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.68 -53.76 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.4 tp -60.58 -27.84 68.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.69 52.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . . . -69.38 -27.97 65.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.266 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.35 -63.6 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -29.42 63.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.064 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.69 -34.84 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -29.13 61.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.0 -173.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -130.98 30.18 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.91 -30.28 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.55 -29.88 33.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -75.15 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.32 139.68 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.58 131.02 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.867 HD13 HD12 ' A' ' 29' ' ' LEU . 20.3 mm -81.77 120.56 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -129.3 126.65 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG2' HG11 ' A' ' 9' ' ' VAL . 3.8 pttp -106.13 155.8 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 30' ' ' ILE . 12.0 p -168.12 155.36 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -98.11 146.22 25.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -85.57 46.04 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.57 20.6 2.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.52 -177.71 5.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -95.91 158.44 15.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.827 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.4 t0 51.11 40.59 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 75' ' ' VAL . 9.2 p -129.36 100.13 20.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.65 -73.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.637 2.225 . . . . 0.0 112.134 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 44.1 93.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.658 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.09 101.14 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.534 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.85 160.28 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.614 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -43.58 12.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.451 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.57 141.14 16.75 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.945 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.616 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -47.3 -46.84 57.68 Favored Pre-proline 0 CA--C 1.485 -1.522 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.22 74.07 2.56 Favored 'Trans proline' 0 N--CA 1.422 -2.699 0 CA-C-N 119.422 0.829 . . . . 0.0 110.866 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.624 ' CG2' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -98.88 121.2 40.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.203 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.574 HD11 ' CB ' ' A' ' 102' ' ' SER . 3.0 mp -102.47 116.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' NZ ' HG23 ' A' ' 98' ' ' THR . 4.6 tptt -103.34 122.23 44.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -105.8 133.5 50.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.091 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 40.8 m-85 -129.76 93.38 34.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.674 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.21 140.64 41.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.841 2.361 . . . . 0.0 112.271 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.01 115.85 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.62 -34.31 5.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.64 12.29 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.643 0.259 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -168.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.63 -17.78 42.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.421 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 130.58 23.48 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.563 0.22 . . . . 0.0 110.555 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.94 112.71 3.48 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.393 2.062 . . . . 0.0 112.439 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.2 t -80.01 105.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.948 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -90.59 119.3 30.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -66.33 -175.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -26.09 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.728 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.88 127.29 1.02 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.758 ' OG ' HD21 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.86 145.15 27.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -56.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 m -134.63 155.97 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -73.87 -27.02 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.331 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.23 -35.98 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.042 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.64 -31.03 57.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.748 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.1 tt -67.68 -51.38 50.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.933 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -58.98 -45.96 91.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.206 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 109' ' ' ILE . 13.3 ttmt -58.01 -33.89 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.0 56.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.5 mt -56.36 -29.15 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' A' ' 119' ' ' LYS . . . -82.6 -37.05 25.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -72.17 -29.58 64.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.22 23.07 12.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.05 144.0 15.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.56 -29.75 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 111.038 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.29 17.21 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.407 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -128.1 29.55 5.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.88 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.32 119.94 39.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.034 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.24 172.69 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.577 2.185 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.87 -36.62 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 -30.84 9.37 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -61.26 -31.14 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -105.16 -29.86 10.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -141.5 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.756 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 2.7 Cg_exo -75.18 98.09 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.875 2.383 . . . . 0.0 111.977 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG13 ' HG2' ' A' ' 67' ' ' LYS . 28.8 t -144.58 141.51 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.4 m -116.4 121.65 42.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.25 143.36 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -129.57 97.81 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.014 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 14' ' ' ALA . 6.6 t -99.4 162.7 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.696 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -52.04 -36.16 49.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.776 0.322 . . . . 0.0 111.456 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -9.19 56.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -41.13 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.556 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -58.47 -39.84 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.4 p-10 -56.82 -38.81 73.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.92 -43.92 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 12' ' ' VAL . 20.9 pt -66.8 -45.44 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 19.4 m -70.03 -36.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 18' ' ' ASN . 85.3 mt -76.83 -14.74 59.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 110.15 1.04 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.77 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 12.2 t70 -79.24 -12.29 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.405 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -106.62 14.91 26.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 141.85 19.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -98.69 127.5 44.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.692 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 64' ' ' VAL . 38.4 t -133.91 147.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 111.438 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -128.84 114.73 16.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.764 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.765 HD11 HG11 ' A' ' 68' ' ' VAL . 8.3 tt -105.03 118.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.203 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.9 tm-20 -109.31 131.54 54.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 75' ' ' VAL . 28.2 m-85 -103.36 126.1 50.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 111.364 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 44' ' ' ALA . 32.8 p90 -152.84 171.17 18.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.59 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 155.63 59.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 27.2 Cg_endo -63.35 -56.88 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.55 2.167 . . . . 0.0 112.103 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p90 -61.91 -18.46 60.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.701 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 t -42.87 -39.97 2.74 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.563 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.72 -64.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.27 -69.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 7.3 p -67.15 -13.64 62.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.446 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -51.3 -27.38 9.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.896 0.379 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.36 63.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -61.05 -22.33 64.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . . . -66.73 -63.13 3.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.549 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 12.0 Cg_endo -56.24 -35.7 95.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -70.09 -25.8 63.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -77.42 -29.03 52.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.234 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 1.6 pt-20 -77.29 -31.15 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.33 -51.36 37.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' HB ' ' A' ' 105' ' ' VAL . 30.5 tp -70.25 -30.52 67.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.5 -50.66 63.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.313 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . . . -66.62 -38.82 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.946 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -60.34 3.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.797 ' CE1' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.55 -27.6 58.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.15 -33.06 33.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -77.18 -30.71 55.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 m -58.91 176.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.73 -10.84 60.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -95.96 38.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -30.35 65.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -105.71 16.22 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -116.48 -41.24 3.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.797 HG11 ' CE1' ' A' ' 54' ' ' TYR . 14.3 p -126.55 150.23 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.735 ' CG1' HG22 ' A' ' 28' ' ' VAL . 11.7 p -138.88 122.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.608 HG22 ' CE2' ' A' ' 47' ' ' TYR . 15.1 mm -87.86 110.41 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.799 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -113.43 128.44 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.93 144.31 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.561 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.765 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -151.38 156.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.256 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.458 ' N ' HG22 ' A' ' 68' ' ' VAL . 20.8 m-20 -94.79 146.23 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.59 51.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.41 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -137.75 19.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.923 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -177.78 6.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 111.407 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.6 m120 -118.39 153.15 34.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.834 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 58.02 47.0 15.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.5 p -133.18 89.57 32.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.549 2.166 . . . . 0.0 112.077 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -112.22 84.91 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.06 109.72 20.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.864 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.77 160.17 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.597 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.29 -43.3 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.31 141.34 16.5 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.896 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -45.09 -45.96 28.97 Favored Pre-proline 0 CA--C 1.487 -1.472 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 37.3 Cg_endo -67.75 80.35 0.48 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 CA-C-N 119.548 0.874 . . . . 0.0 111.435 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.864 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -86.09 137.28 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.134 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 28.6 mt -130.93 109.53 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.774 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 30' ' ' ILE . 10.1 mptt -103.38 119.36 38.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.06 128.1 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 11.3 m-85 -132.74 93.4 24.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.43 154.17 21.17 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.595 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.16 117.66 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.05 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.98 -38.0 3.35 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.46 11.26 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.658 0.266 . . . . 0.0 111.486 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -173.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.2 -17.84 43.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.367 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.82 121.93 21.21 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.519 0.2 . . . . 0.0 110.636 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.17 107.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.324 2.016 . . . . 0.0 112.176 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.1 105.83 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.7 p -93.09 128.9 39.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.4 m-85 -69.54 176.82 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.6 -24.88 12.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.82 117.04 0.62 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 43' ' ' LEU . 25.7 p -76.65 145.86 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -148.19 -72.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.465 HG21 ' OE2' ' A' ' 106' ' ' GLU . 3.8 m -132.35 165.18 24.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.766 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -72.82 -29.06 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.43 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.465 ' OE2' HG21 ' A' ' 104' ' ' THR . 8.4 pt-20 -57.06 -31.36 65.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.951 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.04 -30.28 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tp -72.02 -49.99 32.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.5 tt -57.22 -46.38 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' N ' HG23 ' A' ' 109' ' ' ILE . 14.3 ttpt -63.13 -37.36 86.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.66 51.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 109' ' ' ILE . 3.8 mt -55.11 -29.83 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.42 63.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.59 -26.43 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -116.14 23.0 12.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.148 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.53 138.8 10.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.519 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -6.29 58.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.584 0.231 . . . . 0.0 111.366 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 3.2 m-85 -93.35 22.06 5.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.629 0.252 . . . . 0.0 111.323 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -22.97 22.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.049 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 61.83 90.35 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.114 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.93 155.55 65.1 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.599 2.199 . . . . 0.0 112.292 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 3' ' ' LEU . 0.3 OUTLIER -61.34 -31.14 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.97 89.48 1.54 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -82.65 -59.68 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -76.49 -29.82 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.85 65.47 2.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.34 -27.84 40.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.582 2.188 . . . . 0.0 112.253 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 67' ' ' LYS . 23.3 t -91.65 130.32 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.9 m -111.01 127.65 55.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.66 143.39 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -133.25 97.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.5 t -105.26 167.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -51.54 -41.23 60.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.552 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -86.73 -7.65 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.934 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.54 -52.67 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.492 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -49.23 -55.7 11.72 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.41 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 8.0 p-10 -46.2 -34.95 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -73.66 -59.35 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.7 HD11 HG13 ' A' ' 12' ' ' VAL . 9.0 pt -55.9 -49.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.852 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' TYR . 33.1 m -56.53 -43.05 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.474 ' N ' HG23 ' A' ' 21' ' ' VAL . 85.0 mt -73.22 -12.63 60.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.413 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -58.75 96.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.862 0.363 . . . . 0.0 110.804 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.772 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.2 m-20 -68.1 -19.25 64.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.371 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.74 27.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.645 0.26 . . . . 0.0 111.279 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -176.94 145.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.585 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 20' ' ' ILE . 5.8 t -133.85 146.44 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.871 0.367 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.802 HD12 HD13 ' A' ' 65' ' ' ILE . 1.9 mt -136.67 101.21 4.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.773 HD11 HG11 ' A' ' 68' ' ' VAL . 7.9 tt -102.36 119.11 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.201 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.691 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -108.19 131.33 54.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 25.5 m-85 -101.05 123.78 45.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.801 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 35.1 p90 -146.73 174.47 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.76 147.68 39.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.31 -42.11 4.18 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.622 2.215 . . . . 0.0 112.333 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -78.21 -3.44 42.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.392 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.2 t -51.43 -49.58 61.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -39.73 2.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.473 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -108.79 -3.2 17.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.623 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 16.4 m -107.22 -20.78 13.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -49.55 -27.88 4.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.78 41.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.823 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -62.97 -31.71 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.78 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -60.3 -62.32 6.16 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.447 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.7 Cg_endo -60.8 -37.32 79.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.466 2.111 . . . . 0.0 112.314 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -64.04 -29.2 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.78 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.51 -24.34 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.948 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -71.06 -35.63 72.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -52.99 9.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.0 tp -60.36 -29.12 68.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.21 -44.91 58.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.03 65.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.59 -57.56 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.13 -45.9 83.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.013 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.35 71.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.38 38.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.9 m -129.22 177.78 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.42 -21.31 64.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -95.29 38.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -74.8 -39.81 61.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.07 16.11 15.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.88 -51.56 2.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.806 0.336 . . . . 0.0 110.797 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.94 149.72 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.31 120.97 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 29' ' ' LEU . 20.9 mm -83.74 106.18 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -110.17 127.84 55.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.07 140.51 46.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.657 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 30' ' ' ILE . 12.1 p -157.11 153.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.31 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -95.5 146.2 24.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -76.3 55.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 111.345 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -137.65 20.52 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.3 -177.77 5.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 111.339 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 1.5 m120 -116.52 154.66 30.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.09 62.08 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.057 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 32' ' ' PHE . 42.5 t -154.47 104.03 2.37 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 78.59 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.491 2.127 . . . . 0.0 112.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -104.38 74.2 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -93.54 98.51 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.823 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.19 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.726 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -48.5 16.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.087 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.13 16.7 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.628 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -45.94 -44.91 36.86 Favored Pre-proline 0 CA--C 1.486 -1.49 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 7.6 Cg_exo -66.6 80.97 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.57 0 CA-C-N 119.239 0.764 . . . . 0.0 111.327 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.823 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -102.95 142.92 33.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.211 -178.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 102' ' ' SER . 4.1 mp -126.36 117.95 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.802 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HB2' HG23 ' A' ' 30' ' ' ILE . 6.2 mmtt -103.28 112.11 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.62 131.48 43.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.174 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.468 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 34.4 m-85 -132.87 93.23 24.05 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.2 145.19 17.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.672 2.248 . . . . 0.0 112.664 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.78 124.04 27.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.64 -23.9 31.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.53 29.65 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -165.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.24 -18.09 42.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.23 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -129.19 119.96 19.89 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.449 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.35 111.26 2.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.243 1.962 . . . . 0.0 112.058 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.01 105.84 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.38 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.4 p -96.55 123.18 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.481 ' CB ' HD13 ' A' ' 85' ' ' ILE . 3.6 m-85 -74.14 178.75 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -118.41 15.83 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.08 123.0 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 85' ' ' ILE . 5.8 t -100.96 155.29 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.925 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -139.72 -47.05 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.635 HG21 ' OE1' ' A' ' 106' ' ' GLU . 3.9 m -143.87 152.26 40.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.889 ' HB ' HD22 ' A' ' 50' ' ' LEU . 19.2 m -62.35 -27.05 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.4 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.635 ' OE1' HG21 ' A' ' 104' ' ' THR . 3.4 pt-20 -57.05 -34.2 68.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.097 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.53 -30.68 59.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.992 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.595 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -70.7 -53.74 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.617 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -55.81 -45.49 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.8 mtmt -58.11 -39.83 79.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.011 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CB ' ' HH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -66.4 -48.57 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -58.18 -23.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.289 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.43 33.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.56 -29.2 19.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.52 -30.99 14.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.22 136.14 20.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.51 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.43 -7.75 57.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.579 0.228 . . . . 0.0 111.355 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -93.42 22.13 5.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 7.57 26.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.458 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 61.63 115.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 111.168 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.064 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.46 -49.23 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.531 2.154 . . . . 0.0 112.257 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.0 mm? 57.37 173.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.67 -31.09 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -72.33 -13.08 61.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.641 0.258 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -93.77 20.17 7.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.659 0.266 . . . . 0.0 111.263 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -49.69 -60.87 6.06 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.81 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' GLY . 24.7 Cg_endo -61.95 -27.2 79.54 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.265 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.88 143.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -136.94 142.92 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.36 143.43 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.025 HG11 HD12 ' A' ' 30' ' ' ILE . 15.7 t -135.6 97.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.6 p -105.2 161.66 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.776 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.9 -35.59 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -86.61 -7.48 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -112.29 -47.6 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.622 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.08 -49.06 8.98 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.473 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.5 p-10 -51.11 -32.08 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -79.37 -59.39 2.78 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.843 HD11 HG13 ' A' ' 12' ' ' VAL . 20.3 pt -54.97 -38.36 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.1 m -74.52 -37.99 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.698 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.06 -6.39 52.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.546 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.42 105.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.927 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 11.5 p-10 -79.39 -12.39 59.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.418 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 28.05 8.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.205 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.88 131.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 137.41 33.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.7 t -133.82 147.45 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.397 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -133.45 104.92 6.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.693 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.025 HD12 HG11 ' A' ' 12' ' ' VAL . 9.1 tt -100.65 129.29 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -118.55 126.37 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 38.6 m-85 -97.1 117.91 32.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE1' ' HD2' ' A' ' 67' ' ' LYS . 11.9 p90 -134.91 174.33 10.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.71 145.76 32.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -46.67 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.536 2.158 . . . . 0.0 112.329 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -78.91 -3.41 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 29.6 t -48.63 -46.78 40.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.6 -36.92 3.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.595 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -114.83 -2.76 12.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.791 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.6 m -105.06 -22.3 13.13 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.063 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -49.52 -27.99 4.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.045 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.51 -28.09 37.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -60.77 -31.6 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.778 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.62 -62.68 5.27 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.629 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.5 Cg_endo -60.19 -36.55 88.0 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.436 2.09 . . . . 0.0 112.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.55 -29.23 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.45 ' CD2' ' HG3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -81.24 -24.25 37.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.56 -33.27 66.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.619 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.71 -54.15 7.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.2 tp -60.58 -31.52 70.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.733 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.46 -42.47 81.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.35 63.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 -59.58 2.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.408 ' CE1' HG13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -57.88 -39.53 78.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.61 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 t -113.1 -173.85 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.52 -18.22 58.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.271 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.13 35.8 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.989 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -29.24 70.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.157 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -103.14 16.25 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.373 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -116.9 -74.64 0.6 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 29' ' ' LEU . 21.4 t -97.32 141.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.41 128.26 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.794 HD13 HD12 ' A' ' 29' ' ' LEU . 23.4 mm -83.47 111.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -113.51 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.169 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -106.8 151.95 24.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.808 HG11 HD11 ' A' ' 30' ' ' ILE . 11.4 p -168.14 156.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 m-20 -103.62 146.13 29.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -84.23 51.69 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.864 0.364 . . . . 0.0 111.21 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 p -137.63 20.61 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.4 -177.74 4.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 111.201 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -107.63 164.05 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.66 31.58 17.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.991 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.68 HG22 ' OD1' ' A' ' 77' ' ' ASP . 8.3 p -132.13 101.95 14.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.82 -68.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.463 2.109 . . . . 0.0 112.206 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.68 ' OD1' HG22 ' A' ' 75' ' ' VAL . 5.9 p-10 42.12 83.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.715 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.12 102.84 15.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.669 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.79 160.22 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.581 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.44 -46.05 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.38 141.24 16.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.951 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -47.44 -46.23 58.07 Favored Pre-proline 0 CA--C 1.485 -1.521 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.18 71.59 3.59 Favored 'Trans proline' 0 N--CA 1.423 -2.672 0 CA-C-N 119.469 0.846 . . . . 0.0 110.973 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -92.13 142.87 27.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.181 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' CD2' ' A' ' 99' ' ' TYR . 7.9 mt -123.21 116.53 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.97 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -103.54 116.85 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.567 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -101.08 130.87 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.174 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.47 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 3.5 m-85 -132.82 93.36 23.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.708 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.21 142.96 19.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.653 2.235 . . . . 0.0 112.478 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -72.93 131.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.98 -36.56 3.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.265 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.65 2.78 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.69 -17.78 41.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.489 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -128.76 118.94 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.597 0.237 . . . . 0.0 110.644 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLN . 25.4 Cg_exo -62.33 111.01 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.36 2.04 . . . . 0.0 112.267 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 87' ' ' LEU . 25.8 t -80.13 105.78 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.69 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.16 124.09 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.02 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 85' ' ' ILE . 2.8 m-85 -81.08 -176.86 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.028 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.4 m -102.54 -25.5 13.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.685 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.07 140.24 2.88 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.544 ' OG ' HD21 ' A' ' 43' ' ' LEU . 6.0 t -95.21 145.11 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -145.22 -66.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -121.22 160.3 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.647 HG11 ' O ' ' A' ' 46' ' ' LYS . 10.3 m -76.95 -28.58 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.284 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.68 -33.43 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.57 -35.28 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 112' ' ' ILE . 53.0 tp -72.71 -46.69 52.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -57.16 -38.91 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.58 -49.81 71.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.47 -46.98 85.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 109' ' ' ILE . 18.8 mt -51.46 -41.03 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.176 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 119' ' ' LYS . . . -67.98 -30.06 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -75.05 -51.6 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.68 -43.9 58.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 138.57 49.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.58 -38.7 28.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -57.5 -29.58 64.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -91.14 -22.99 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.01 -170.1 1.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.09 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.9 144.26 52.7 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.589 2.193 . . . . 0.0 112.376 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.01 -51.74 62.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.33 125.5 2.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.6 p -68.06 -30.36 69.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -97.79 20.13 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.38 -118.72 4.39 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.461 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.26 -56.69 2.65 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.419 2.079 . . . . 0.0 112.304 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.23 126.4 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.1 m -129.42 135.73 49.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.2 139.15 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.984 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 30' ' ' ILE . 7.1 t -123.99 97.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.8 t -96.54 166.46 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.679 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -53.15 -39.05 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 111.31 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.82 -9.99 54.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.76 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -47.19 4.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.777 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -46.97 -50.56 18.86 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.395 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.9 p-10 -51.67 -32.84 31.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.25 -59.25 2.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.948 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.851 HD11 HG13 ' A' ' 12' ' ' VAL . 11.0 pt -56.37 -47.62 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 17' ' ' TYR . 28.0 m -62.74 -38.27 81.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.652 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 71.2 mt -77.32 -10.47 59.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.51 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.88 104.31 0.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 5.8 m-20 -79.35 -20.08 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -95.48 22.12 7.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.303 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -177.03 137.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.381 . . . . 0.0 111.048 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 t0 -83.78 140.01 32.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.701 HG11 ' HB ' ' A' ' 20' ' ' ILE . 16.0 t -133.79 141.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 111.462 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -128.25 118.94 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.711 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -111.66 123.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.765 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -111.84 132.46 54.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.2 m-85 -101.98 129.5 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 41.5 p90 -152.11 173.36 15.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.7 145.93 32.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 44.5 Cg_endo -68.59 -42.08 5.43 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.45 2.1 . . . . 0.0 112.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 25.8 p90 -79.44 -3.47 46.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.7 t -53.8 -48.57 69.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.27 -42.2 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.415 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.68 -1.93 25.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.715 0.293 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 13.3 m -110.06 -22.48 11.79 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -27.34 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.246 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.47 -29.28 52.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.027 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.838 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -64.3 -30.9 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -59.6 -62.0 6.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 27.4 Cg_endo -62.45 -36.78 63.98 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.9 mttp -63.9 -29.16 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -82.16 -25.4 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.35 -36.31 66.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' HD12 ' A' ' 53' ' ' LEU . 17.2 tt0 -73.52 -56.79 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.7 tp -60.39 -28.93 68.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.66 -50.62 53.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.09 -30.14 67.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.454 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.2 mt -70.63 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.565 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.84 -31.04 66.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.02 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.93 72.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.33 35.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -118.21 -176.35 3.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.35 -28.67 68.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -96.63 38.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -70.94 -37.47 72.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.18 16.25 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 118' ' ' TYR . 5.9 mtt180 -110.77 -31.72 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 54' ' ' TYR . 9.9 p -144.08 155.72 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 64' ' ' VAL . 12.1 p -135.28 123.18 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.259 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.499 HD13 HD12 ' A' ' 29' ' ' LEU . 19.8 mm -84.55 106.16 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.74 126.62 53.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.53 150.4 27.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 30' ' ' ILE . 11.5 p -164.28 154.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.219 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 68' ' ' VAL . 44.1 m-20 -95.23 146.15 24.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -77.47 56.83 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 111.252 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -137.63 20.63 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.0 -177.72 6.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.254 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.4 m120 -116.65 157.2 25.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.52 48.49 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.637 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -131.82 93.19 28.26 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.006 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 79.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.592 2.195 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -114.02 117.61 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -119.62 107.44 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.804 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.8 160.06 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.26 -36.55 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.28 141.31 12.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.509 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -40.69 -44.28 4.84 Favored Pre-proline 0 CA--C 1.487 -1.455 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 15.8 Cg_exo -63.98 81.21 0.15 Allowed 'Trans proline' 0 N--CA 1.427 -2.399 0 CA-C-N 119.318 0.792 . . . . 0.0 111.382 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.804 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -91.17 142.32 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.388 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.765 HG23 ' OE1' ' A' ' 31' ' ' GLU . 6.9 mt -132.87 107.81 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 30' ' ' ILE . 4.4 mtpt -103.86 129.99 51.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.915 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -113.62 132.06 55.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 39.2 m-85 -130.26 93.42 33.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.5 142.2 36.2 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.542 2.161 . . . . 0.0 112.436 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.21 115.92 17.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.65 -21.6 27.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.6 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.44 47.47 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 111.512 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -89.39 -164.12 1.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.32 -17.95 42.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.557 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -129.01 112.42 18.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.675 0.274 . . . . 0.0 110.621 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 110.91 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.349 2.033 . . . . 0.0 112.106 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.0 t -80.01 105.76 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.05 130.95 40.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' A' ' 85' ' ' ILE . 4.2 m-85 -75.62 -178.06 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.023 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -106.69 -26.78 11.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.29 127.17 1.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.564 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.838 ' OG ' HD21 ' A' ' 43' ' ' LEU . 4.6 t -89.41 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -147.37 -77.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.47 HG21 ' OE1' ' A' ' 106' ' ' GLU . 5.6 m -115.46 155.89 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' A' ' 50' ' ' LEU . 7.0 m -69.24 -26.84 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.326 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' OE1' HG21 ' A' ' 104' ' ' THR . 4.6 pt-20 -57.45 -35.33 70.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.3 -29.17 61.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.67 ' HG ' HD11 ' A' ' 112' ' ' ILE . 19.8 tp -72.63 -51.05 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.096 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.2 tt -56.04 -45.62 80.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.482 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.7 tttt -57.03 -48.97 77.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.04 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -52.24 66.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.67 HD11 ' HG ' ' A' ' 108' ' ' LEU . 15.3 mt -48.57 -34.52 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.79 -30.43 62.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.822 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -80.54 -46.29 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -81.25 -33.95 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.993 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.93 23.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.646 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -26.73 37.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.778 0.323 . . . . 0.0 110.963 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' A' ' 62' ' ' ARG . 18.3 m-85 -54.58 -29.09 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -92.61 -22.97 19.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.09 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.42 100.57 6.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.085 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.489 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.22 132.77 45.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 1' ' ' GLY . 1.7 mp -130.7 -59.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.32 -135.65 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.506 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -65.18 -46.64 79.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -65.26 -29.52 70.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.56 119.96 18.93 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.67 -51.28 11.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.426 2.084 . . . . 0.0 112.316 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG12 ' HD3' ' A' ' 67' ' ' LYS . 6.0 m -66.49 121.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -119.86 129.64 54.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.75 143.36 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.59 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -134.65 97.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 16' ' ' ASN . 10.9 p -114.0 160.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -46.82 -34.4 5.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.051 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -86.79 -7.43 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -115.55 -51.61 2.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.16 -51.29 10.65 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.56 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 6.6 p-10 -48.14 -34.43 9.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -75.79 -59.2 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG21 ' A' ' 28' ' ' VAL . 9.7 pt -54.69 -47.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.9 m -62.0 -44.96 99.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.493 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' ASN . 84.8 mt -69.06 -12.41 61.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.369 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' HG22 ' A' ' 25' ' ' THR . 1.1 t0 -72.13 103.15 3.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.786 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.8 p30 -79.33 -12.36 59.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.461 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.611 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.3 t -68.66 -28.81 67.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.722 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -143.45 159.4 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.798 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.7 t -133.88 141.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.4 mt -127.53 142.38 51.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 68' ' ' VAL . 11.4 tt -139.73 122.02 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 43' ' ' LEU . 1.2 tp10 -110.94 143.94 40.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.8 m-85 -113.47 113.85 25.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 45.1 p90 -135.75 171.5 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.69 147.97 41.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.23 -43.83 2.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.494 2.129 . . . . 0.0 112.386 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -78.77 -3.39 44.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.477 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.2 t -50.21 -48.67 54.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.807 0.337 . . . . 0.0 111.312 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.3 -36.26 4.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.495 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -114.69 -4.59 12.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.686 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 22.5 m -104.08 -19.91 14.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -49.47 -28.05 4.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.045 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.41 44.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.575 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -61.4 -30.72 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.77 -62.8 5.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.8 Cg_endo -60.69 -35.32 89.89 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 112.149 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 105' ' ' VAL . 18.1 mmtm -65.75 -28.98 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.802 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -79.23 -27.77 42.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -72.22 -31.46 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -75.49 -60.2 2.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD22 ' HB ' ' A' ' 105' ' ' VAL . 32.4 tp -58.82 -30.42 67.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.06 -41.94 79.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.68 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -57.15 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -29.93 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.98 -30.12 58.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -74.26 -31.31 62.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -59.71 -173.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.16 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 29.9 m-85 -119.48 37.08 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.1 -46.87 87.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.15 16.21 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -110.77 -53.55 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.89 152.27 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.21 126.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.535 HG22 ' CE2' ' A' ' 47' ' ' TYR . 14.0 mm -82.97 113.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 29' ' ' LEU . . . -113.6 126.72 55.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HD3' HG12 ' A' ' 9' ' ' VAL . 7.6 ptmt -109.42 134.56 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.734 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 30' ' ' ILE . 10.0 p -144.6 158.2 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.271 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 p30 -100.98 146.3 27.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.502 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -83.09 47.65 1.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.283 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -137.68 20.61 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.92 -177.76 5.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.302 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -110.16 157.13 19.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.11 40.18 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.9 p -124.17 78.12 59.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 79.02 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.578 2.185 . . . . 0.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -127.44 88.93 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.089 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.16 118.95 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.783 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.54 160.06 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.467 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -44.34 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.773 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.96 141.3 13.39 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.952 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -46.44 -45.96 45.84 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.46 72.06 3.02 Favored 'Trans proline' 0 N--CA 1.424 -2.602 0 CA-C-N 119.444 0.837 . . . . 0.0 111.152 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.783 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -87.0 142.97 27.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.249 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 99' ' ' TYR . 10.0 mt -126.58 111.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 30' ' ' ILE . 31.4 mttp -103.45 127.29 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -109.38 136.52 48.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.455 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 27.8 m-85 -132.67 93.56 24.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.09 144.96 38.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 112.436 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.89 118.87 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -36.1 4.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.377 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -124.12 16.67 9.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -173.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.77 47.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.543 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 112.95 19.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.593 0.235 . . . . 0.0 110.681 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.23 118.56 5.67 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.377 2.051 . . . . 0.0 112.356 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.13 105.99 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 109.47 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.1 m-85 -64.43 -176.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.034 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -116.43 15.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.931 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.42 131.53 3.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.575 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.4 t -89.93 162.93 15.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -159.78 -67.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 m -131.34 156.55 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 46' ' ' LYS . 31.5 m -68.41 -30.63 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.255 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -59.82 -34.19 72.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.63 -29.3 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.844 HD23 HD11 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -72.45 -50.25 27.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -58.94 -45.89 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' N ' HG23 ' A' ' 109' ' ' ILE . 6.8 ttpt -58.32 -41.43 84.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.98 -46.93 76.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.844 HD11 HD23 ' A' ' 108' ' ' LEU . 14.2 mt -54.05 -30.14 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' HA ' ' CB ' ' A' ' 119' ' ' LYS . . . -79.85 -30.6 40.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -80.03 -28.72 39.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -114.77 22.2 13.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.025 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -108.42 147.96 16.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -80.54 -31.97 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -76.47 -32.36 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' CB ' ' HA ' ' A' ' 113' ' ' ALA . 2.1 mptp? -92.99 -23.05 18.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.38 39.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.123 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.114 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.31 -177.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.194 . . . . 0.0 112.255 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 3' ' ' LEU . 7.5 tp -94.34 -50.71 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.21 -43.39 1.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 m -76.41 -31.25 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.907 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -95.24 -29.77 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.86 91.05 0.78 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.55 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.91 -25.34 28.03 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.536 2.157 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.6 m -57.36 144.6 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.19 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -118.56 144.24 46.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 143.36 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.853 HG11 HD12 ' A' ' 30' ' ' ILE . 21.8 t -144.12 97.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.255 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 16' ' ' ASN . 9.9 p -103.37 161.01 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.649 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.514 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -47.32 -33.56 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.67 -7.59 58.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.573 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -113.73 -46.26 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 111.627 -179.39 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.787 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -43.59 -47.93 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.674 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 5.8 p-10 -51.03 -33.1 23.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.727 0.299 . . . . 0.0 111.769 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -59.24 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 12' ' ' VAL . 11.4 pt -56.1 -46.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.4 m -65.08 -38.72 83.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.662 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.94 -9.67 58.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.431 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.49 104.32 2.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.785 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.5 p-10 -79.27 -12.37 59.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.4 p -68.75 -44.27 74.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.773 0.32 . . . . 0.0 111.08 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.734 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 27.3 mttm -127.73 166.13 18.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.068 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -91.44 148.21 22.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.754 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.2 t -133.84 145.92 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.248 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 65' ' ' ILE . 6.6 mt -130.5 98.17 4.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.853 HD12 HG11 ' A' ' 12' ' ' VAL . 8.1 tt -102.34 117.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.755 ' OE1' HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -107.93 127.25 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 29.0 m-85 -93.45 119.83 33.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.611 ' HB3' HD13 ' A' ' 43' ' ' LEU . 15.0 p90 -136.96 174.17 10.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.85 144.42 26.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.26 -45.03 2.04 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.422 2.082 . . . . 0.0 112.124 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -3.88 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 32.5 t -52.38 -49.97 63.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.45 -39.52 2.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.312 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -108.03 -2.29 19.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 18.1 m -108.93 -21.17 12.77 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.265 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -27.18 6.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.53 -22.98 43.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -59.22 -29.43 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -65.3 -62.71 4.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.483 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.3 Cg_endo -59.01 -26.56 82.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.571 2.181 . . . . 0.0 112.356 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.591 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -78.56 -28.94 46.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -79.26 -30.03 42.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.161 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 10.9 pt-20 -74.98 -38.28 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.05 -53.66 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' A' ' 105' ' ' VAL . 24.0 tp -64.8 -32.92 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.655 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.15 97.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.6 65.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.43 -57.63 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.79 69.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.45 -24.23 57.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.24 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -95.48 37.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 m -126.48 -173.73 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.789 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 37.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.964 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -138.68 30.02 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.28 72.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -94.05 16.28 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.232 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -113.29 -63.87 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 29' ' ' LEU . 19.7 t -122.7 155.84 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 63' ' ' VAL . 11.8 p -141.37 128.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.162 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.958 HD13 HD12 ' A' ' 29' ' ' LEU . 24.2 mm -83.96 118.59 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -129.93 132.42 46.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.361 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -102.32 160.65 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 30' ' ' ILE . 14.4 p -167.98 158.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 m-20 -105.58 146.14 30.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.553 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -90.48 44.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.6 20.76 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.93 -177.73 6.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 111.2 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.54 142.65 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.748 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 63.37 51.52 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -138.03 86.25 18.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.42 79.89 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -110.31 105.69 14.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 105.06 14.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.67 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.1 OUTLIER -136.75 160.08 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.612 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -69.43 -57.89 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.24 16.77 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.562 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.585 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -43.19 -48.14 15.8 Favored Pre-proline 0 CA--C 1.484 -1.577 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -68.39 76.44 0.71 Allowed 'Trans proline' 0 N--CA 1.423 -2.652 0 CA-C-N 119.282 0.779 . . . . 0.0 110.785 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.67 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -97.39 139.88 32.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.24 -178.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 99' ' ' TYR . 6.8 mt -115.5 120.02 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.6 ' HB2' HG23 ' A' ' 30' ' ' ILE . 7.7 mttp -105.34 112.86 26.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.486 HD21 HG12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.998 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.431 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 49.1 m-85 -132.71 93.5 24.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.45 133.37 20.62 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.605 2.204 . . . . 0.0 112.454 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -71.27 117.32 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -35.72 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.32 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.38 17.61 11.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 0.0 111.302 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -170.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.84 41.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -128.97 112.45 18.62 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.71 0.29 . . . . 0.0 110.636 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.84 117.39 4.86 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.442 2.095 . . . . 0.0 112.29 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.3 t -80.15 105.81 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.64 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.3 112.16 23.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.3 m-85 -66.32 -178.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -109.42 -24.99 10.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.839 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.01 132.02 1.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.276 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.54 ' CB ' HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -145.3 161.74 38.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.36 26.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.14 146.87 14.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' A' ' 50' ' ' LEU . 11.9 m -77.8 -30.85 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.1 -36.78 78.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.12 -30.07 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.755 HD11 ' OE1' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -69.27 -53.54 19.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.901 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -56.33 -45.83 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' N ' HG23 ' A' ' 109' ' ' ILE . 5.1 mttm -58.03 -44.42 87.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -43.91 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.901 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.7 mt -56.35 -31.18 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.097 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.74 -30.4 51.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.99 -28.15 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 25.89 9.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.22 142.96 16.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -80.54 -28.17 37.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -93.3 19.79 7.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.357 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 28.4 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.754 0.311 . . . . 0.0 111.023 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 57.31 92.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.653 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.27 -42.33 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 1' ' ' GLY . 4.3 mp 60.53 31.05 20.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 23.01 9.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.562 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 t -86.51 -50.67 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -100.02 20.12 15.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.75 -61.7 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.588 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.15 -30.14 20.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.578 2.185 . . . . 0.0 112.343 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.525 HG13 ' HG2' ' A' ' 67' ' ' LYS . 34.8 t -66.72 139.05 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -135.59 138.1 42.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.33 143.46 11.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.096 HG11 HD12 ' A' ' 30' ' ' ILE . 3.4 t -135.36 109.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.9 p -124.79 166.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -44.14 -38.65 3.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.8 ptpt -86.63 -7.5 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -111.41 -52.64 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.588 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.792 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -47.09 -52.55 14.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.437 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 7.4 p-10 -50.23 -35.7 27.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 111.795 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -75.87 -59.28 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.741 ' O ' HG21 ' A' ' 28' ' ' VAL . 13.3 pt -54.7 -47.0 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.6 m -64.59 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.626 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.34 -9.74 58.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.407 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -69.78 103.45 2.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.868 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.1 p30 -79.28 -12.47 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.5 p -94.53 19.65 9.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.659 0.266 . . . . 0.0 111.337 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -173.49 143.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.641 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -83.78 140.16 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 20' ' ' ILE . 16.2 t -133.43 137.6 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -130.37 104.66 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.096 HD12 HG11 ' A' ' 12' ' ' VAL . 5.2 tt -105.23 130.38 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 10.6 tm-20 -122.55 118.23 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HG13 ' A' ' 68' ' ' VAL . 41.4 m-85 -88.25 125.44 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.632 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -143.26 164.46 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.2 148.5 57.4 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 -37.81 11.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.512 2.141 . . . . 0.0 112.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -3.47 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.0 t -52.46 -46.6 66.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.88 -37.07 3.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.671 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -116.07 -6.51 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 110.94 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.9 m -98.12 -20.38 17.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.951 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -49.48 -28.29 5.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.57 -26.8 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 102' ' ' SER . 0.2 OUTLIER -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.631 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.33 -62.76 4.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.631 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.3 Cg_endo -59.62 -31.6 94.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 0.0 112.225 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -71.11 -29.19 64.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.755 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.19 -25.85 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -71.37 -38.87 71.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -70.08 -50.63 39.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.622 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.4 tp -60.31 -35.22 75.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.617 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.02 -39.12 96.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.324 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.57 75.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -52.81 14.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.737 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' HD2' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -59.06 -29.43 67.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.23 -27.02 32.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.38 32.56 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 -173.64 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.756 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 22.68 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -138.77 28.44 2.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.837 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -34.42 77.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -79.87 -29.39 39.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -56.38 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 29' ' ' LEU . 21.2 t -116.46 148.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.5 p -134.48 122.1 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.834 HD13 HD12 ' A' ' 29' ' ' LEU . 22.9 mm -81.86 124.73 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.62 126.75 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.56 139.79 44.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.775 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.858 HG11 HD11 ' A' ' 30' ' ' ILE . 11.1 p -154.26 151.73 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.23 146.26 26.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.409 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -74.59 51.2 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.417 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -137.76 20.56 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.15 -178.08 2.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.936 0.398 . . . . 0.0 111.369 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -123.04 151.17 42.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.921 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.51 57.47 6.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 73' ' ' ASN . 36.1 t -144.44 93.89 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.995 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.71 78.29 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.527 2.151 . . . . 0.0 112.228 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -108.03 82.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 112.89 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.632 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -137.04 160.21 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.537 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.77 -29.47 22.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 83' ' ' PRO . . . -132.29 141.63 13.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.763 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -42.17 -45.41 9.62 Favored Pre-proline 0 CA--C 1.488 -1.408 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 36.0 Cg_endo -66.38 75.9 0.36 Allowed 'Trans proline' 0 N--CA 1.427 -2.393 0 CA-C-N 119.759 0.95 . . . . 0.0 111.605 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 1.1 m -77.69 136.07 38.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.25 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 102' ' ' SER . 6.3 mt -132.7 107.99 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' HG23 ' A' ' 30' ' ' ILE . 13.8 mttm -104.04 121.31 42.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -105.68 133.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.445 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m-85 -132.75 93.35 24.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.802 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.85 145.45 19.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.574 2.182 . . . . 0.0 112.414 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.868 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.94 143.16 39.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.9 -37.34 3.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.349 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.27 13.24 7.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.622 0.249 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' N ' ' CE ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -55.36 -173.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.44 -17.28 43.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.5 116.07 32.21 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.575 0.226 . . . . 0.0 110.622 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.5 114.95 3.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.366 2.044 . . . . 0.0 112.355 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -80.07 105.88 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -89.15 109.3 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.4 m-85 -68.55 -178.36 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.6 t -110.04 -28.9 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.36 143.51 4.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -108.35 -177.75 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.006 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 179.6 -35.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 106' ' ' GLU . 5.2 m -148.64 148.6 30.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.622 ' HB ' HD22 ' A' ' 50' ' ' LEU . 10.5 m -67.1 -27.01 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.317 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 104' ' ' THR . 18.1 pt-20 -59.49 -35.19 73.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.967 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.34 -30.71 57.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -69.74 -51.75 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.916 ' HA ' HD12 ' A' ' 112' ' ' ILE . 5.1 tt -57.95 -45.96 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.223 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 109' ' ' ILE . 58.9 tttt -58.1 -37.68 74.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.186 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -42.54 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.068 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.4 mt -57.87 -28.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -83.95 -28.76 27.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -28.13 42.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 23.61 11.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.24 124.32 5.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.57 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -67.5 -32.38 73.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -60.99 -29.55 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmpp? -88.66 -22.97 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 60.59 87.3 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.111 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.15 -38.63 71.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 3' ' ' LEU . 3.2 mm? -65.24 103.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 9' ' ' VAL . . . 173.97 -93.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.577 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 m -79.46 -30.6 42.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -97.88 20.17 12.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.63 -99.05 0.88 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.666 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.72 -62.77 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.12 . . . . 0.0 112.455 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 4' ' ' GLY . 9.0 m -75.9 147.59 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.4 m -126.47 144.33 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 143.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.908 HG11 HD12 ' A' ' 30' ' ' ILE . 15.6 t -143.91 97.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.3 p -105.26 162.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.77 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.81 -35.79 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -86.65 -7.54 58.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.601 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -111.8 -47.22 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 111.639 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.45 -48.59 13.8 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.518 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 6.3 p-10 -50.98 -34.3 28.41 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.78 -59.31 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.753 HD11 HG13 ' A' ' 12' ' ' VAL . 16.3 pt -55.26 -46.43 78.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 21.9 m -66.16 -38.27 81.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.631 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.74 -10.35 59.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.39 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.7 105.06 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.911 0.386 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 25' ' ' THR . 25.5 p30 -79.29 -12.45 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 24' ' ' ASP . 67.0 p -112.13 23.17 14.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.642 0.258 . . . . 0.0 111.291 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -167.13 130.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.66 136.23 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.84 146.31 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -126.94 107.65 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.908 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -107.76 115.94 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.703 ' OE2' HD21 ' A' ' 43' ' ' LEU . 3.0 tt0 -111.18 122.12 47.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 35.3 m-85 -88.39 132.21 34.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 43' ' ' LEU . 32.9 p90 -153.61 168.15 27.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.89 147.66 52.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 -45.13 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -75.53 -5.06 43.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.9 t -50.09 -49.15 52.49 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.813 0.339 . . . . 0.0 111.365 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.8 -35.49 4.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.662 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.23 -3.93 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.743 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 28.6 m -103.12 -20.24 14.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.47 -27.05 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.39 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.942 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.703 HD21 ' OE2' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -61.02 -27.83 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.53 -62.89 4.67 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.507 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.1 Cg_endo -59.38 -39.99 71.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.431 2.087 . . . . 0.0 112.204 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.676 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -60.69 -28.98 69.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.86 -24.59 35.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -34.83 60.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -76.48 -62.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.639 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.9 tp -59.68 -29.17 67.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.79 -46.16 69.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.09 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 111.196 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.21 -61.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.674 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.59 -29.46 64.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.5 -26.86 51.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -96.29 38.18 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -127.5 -176.2 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.94 -3.85 46.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' ' 63' ' ' VAL . 22.8 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -72.6 -42.74 64.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -93.87 16.18 14.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.31 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 34.9 mtt180 -120.5 -55.73 2.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 54' ' ' TYR . 8.9 p -128.96 132.48 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.74 136.06 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.373 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.762 HG22 ' CE2' ' A' ' 47' ' ' TYR . 12.5 mm -89.29 117.23 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.87 130.57 50.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.001 0.429 . . . . 0.0 111.508 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 160.71 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 30' ' ' ILE . 9.1 p -168.12 149.73 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.32 145.33 37.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -79.54 51.62 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -137.67 15.13 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.61 -177.74 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.3 m-80 -127.27 165.7 19.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.88 35.23 23.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.194 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ASN . 27.4 t -131.48 94.03 27.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.15 79.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.318 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.08 106.39 15.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -108.41 113.81 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.82 160.12 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.6 -45.21 54.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.85 141.57 14.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.337 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.5 OUTLIER -37.3 -45.09 1.59 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 20.6 Cg_exo -62.53 78.49 0.1 Allowed 'Trans proline' 0 N--CA 1.429 -2.315 0 CA-C-N 119.292 0.783 . . . . 0.0 111.442 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.687 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -81.21 142.11 33.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.381 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 1.8 mp -132.91 107.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.358 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 30' ' ' ILE . 25.5 mmtt -103.38 124.48 48.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.414 ' CB ' ' HB ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -110.1 130.14 55.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.861 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 47.9 m-85 -132.81 93.56 23.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.33 147.98 23.44 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.577 2.185 . . . . 0.0 112.482 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.14 139.08 39.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.07 -38.04 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.173 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.59 57.98 1.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.0 0.429 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 -172.59 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.55 -10.04 45.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.9 pm0 -128.72 112.76 19.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.711 0.291 . . . . 0.0 110.704 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.28 111.14 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.443 2.095 . . . . 0.0 112.318 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 31.5 t -80.14 105.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -95.26 123.96 39.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.041 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.473 ' OH ' HD12 ' A' ' 108' ' ' LEU . 3.1 m-85 -69.35 -176.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.0 m -122.5 15.74 10.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.55 123.93 2.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.553 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.11 167.57 11.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.891 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.51 -66.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.509 HG21 ' OE1' ' A' ' 106' ' ' GLU . 11.2 m -128.6 154.37 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 46' ' ' LYS . 30.3 m -65.53 -28.67 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.314 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.509 ' OE1' HG21 ' A' ' 104' ' ' THR . 5.5 pt-20 -58.03 -38.81 76.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.977 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -72.89 -38.54 66.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.473 HD12 ' OH ' ' A' ' 99' ' ' TYR . 62.0 tp -60.43 -58.81 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.868 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.1 tt -51.43 -45.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.5 ' N ' HG23 ' A' ' 109' ' ' ILE . 3.2 tttt -57.5 -30.82 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -31.15 40.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 109' ' ' ILE . 27.0 mt -67.72 -28.89 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.65 -37.31 21.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -28.89 62.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.88 23.72 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.48 146.48 18.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -31.2 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 62' ' ' ARG . 5.5 m-85 -71.25 -28.17 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -93.35 -23.07 18.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -106.95 159.97 15.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.124 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.126 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.839 HG13 ' HD3' ' A' ' 67' ' ' LYS . 25.9 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 m -133.14 140.66 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.03 143.38 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 30' ' ' ILE . 17.6 t -138.49 97.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.613 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.7 p -105.72 161.5 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.31 -36.57 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HG3' HG13 ' A' ' 13' ' ' VAL . 4.7 pttt -86.64 -7.5 58.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -111.91 -46.31 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.708 0.289 . . . . 0.0 111.572 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.788 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.8 -48.77 10.95 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.593 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.547 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -51.47 -34.23 34.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.311 . . . . 0.0 111.655 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -59.2 2.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 12' ' ' VAL . 12.9 pt -56.03 -47.31 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.0 m -63.25 -38.93 83.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 18' ' ' ASN . 81.7 mt -77.63 -8.95 58.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -72.51 105.35 4.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.874 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.1 p30 -79.3 -15.58 57.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.393 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 111.076 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.558 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 25.3 tttt -142.22 150.68 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.074 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 64' ' ' VAL . 19.5 t0 -83.67 145.04 29.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.1 t -133.85 142.29 41.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.258 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.717 HD12 HD13 ' A' ' 65' ' ' ILE . 3.2 mt -125.96 103.83 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.82 HD12 HG11 ' A' ' 12' ' ' VAL . 8.8 tt -100.61 116.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.708 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -106.53 129.9 54.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.143 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 28.7 m-85 -100.15 120.19 39.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.802 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.71 176.56 8.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.62 148.16 42.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.092 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.67 -45.14 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.541 2.161 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -78.15 -3.5 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 17.9 t -50.2 -46.45 54.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.65 -40.42 2.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.48 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -108.65 -3.12 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 12.4 m -108.48 -19.98 13.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -49.65 -28.19 5.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 110.958 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.5 -27.8 37.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -33.26 72.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.849 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.98 -62.35 5.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.378 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.624 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 20.4 Cg_endo -60.9 -34.28 91.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.518 2.145 . . . . 0.0 112.272 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -29.04 68.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -78.66 -28.53 45.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.77 -35.73 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.801 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.62 -55.45 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.582 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.0 tp -60.35 -28.68 68.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.21 -43.15 90.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.575 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.07 -30.01 62.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.118 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -55.43 5.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.81 -32.66 74.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.11 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.22 -28.91 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -173.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 43.36 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -138.68 33.63 2.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.42 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.48 16.16 16.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.82 -49.77 2.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.358 . . . . 0.0 110.916 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 54' ' ' TYR . 11.9 p -135.75 139.65 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.1 p -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.717 HD13 HD12 ' A' ' 29' ' ' LEU . 20.6 mm -85.86 106.23 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.977 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.77 134.39 52.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.839 ' HD3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.51 153.16 30.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.748 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -168.16 150.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.36 146.13 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.592 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -88.11 48.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 p -137.47 20.66 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.21 -177.72 6.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.611 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -106.55 160.06 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.82 41.7 31.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.0 p -128.78 82.8 67.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 80.3 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.713 2.275 . . . . 0.0 112.344 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -125.92 93.4 3.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.47 118.18 27.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.744 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.76 160.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.546 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -76.34 -48.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.215 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.73 141.2 14.32 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.638 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -42.75 -49.12 13.68 Favored Pre-proline 0 CA--C 1.485 -1.536 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -65.91 78.52 0.29 Allowed 'Trans proline' 0 N--CA 1.424 -2.572 0 CA-C-N 119.124 0.723 . . . . 0.0 111.176 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.744 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -101.1 143.06 31.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.089 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 ' OE1' ' A' ' 31' ' ' GLU . 3.2 mp -127.8 119.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -103.42 115.34 30.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -97.3 131.24 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.0 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.446 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.8 m-85 -132.7 93.48 24.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 147.98 47.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.427 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.874 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.13 115.85 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.1 -36.87 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.291 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.98 30.0 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.012 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -172.18 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.53 -15.22 46.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.591 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.7 pm0 -128.85 112.67 18.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.771 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.95 108.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.443 2.095 . . . . 0.0 112.157 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 21.5 t -80.14 105.88 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.67 126.9 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -73.26 -177.14 2.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 p -109.58 -26.96 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.7 133.52 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 169.83 9.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -175.55 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 106' ' ' GLU . 19.8 m -149.25 148.38 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HB ' HD22 ' A' ' 50' ' ' LEU . 4.0 m -62.01 -27.91 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 104' ' ' THR . 18.7 pt-20 -58.11 -35.82 72.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.938 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.57 -29.23 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 112' ' ' ILE . 60.7 tp -70.63 -51.5 27.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.52 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.3 tt -57.39 -45.94 85.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.497 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.5 tttp -58.54 -50.9 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.003 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.07 -52.23 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.647 HG12 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -50.83 -30.86 9.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.82 -27.94 58.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.5 -38.0 22.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -92.04 -44.44 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.113 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.76 136.47 19.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.604 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -32.6 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.439 HG11 ' HG2' ' A' ' 67' ' ' LYS . 4.3 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.782 0.325 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.9 m -100.28 144.38 29.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.72 143.52 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.794 HG13 HD11 ' A' ' 20' ' ' ILE . 1.5 t -118.21 100.87 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 14' ' ' ALA . 4.6 t -94.04 163.85 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -56.33 -39.5 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.317 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.65 -7.69 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.656 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -44.64 5.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 0.0 111.356 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.28 -49.91 63.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.357 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.9 -34.68 29.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.728 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -75.28 -59.32 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG13 ' A' ' 12' ' ' VAL . 13.3 pt -56.06 -46.94 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.3 m -64.69 -37.23 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.66 -11.11 59.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.436 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.75 108.85 8.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.814 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 19.0 p-10 -79.33 -12.39 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -91.69 11.27 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.539 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -163.49 134.43 4.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.75 139.87 32.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.656 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 20' ' ' ILE . 20.9 t -133.85 141.32 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.385 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.867 HD12 HD13 ' A' ' 65' ' ' ILE . 1.7 mt -124.72 103.31 8.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.692 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.769 HD11 HG11 ' A' ' 68' ' ' VAL . 6.9 tt -101.67 127.72 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 14.8 tm-20 -117.64 124.3 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.22 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.638 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-85 -95.18 118.74 32.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.833 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 13.4 p90 -139.76 174.71 10.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.77 145.36 30.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.11 -46.48 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.476 2.118 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -78.02 -3.44 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 19.5 t -50.58 -47.19 58.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.784 0.326 . . . . 0.0 111.318 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.22 -39.84 2.73 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.574 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -110.14 -1.93 17.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.835 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 20.8 m -107.19 -22.86 12.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.45 -27.22 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.37 -28.75 41.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.758 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -62.59 -29.93 70.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.89 -61.99 6.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.615 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 17.8 Cg_endo -60.12 -36.68 88.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.428 2.085 . . . . 0.0 112.399 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -65.45 -29.09 69.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -80.52 -26.4 38.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.34 -35.62 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.659 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.68 -53.76 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.4 tp -60.58 -27.84 68.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.69 52.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.38 -27.97 65.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.266 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.35 -63.6 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -29.42 63.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.064 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.69 -34.84 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -29.13 61.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.0 -173.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -130.98 30.18 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.91 -30.28 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.55 -29.88 33.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -75.15 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.32 139.68 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.58 131.02 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.867 HD13 HD12 ' A' ' 29' ' ' LEU . 20.3 mm -81.77 120.56 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -129.3 126.65 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG2' HG11 ' A' ' 9' ' ' VAL . 3.8 pttp -106.13 155.8 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 30' ' ' ILE . 12.0 p -168.12 155.36 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -98.11 146.22 25.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -85.57 46.04 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.57 20.6 2.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.52 -177.71 5.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -95.91 158.44 15.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.827 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.4 t0 51.11 40.59 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.2 p -129.36 100.13 20.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.65 -73.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.637 2.225 . . . . 0.0 112.134 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 44.1 93.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.658 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.09 101.14 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.534 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.85 160.28 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.614 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -43.58 12.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.451 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.57 141.14 16.75 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.945 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.616 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -47.3 -46.84 57.68 Favored Pre-proline 0 CA--C 1.485 -1.522 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.22 74.07 2.56 Favored 'Trans proline' 0 N--CA 1.422 -2.699 0 CA-C-N 119.422 0.829 . . . . 0.0 110.866 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.624 ' CG2' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -98.88 121.2 40.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.203 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.574 HD11 ' CB ' ' A' ' 102' ' ' SER . 3.0 mp -102.47 116.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.48 ' NZ ' HG23 ' A' ' 98' ' ' THR . 4.6 tptt -103.34 122.23 44.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -105.8 133.5 50.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.091 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 40.8 m-85 -129.76 93.38 34.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.674 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.21 140.64 41.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.841 2.361 . . . . 0.0 112.271 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.01 115.85 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.62 -34.31 5.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.64 12.29 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.643 0.259 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -168.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.63 -17.78 42.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.421 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -128.77 130.58 23.48 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.563 0.22 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.94 112.71 3.48 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.393 2.062 . . . . 0.0 112.439 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.2 t -80.01 105.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.948 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -90.59 119.3 30.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -66.33 -175.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -26.09 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.728 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.88 127.29 1.02 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.758 ' OG ' HD21 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.86 145.15 27.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -56.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 m -134.63 155.97 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -73.87 -27.02 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.331 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.23 -35.98 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.042 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.64 -31.03 57.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.748 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.1 tt -67.68 -51.38 50.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.933 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -58.98 -45.96 91.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.206 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 109' ' ' ILE . 13.3 ttmt -58.01 -33.89 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.0 56.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.5 mt -56.36 -29.15 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.6 -37.05 25.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -72.17 -29.58 64.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.22 23.07 12.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.05 144.0 15.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.56 -29.75 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 111.038 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.407 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.766 HG13 ' HG2' ' A' ' 67' ' ' LYS . 28.8 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.833 0.349 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.4 m -116.4 121.65 42.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.25 143.36 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -129.57 97.81 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.014 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 14' ' ' ALA . 6.6 t -99.4 162.7 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.696 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -52.04 -36.16 49.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.776 0.322 . . . . 0.0 111.456 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -9.19 56.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -41.13 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.556 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -58.47 -39.84 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -56.82 -38.81 73.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.92 -43.92 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 12' ' ' VAL . 20.9 pt -66.8 -45.44 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 19.4 m -70.03 -36.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 18' ' ' ASN . 85.3 mt -76.83 -14.74 59.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 110.15 1.04 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.77 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 12.2 t70 -79.24 -12.29 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.405 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -106.62 14.91 26.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 141.85 19.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -98.69 127.5 44.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.692 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 64' ' ' VAL . 38.4 t -133.91 147.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 111.438 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -128.84 114.73 16.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.764 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.765 HD11 HG11 ' A' ' 68' ' ' VAL . 8.3 tt -105.03 118.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.203 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.9 tm-20 -109.31 131.54 54.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 75' ' ' VAL . 28.2 m-85 -103.36 126.1 50.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 111.364 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 44' ' ' ALA . 32.8 p90 -152.84 171.17 18.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.59 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 155.63 59.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 27.2 Cg_endo -63.35 -56.88 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.55 2.167 . . . . 0.0 112.103 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p90 -61.91 -18.46 60.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.701 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 t -42.87 -39.97 2.74 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.563 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.72 -64.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.27 -69.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 7.3 p -67.15 -13.64 62.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.446 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -51.3 -27.38 9.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.896 0.379 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.36 63.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -61.05 -22.33 64.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . . . -66.73 -63.13 3.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.549 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 12.0 Cg_endo -56.24 -35.7 95.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -70.09 -25.8 63.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -77.42 -29.03 52.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.234 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 1.6 pt-20 -77.29 -31.15 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.33 -51.36 37.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' HB ' ' A' ' 105' ' ' VAL . 30.5 tp -70.25 -30.52 67.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.5 -50.66 63.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.313 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.62 -38.82 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.946 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -60.34 3.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.797 ' CE1' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.55 -27.6 58.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.15 -33.06 33.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -77.18 -30.71 55.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 m -58.91 176.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.73 -10.84 60.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -95.96 38.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -30.35 65.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -105.71 16.22 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -116.48 -41.24 3.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.797 HG11 ' CE1' ' A' ' 54' ' ' TYR . 14.3 p -126.55 150.23 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.735 ' CG1' HG22 ' A' ' 28' ' ' VAL . 11.7 p -138.88 122.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.608 HG22 ' CE2' ' A' ' 47' ' ' TYR . 15.1 mm -87.86 110.41 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.799 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -113.43 128.44 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.93 144.31 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.561 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.765 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -151.38 156.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.256 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.458 ' N ' HG22 ' A' ' 68' ' ' VAL . 20.8 m-20 -94.79 146.23 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.59 51.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.41 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -137.75 19.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.923 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -177.78 6.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 111.407 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -118.39 153.15 34.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.834 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 58.02 47.0 15.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.5 p -133.18 89.57 32.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.549 2.166 . . . . 0.0 112.077 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -112.22 84.91 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.06 109.72 20.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.864 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.77 160.17 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.597 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.29 -43.3 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.31 141.34 16.5 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.896 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -45.09 -45.96 28.97 Favored Pre-proline 0 CA--C 1.487 -1.472 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 37.3 Cg_endo -67.75 80.35 0.48 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 CA-C-N 119.548 0.874 . . . . 0.0 111.435 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.864 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -86.09 137.28 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.134 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 28.6 mt -130.93 109.53 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.774 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 30' ' ' ILE . 10.1 mptt -103.38 119.36 38.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.06 128.1 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 11.3 m-85 -132.74 93.4 24.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.43 154.17 21.17 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.595 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.16 117.66 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.05 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.98 -38.0 3.35 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.46 11.26 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.658 0.266 . . . . 0.0 111.486 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -173.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.2 -17.84 43.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.367 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.82 121.93 21.21 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.519 0.2 . . . . 0.0 110.636 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.17 107.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.324 2.016 . . . . 0.0 112.176 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.1 105.83 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.7 p -93.09 128.9 39.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.4 m-85 -69.54 176.82 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.6 -24.88 12.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.82 117.04 0.62 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 43' ' ' LEU . 25.7 p -76.65 145.86 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -148.19 -72.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.465 HG21 ' OE2' ' A' ' 106' ' ' GLU . 3.8 m -132.35 165.18 24.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.766 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -72.82 -29.06 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.43 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.465 ' OE2' HG21 ' A' ' 104' ' ' THR . 8.4 pt-20 -57.06 -31.36 65.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.951 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.04 -30.28 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tp -72.02 -49.99 32.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.5 tt -57.22 -46.38 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' N ' HG23 ' A' ' 109' ' ' ILE . 14.3 ttpt -63.13 -37.36 86.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.66 51.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 109' ' ' ILE . 3.8 mt -55.11 -29.83 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.42 63.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.59 -26.43 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -116.14 23.0 12.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.148 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.53 138.8 10.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.519 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -6.29 58.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.584 0.231 . . . . 0.0 111.366 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 3.2 m-85 . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.629 0.252 . . . . 0.0 111.323 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 67' ' ' LYS . 23.3 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.804 0.335 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.9 m -111.01 127.65 55.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.66 143.39 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -133.25 97.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.5 t -105.26 167.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -51.54 -41.23 60.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.552 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -86.73 -7.65 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.934 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.54 -52.67 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.492 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -49.23 -55.7 11.72 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.41 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -46.2 -34.95 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -73.66 -59.35 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.7 HD11 HG13 ' A' ' 12' ' ' VAL . 9.0 pt -55.9 -49.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.852 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' TYR . 33.1 m -56.53 -43.05 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.474 ' N ' HG23 ' A' ' 21' ' ' VAL . 85.0 mt -73.22 -12.63 60.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.413 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -58.75 96.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.862 0.363 . . . . 0.0 110.804 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.772 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.2 m-20 -68.1 -19.25 64.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.371 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.74 27.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.645 0.26 . . . . 0.0 111.279 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -176.94 145.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.585 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 20' ' ' ILE . 5.8 t -133.85 146.44 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.871 0.367 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.802 HD12 HD13 ' A' ' 65' ' ' ILE . 1.9 mt -136.67 101.21 4.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.773 HD11 HG11 ' A' ' 68' ' ' VAL . 7.9 tt -102.36 119.11 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.201 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.691 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -108.19 131.33 54.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 25.5 m-85 -101.05 123.78 45.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.801 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 35.1 p90 -146.73 174.47 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.76 147.68 39.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.31 -42.11 4.18 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.622 2.215 . . . . 0.0 112.333 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -78.21 -3.44 42.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.392 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.2 t -51.43 -49.58 61.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -39.73 2.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.473 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -108.79 -3.2 17.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.623 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 16.4 m -107.22 -20.78 13.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -49.55 -27.88 4.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.78 41.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.823 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -62.97 -31.71 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.78 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -60.3 -62.32 6.16 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.447 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.622 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.7 Cg_endo -60.8 -37.32 79.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.466 2.111 . . . . 0.0 112.314 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -64.04 -29.2 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.78 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.51 -24.34 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.948 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -71.06 -35.63 72.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -52.99 9.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.0 tp -60.36 -29.12 68.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.21 -44.91 58.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.03 65.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.59 -57.56 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.13 -45.9 83.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.013 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.35 71.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.38 38.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.9 m -129.22 177.78 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.42 -21.31 64.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -95.29 38.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -74.8 -39.81 61.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.07 16.11 15.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.88 -51.56 2.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.806 0.336 . . . . 0.0 110.797 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.94 149.72 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.31 120.97 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 29' ' ' LEU . 20.9 mm -83.74 106.18 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -110.17 127.84 55.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.07 140.51 46.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.657 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 30' ' ' ILE . 12.1 p -157.11 153.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.31 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -95.5 146.2 24.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -76.3 55.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 111.345 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -137.65 20.52 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.3 -177.77 5.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 111.339 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -116.52 154.66 30.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.09 62.08 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.057 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 32' ' ' PHE . 42.5 t -154.47 104.03 2.37 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 78.59 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.491 2.127 . . . . 0.0 112.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -104.38 74.2 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -93.54 98.51 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.823 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.19 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.726 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -48.5 16.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.087 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.13 16.7 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.628 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -45.94 -44.91 36.86 Favored Pre-proline 0 CA--C 1.486 -1.49 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 7.6 Cg_exo -66.6 80.97 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.57 0 CA-C-N 119.239 0.764 . . . . 0.0 111.327 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.823 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -102.95 142.92 33.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.211 -178.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 102' ' ' SER . 4.1 mp -126.36 117.95 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.802 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HB2' HG23 ' A' ' 30' ' ' ILE . 6.2 mmtt -103.28 112.11 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.62 131.48 43.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.174 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.468 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 34.4 m-85 -132.87 93.23 24.05 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.2 145.19 17.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.672 2.248 . . . . 0.0 112.664 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.78 124.04 27.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.64 -23.9 31.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.53 29.65 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -165.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.24 -18.09 42.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.23 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -129.19 119.96 19.89 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.449 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.35 111.26 2.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.243 1.962 . . . . 0.0 112.058 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.01 105.84 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.38 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.4 p -96.55 123.18 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.481 ' CB ' HD13 ' A' ' 85' ' ' ILE . 3.6 m-85 -74.14 178.75 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -118.41 15.83 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.08 123.0 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 85' ' ' ILE . 5.8 t -100.96 155.29 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.925 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -139.72 -47.05 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.635 HG21 ' OE1' ' A' ' 106' ' ' GLU . 3.9 m -143.87 152.26 40.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.889 ' HB ' HD22 ' A' ' 50' ' ' LEU . 19.2 m -62.35 -27.05 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.4 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.635 ' OE1' HG21 ' A' ' 104' ' ' THR . 3.4 pt-20 -57.05 -34.2 68.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.097 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.53 -30.68 59.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.992 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.595 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -70.7 -53.74 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.617 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -55.81 -45.49 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.8 mtmt -58.11 -39.83 79.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.011 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CB ' ' HH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -66.4 -48.57 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -58.18 -23.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.289 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.43 33.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.56 -29.2 19.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.52 -30.99 14.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.22 136.14 20.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.51 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.43 -7.75 57.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.579 0.228 . . . . 0.0 111.355 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 111.279 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.793 0.33 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -136.94 142.92 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.36 143.43 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.025 HG11 HD12 ' A' ' 30' ' ' ILE . 15.7 t -135.6 97.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.6 p -105.2 161.66 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.776 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.9 -35.59 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -86.61 -7.48 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -112.29 -47.6 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.622 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.08 -49.06 8.98 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.473 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.11 -32.08 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -79.37 -59.39 2.78 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.843 HD11 HG13 ' A' ' 12' ' ' VAL . 20.3 pt -54.97 -38.36 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.1 m -74.52 -37.99 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.698 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.06 -6.39 52.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.546 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.42 105.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.927 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 11.5 p-10 -79.39 -12.39 59.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.418 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 28.05 8.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.205 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.88 131.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 137.41 33.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.7 t -133.82 147.45 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.397 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -133.45 104.92 6.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.693 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.025 HD12 HG11 ' A' ' 12' ' ' VAL . 9.1 tt -100.65 129.29 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -118.55 126.37 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 38.6 m-85 -97.1 117.91 32.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE1' ' HD2' ' A' ' 67' ' ' LYS . 11.9 p90 -134.91 174.33 10.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.71 145.76 32.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -46.67 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.536 2.158 . . . . 0.0 112.329 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -78.91 -3.41 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 29.6 t -48.63 -46.78 40.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.6 -36.92 3.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.595 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -114.83 -2.76 12.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.791 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.6 m -105.06 -22.3 13.13 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.063 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -49.52 -27.99 4.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.045 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.51 -28.09 37.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -60.77 -31.6 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.778 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.62 -62.68 5.27 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.629 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.5 Cg_endo -60.19 -36.55 88.0 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.436 2.09 . . . . 0.0 112.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.55 -29.23 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.45 ' CD2' ' HG3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -81.24 -24.25 37.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.56 -33.27 66.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.619 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.71 -54.15 7.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.2 tp -60.58 -31.52 70.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.733 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.46 -42.47 81.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.35 63.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 -59.58 2.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.408 ' CE1' HG13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -57.88 -39.53 78.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.61 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 t -113.1 -173.85 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.52 -18.22 58.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.271 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.13 35.8 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.989 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -29.24 70.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.157 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -103.14 16.25 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.373 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -116.9 -74.64 0.6 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 29' ' ' LEU . 21.4 t -97.32 141.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.41 128.26 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.794 HD13 HD12 ' A' ' 29' ' ' LEU . 23.4 mm -83.47 111.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -113.51 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.169 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -106.8 151.95 24.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.808 HG11 HD11 ' A' ' 30' ' ' ILE . 11.4 p -168.14 156.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 m-20 -103.62 146.13 29.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -84.23 51.69 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.864 0.364 . . . . 0.0 111.21 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 p -137.63 20.61 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.4 -177.74 4.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 111.201 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -107.63 164.05 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.66 31.58 17.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.991 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.68 HG22 ' OD1' ' A' ' 77' ' ' ASP . 8.3 p -132.13 101.95 14.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.82 -68.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.463 2.109 . . . . 0.0 112.206 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.68 ' OD1' HG22 ' A' ' 75' ' ' VAL . 5.9 p-10 42.12 83.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.715 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.12 102.84 15.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.669 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.79 160.22 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.581 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.44 -46.05 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.38 141.24 16.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.951 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -47.44 -46.23 58.07 Favored Pre-proline 0 CA--C 1.485 -1.521 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.18 71.59 3.59 Favored 'Trans proline' 0 N--CA 1.423 -2.672 0 CA-C-N 119.469 0.846 . . . . 0.0 110.973 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -92.13 142.87 27.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.181 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' CD2' ' A' ' 99' ' ' TYR . 7.9 mt -123.21 116.53 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.97 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -103.54 116.85 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.567 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -101.08 130.87 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.174 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.47 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 3.5 m-85 -132.82 93.36 23.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.708 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.21 142.96 19.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.653 2.235 . . . . 0.0 112.478 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -72.93 131.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.98 -36.56 3.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.265 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.65 2.78 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.69 -17.78 41.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.489 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.76 118.94 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.597 0.237 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLN . 25.4 Cg_exo -62.33 111.01 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.36 2.04 . . . . 0.0 112.267 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 87' ' ' LEU . 25.8 t -80.13 105.78 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.69 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.16 124.09 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.02 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 85' ' ' ILE . 2.8 m-85 -81.08 -176.86 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.028 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.4 m -102.54 -25.5 13.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.685 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.07 140.24 2.88 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.544 ' OG ' HD21 ' A' ' 43' ' ' LEU . 6.0 t -95.21 145.11 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -145.22 -66.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -121.22 160.3 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.647 HG11 ' O ' ' A' ' 46' ' ' LYS . 10.3 m -76.95 -28.58 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.284 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.68 -33.43 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.57 -35.28 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 112' ' ' ILE . 53.0 tp -72.71 -46.69 52.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -57.16 -38.91 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.58 -49.81 71.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.47 -46.98 85.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 109' ' ' ILE . 18.8 mt -51.46 -41.03 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.176 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -67.98 -30.06 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -75.05 -51.6 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.68 -43.9 58.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 138.57 49.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.58 -38.7 28.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.03 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.1 m -129.42 135.73 49.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.2 139.15 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.984 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 30' ' ' ILE . 7.1 t -123.99 97.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.8 t -96.54 166.46 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.679 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -53.15 -39.05 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 111.31 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.82 -9.99 54.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.76 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -47.19 4.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.777 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -46.97 -50.56 18.86 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.395 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.501 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.67 -32.84 31.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.25 -59.25 2.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.948 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.851 HD11 HG13 ' A' ' 12' ' ' VAL . 11.0 pt -56.37 -47.62 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 17' ' ' TYR . 28.0 m -62.74 -38.27 81.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.652 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 71.2 mt -77.32 -10.47 59.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.51 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.88 104.31 0.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 5.8 m-20 -79.35 -20.08 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -95.48 22.12 7.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.303 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -177.03 137.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.381 . . . . 0.0 111.048 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 t0 -83.78 140.01 32.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.701 HG11 ' HB ' ' A' ' 20' ' ' ILE . 16.0 t -133.79 141.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 111.462 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -128.25 118.94 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.711 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -111.66 123.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.765 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -111.84 132.46 54.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.2 m-85 -101.98 129.5 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 41.5 p90 -152.11 173.36 15.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.7 145.93 32.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 44.5 Cg_endo -68.59 -42.08 5.43 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.45 2.1 . . . . 0.0 112.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 25.8 p90 -79.44 -3.47 46.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.7 t -53.8 -48.57 69.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.27 -42.2 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.415 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.68 -1.93 25.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.715 0.293 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 13.3 m -110.06 -22.48 11.79 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -27.34 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.246 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.47 -29.28 52.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.027 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.838 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -64.3 -30.9 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -59.6 -62.0 6.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 27.4 Cg_endo -62.45 -36.78 63.98 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.9 mttp -63.9 -29.16 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -82.16 -25.4 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.35 -36.31 66.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' HD12 ' A' ' 53' ' ' LEU . 17.2 tt0 -73.52 -56.79 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.7 tp -60.39 -28.93 68.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.66 -50.62 53.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.09 -30.14 67.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.454 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.2 mt -70.63 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.565 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.84 -31.04 66.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.02 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.93 72.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.33 35.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -118.21 -176.35 3.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.35 -28.67 68.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -96.63 38.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -70.94 -37.47 72.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.18 16.25 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 118' ' ' TYR . 5.9 mtt180 -110.77 -31.72 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 54' ' ' TYR . 9.9 p -144.08 155.72 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 64' ' ' VAL . 12.1 p -135.28 123.18 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.259 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.499 HD13 HD12 ' A' ' 29' ' ' LEU . 19.8 mm -84.55 106.16 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.74 126.62 53.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.53 150.4 27.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 30' ' ' ILE . 11.5 p -164.28 154.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.219 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 68' ' ' VAL . 44.1 m-20 -95.23 146.15 24.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -77.47 56.83 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 111.252 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -137.63 20.63 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.0 -177.72 6.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.254 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -116.65 157.2 25.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.52 48.49 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.1 p -131.82 93.19 28.26 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.006 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 79.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.592 2.195 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -114.02 117.61 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -119.62 107.44 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.804 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.8 160.06 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.26 -36.55 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.28 141.31 12.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.509 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -40.69 -44.28 4.84 Favored Pre-proline 0 CA--C 1.487 -1.455 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 15.8 Cg_exo -63.98 81.21 0.15 Allowed 'Trans proline' 0 N--CA 1.427 -2.399 0 CA-C-N 119.318 0.792 . . . . 0.0 111.382 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.804 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -91.17 142.32 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.388 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.765 HG23 ' OE1' ' A' ' 31' ' ' GLU . 6.9 mt -132.87 107.81 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 30' ' ' ILE . 4.4 mtpt -103.86 129.99 51.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.915 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -113.62 132.06 55.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 39.2 m-85 -130.26 93.42 33.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.5 142.2 36.2 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.542 2.161 . . . . 0.0 112.436 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.21 115.92 17.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.65 -21.6 27.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.6 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.44 47.47 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 111.512 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -89.39 -164.12 1.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.32 -17.95 42.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.557 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -129.01 112.42 18.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.675 0.274 . . . . 0.0 110.621 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 110.91 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.349 2.033 . . . . 0.0 112.106 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.0 t -80.01 105.76 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.05 130.95 40.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' A' ' 85' ' ' ILE . 4.2 m-85 -75.62 -178.06 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.023 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -106.69 -26.78 11.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.29 127.17 1.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.564 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.838 ' OG ' HD21 ' A' ' 43' ' ' LEU . 4.6 t -89.41 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -147.37 -77.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.47 HG21 ' OE1' ' A' ' 106' ' ' GLU . 5.6 m -115.46 155.89 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' A' ' 50' ' ' LEU . 7.0 m -69.24 -26.84 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.326 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.47 ' OE1' HG21 ' A' ' 104' ' ' THR . 4.6 pt-20 -57.45 -35.33 70.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.3 -29.17 61.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.67 ' HG ' HD11 ' A' ' 112' ' ' ILE . 19.8 tp -72.63 -51.05 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.096 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.2 tt -56.04 -45.62 80.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.482 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.7 tttt -57.03 -48.97 77.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.04 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -52.24 66.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.67 HD11 ' HG ' ' A' ' 108' ' ' LEU . 15.3 mt -48.57 -34.52 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.79 -30.43 62.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.822 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -80.54 -46.29 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -81.25 -33.95 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.993 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.93 23.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.646 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -26.73 37.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.778 0.323 . . . . 0.0 110.963 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' A' ' 62' ' ' ARG . 18.3 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG12 ' HD3' ' A' ' 67' ' ' LYS . 6.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -119.86 129.64 54.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.75 143.36 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.59 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -134.65 97.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 16' ' ' ASN . 10.9 p -114.0 160.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -46.82 -34.4 5.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.051 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -86.79 -7.43 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -115.55 -51.61 2.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.16 -51.29 10.65 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.56 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -48.14 -34.43 9.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -75.79 -59.2 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG21 ' A' ' 28' ' ' VAL . 9.7 pt -54.69 -47.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.9 m -62.0 -44.96 99.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.493 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' ASN . 84.8 mt -69.06 -12.41 61.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.369 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' HG22 ' A' ' 25' ' ' THR . 1.1 t0 -72.13 103.15 3.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.786 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.8 p30 -79.33 -12.36 59.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.461 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.611 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.3 t -68.66 -28.81 67.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.722 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -143.45 159.4 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.798 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.7 t -133.88 141.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.4 mt -127.53 142.38 51.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 68' ' ' VAL . 11.4 tt -139.73 122.02 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 43' ' ' LEU . 1.2 tp10 -110.94 143.94 40.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.8 m-85 -113.47 113.85 25.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 45.1 p90 -135.75 171.5 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.69 147.97 41.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.23 -43.83 2.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.494 2.129 . . . . 0.0 112.386 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -78.77 -3.39 44.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.477 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.2 t -50.21 -48.67 54.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.807 0.337 . . . . 0.0 111.312 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.3 -36.26 4.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.495 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -114.69 -4.59 12.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.686 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 22.5 m -104.08 -19.91 14.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -49.47 -28.05 4.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.045 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.41 44.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.575 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -61.4 -30.72 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.77 -62.8 5.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.8 Cg_endo -60.69 -35.32 89.89 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 112.149 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 105' ' ' VAL . 18.1 mmtm -65.75 -28.98 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.802 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -79.23 -27.77 42.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -72.22 -31.46 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -75.49 -60.2 2.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD22 ' HB ' ' A' ' 105' ' ' VAL . 32.4 tp -58.82 -30.42 67.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.06 -41.94 79.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.68 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -57.15 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -29.93 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.98 -30.12 58.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -74.26 -31.31 62.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -59.71 -173.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.16 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 29.9 m-85 -119.48 37.08 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.1 -46.87 87.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.15 16.21 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -110.77 -53.55 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.89 152.27 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.21 126.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.535 HG22 ' CE2' ' A' ' 47' ' ' TYR . 14.0 mm -82.97 113.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 29' ' ' LEU . . . -113.6 126.72 55.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HD3' HG12 ' A' ' 9' ' ' VAL . 7.6 ptmt -109.42 134.56 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.734 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 30' ' ' ILE . 10.0 p -144.6 158.2 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.271 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 p30 -100.98 146.3 27.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.502 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -83.09 47.65 1.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.283 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -137.68 20.61 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.92 -177.76 5.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.302 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -110.16 157.13 19.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.11 40.18 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -124.17 78.12 59.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 79.02 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.578 2.185 . . . . 0.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -127.44 88.93 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.089 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.16 118.95 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.783 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.54 160.06 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.467 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -44.34 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.773 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.96 141.3 13.39 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.952 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -46.44 -45.96 45.84 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.46 72.06 3.02 Favored 'Trans proline' 0 N--CA 1.424 -2.602 0 CA-C-N 119.444 0.837 . . . . 0.0 111.152 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.783 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -87.0 142.97 27.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.249 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 99' ' ' TYR . 10.0 mt -126.58 111.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 30' ' ' ILE . 31.4 mttp -103.45 127.29 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -109.38 136.52 48.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.455 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 27.8 m-85 -132.67 93.56 24.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.09 144.96 38.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 112.436 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.89 118.87 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -36.1 4.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.377 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -124.12 16.67 9.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -173.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.77 47.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.543 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -128.44 112.95 19.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.593 0.235 . . . . 0.0 110.681 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.23 118.56 5.67 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.377 2.051 . . . . 0.0 112.356 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.13 105.99 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 109.47 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.1 m-85 -64.43 -176.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.034 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -116.43 15.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.931 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.42 131.53 3.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.575 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.4 t -89.93 162.93 15.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -159.78 -67.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 m -131.34 156.55 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 46' ' ' LYS . 31.5 m -68.41 -30.63 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.255 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -59.82 -34.19 72.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.63 -29.3 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.844 HD23 HD11 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -72.45 -50.25 27.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -58.94 -45.89 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' N ' HG23 ' A' ' 109' ' ' ILE . 6.8 ttpt -58.32 -41.43 84.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.98 -46.93 76.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.844 HD11 HD23 ' A' ' 108' ' ' LEU . 14.2 mt -54.05 -30.14 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -79.85 -30.6 40.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -80.03 -28.72 39.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.77 22.2 13.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.025 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -108.42 147.96 16.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -80.54 -31.97 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.846 0.355 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -118.56 144.24 46.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 143.36 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.853 HG11 HD12 ' A' ' 30' ' ' ILE . 21.8 t -144.12 97.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.255 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 16' ' ' ASN . 9.9 p -103.37 161.01 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.649 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.514 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -47.32 -33.56 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.67 -7.59 58.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.573 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -113.73 -46.26 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 111.627 -179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.787 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -43.59 -47.93 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.674 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.48 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.03 -33.1 23.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.727 0.299 . . . . 0.0 111.769 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -59.24 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 12' ' ' VAL . 11.4 pt -56.1 -46.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.4 m -65.08 -38.72 83.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.662 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.94 -9.67 58.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.431 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.49 104.32 2.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.785 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.5 p-10 -79.27 -12.37 59.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.4 p -68.75 -44.27 74.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.773 0.32 . . . . 0.0 111.08 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.734 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 27.3 mttm -127.73 166.13 18.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.068 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -91.44 148.21 22.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.754 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.2 t -133.84 145.92 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.248 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 65' ' ' ILE . 6.6 mt -130.5 98.17 4.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.853 HD12 HG11 ' A' ' 12' ' ' VAL . 8.1 tt -102.34 117.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.755 ' OE1' HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -107.93 127.25 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 29.0 m-85 -93.45 119.83 33.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.611 ' HB3' HD13 ' A' ' 43' ' ' LEU . 15.0 p90 -136.96 174.17 10.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.85 144.42 26.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.26 -45.03 2.04 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.422 2.082 . . . . 0.0 112.124 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -3.88 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 32.5 t -52.38 -49.97 63.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.45 -39.52 2.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.312 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -108.03 -2.29 19.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 18.1 m -108.93 -21.17 12.77 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.265 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -27.18 6.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.53 -22.98 43.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -59.22 -29.43 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -65.3 -62.71 4.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.483 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.3 Cg_endo -59.01 -26.56 82.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.571 2.181 . . . . 0.0 112.356 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.591 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -78.56 -28.94 46.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -79.26 -30.03 42.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.161 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 10.9 pt-20 -74.98 -38.28 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.05 -53.66 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' A' ' 105' ' ' VAL . 24.0 tp -64.8 -32.92 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.655 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.15 97.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.6 65.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.43 -57.63 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.79 69.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.45 -24.23 57.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.24 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -95.48 37.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 m -126.48 -173.73 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.789 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 37.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.964 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -138.68 30.02 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.28 72.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -94.05 16.28 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.232 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -113.29 -63.87 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 29' ' ' LEU . 19.7 t -122.7 155.84 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 63' ' ' VAL . 11.8 p -141.37 128.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.162 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.958 HD13 HD12 ' A' ' 29' ' ' LEU . 24.2 mm -83.96 118.59 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -129.93 132.42 46.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.361 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -102.32 160.65 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 30' ' ' ILE . 14.4 p -167.98 158.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 m-20 -105.58 146.14 30.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.553 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -90.48 44.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.6 20.76 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.93 -177.73 6.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 111.2 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.54 142.65 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.748 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 63.37 51.52 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -138.03 86.25 18.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.42 79.89 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -110.31 105.69 14.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 105.06 14.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.67 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.1 OUTLIER -136.75 160.08 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.612 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -69.43 -57.89 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.24 16.77 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.562 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.585 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -43.19 -48.14 15.8 Favored Pre-proline 0 CA--C 1.484 -1.577 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -68.39 76.44 0.71 Allowed 'Trans proline' 0 N--CA 1.423 -2.652 0 CA-C-N 119.282 0.779 . . . . 0.0 110.785 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.67 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -97.39 139.88 32.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.24 -178.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 99' ' ' TYR . 6.8 mt -115.5 120.02 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.6 ' HB2' HG23 ' A' ' 30' ' ' ILE . 7.7 mttp -105.34 112.86 26.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.486 HD21 HG12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.998 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.431 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 49.1 m-85 -132.71 93.5 24.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.45 133.37 20.62 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.605 2.204 . . . . 0.0 112.454 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -71.27 117.32 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -35.72 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.32 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.38 17.61 11.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 0.0 111.302 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -170.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.84 41.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.97 112.45 18.62 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.71 0.29 . . . . 0.0 110.636 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.84 117.39 4.86 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.442 2.095 . . . . 0.0 112.29 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.3 t -80.15 105.81 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.64 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.3 112.16 23.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.3 m-85 -66.32 -178.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -109.42 -24.99 10.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.839 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.01 132.02 1.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.276 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.54 ' CB ' HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -145.3 161.74 38.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.36 26.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.14 146.87 14.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' A' ' 50' ' ' LEU . 11.9 m -77.8 -30.85 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.1 -36.78 78.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.12 -30.07 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.755 HD11 ' OE1' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -69.27 -53.54 19.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.901 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -56.33 -45.83 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' N ' HG23 ' A' ' 109' ' ' ILE . 5.1 mttm -58.03 -44.42 87.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -43.91 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.901 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.7 mt -56.35 -31.18 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.097 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.74 -30.4 51.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.99 -28.15 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 25.89 9.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.22 142.96 16.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -80.54 -28.17 37.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.357 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.525 HG13 ' HG2' ' A' ' 67' ' ' LYS . 34.8 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.799 0.333 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -135.59 138.1 42.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.33 143.46 11.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.096 HG11 HD12 ' A' ' 30' ' ' ILE . 3.4 t -135.36 109.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.9 p -124.79 166.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -44.14 -38.65 3.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.8 ptpt -86.63 -7.5 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -111.41 -52.64 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.588 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.792 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -47.09 -52.55 14.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.437 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.23 -35.7 27.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 111.795 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -75.87 -59.28 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.741 ' O ' HG21 ' A' ' 28' ' ' VAL . 13.3 pt -54.7 -47.0 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.6 m -64.59 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.626 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.34 -9.74 58.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.407 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -69.78 103.45 2.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.868 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.1 p30 -79.28 -12.47 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.5 p -94.53 19.65 9.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.659 0.266 . . . . 0.0 111.337 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -173.49 143.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.641 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -83.78 140.16 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 20' ' ' ILE . 16.2 t -133.43 137.6 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -130.37 104.66 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.096 HD12 HG11 ' A' ' 12' ' ' VAL . 5.2 tt -105.23 130.38 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 10.6 tm-20 -122.55 118.23 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HG13 ' A' ' 68' ' ' VAL . 41.4 m-85 -88.25 125.44 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.632 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -143.26 164.46 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.2 148.5 57.4 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 -37.81 11.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.512 2.141 . . . . 0.0 112.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -3.47 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.0 t -52.46 -46.6 66.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.88 -37.07 3.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.671 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -116.07 -6.51 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 110.94 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.9 m -98.12 -20.38 17.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.951 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -49.48 -28.29 5.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.57 -26.8 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 102' ' ' SER . 0.2 OUTLIER -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.631 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.33 -62.76 4.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.631 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.3 Cg_endo -59.62 -31.6 94.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 0.0 112.225 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -71.11 -29.19 64.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.755 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.19 -25.85 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -71.37 -38.87 71.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -70.08 -50.63 39.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.622 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.4 tp -60.31 -35.22 75.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.617 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.02 -39.12 96.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.324 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.57 75.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -52.81 14.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.737 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE1' ' HB ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.06 -29.43 67.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.23 -27.02 32.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.38 32.56 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 -173.64 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.756 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 22.68 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -138.77 28.44 2.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.837 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -34.42 77.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -79.87 -29.39 39.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -56.38 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 29' ' ' LEU . 21.2 t -116.46 148.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.5 p -134.48 122.1 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.834 HD13 HD12 ' A' ' 29' ' ' LEU . 22.9 mm -81.86 124.73 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.62 126.75 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.56 139.79 44.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.775 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.858 HG11 HD11 ' A' ' 30' ' ' ILE . 11.1 p -154.26 151.73 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.23 146.26 26.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.409 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -74.59 51.2 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.417 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -137.76 20.56 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.15 -178.08 2.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.936 0.398 . . . . 0.0 111.369 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -123.04 151.17 42.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.921 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.51 57.47 6.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 73' ' ' ASN . 36.1 t -144.44 93.89 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.995 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.71 78.29 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.527 2.151 . . . . 0.0 112.228 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -108.03 82.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 112.89 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.632 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -137.04 160.21 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.537 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.77 -29.47 22.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 83' ' ' PRO . . . -132.29 141.63 13.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.763 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -42.17 -45.41 9.62 Favored Pre-proline 0 CA--C 1.488 -1.408 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 36.0 Cg_endo -66.38 75.9 0.36 Allowed 'Trans proline' 0 N--CA 1.427 -2.393 0 CA-C-N 119.759 0.95 . . . . 0.0 111.605 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 1.1 m -77.69 136.07 38.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.25 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 102' ' ' SER . 6.3 mt -132.7 107.99 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' HG23 ' A' ' 30' ' ' ILE . 13.8 mttm -104.04 121.31 42.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -105.68 133.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.445 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m-85 -132.75 93.35 24.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.802 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.85 145.45 19.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.574 2.182 . . . . 0.0 112.414 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.868 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.94 143.16 39.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.9 -37.34 3.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.349 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.27 13.24 7.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.622 0.249 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CE ' ' N ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -55.36 -173.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.44 -17.28 43.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -120.5 116.07 32.21 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.575 0.226 . . . . 0.0 110.622 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.5 114.95 3.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.366 2.044 . . . . 0.0 112.355 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -80.07 105.88 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -89.15 109.3 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.44 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.4 m-85 -68.55 -178.36 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.6 t -110.04 -28.9 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.36 143.51 4.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -108.35 -177.75 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.006 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 179.6 -35.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 106' ' ' GLU . 5.2 m -148.64 148.6 30.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.622 ' HB ' HD22 ' A' ' 50' ' ' LEU . 10.5 m -67.1 -27.01 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.317 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 104' ' ' THR . 18.1 pt-20 -59.49 -35.19 73.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.967 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.34 -30.71 57.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -69.74 -51.75 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.916 ' HA ' HD12 ' A' ' 112' ' ' ILE . 5.1 tt -57.95 -45.96 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.223 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 109' ' ' ILE . 58.9 tttt -58.1 -37.68 74.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.186 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -42.54 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.068 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.4 mt -57.87 -28.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.95 -28.76 27.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -28.13 42.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 23.61 11.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.24 124.32 5.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.57 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -67.5 -32.38 73.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.811 0.339 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.4 m -126.47 144.33 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 143.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.908 HG11 HD12 ' A' ' 30' ' ' ILE . 15.6 t -143.91 97.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.3 p -105.26 162.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.77 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.81 -35.79 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -86.65 -7.54 58.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.601 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -111.8 -47.22 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 111.639 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.45 -48.59 13.8 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.518 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.98 -34.3 28.41 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.78 -59.31 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.753 HD11 HG13 ' A' ' 12' ' ' VAL . 16.3 pt -55.26 -46.43 78.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 21.9 m -66.16 -38.27 81.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.631 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.74 -10.35 59.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.39 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.7 105.06 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.911 0.386 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 25' ' ' THR . 25.5 p30 -79.29 -12.45 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 24' ' ' ASP . 67.0 p -112.13 23.17 14.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.642 0.258 . . . . 0.0 111.291 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -167.13 130.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.66 136.23 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.84 146.31 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -126.94 107.65 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.908 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -107.76 115.94 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.703 ' OE2' HD21 ' A' ' 43' ' ' LEU . 3.0 tt0 -111.18 122.12 47.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 35.3 m-85 -88.39 132.21 34.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 43' ' ' LEU . 32.9 p90 -153.61 168.15 27.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.89 147.66 52.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 -45.13 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -75.53 -5.06 43.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.9 t -50.09 -49.15 52.49 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.813 0.339 . . . . 0.0 111.365 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.8 -35.49 4.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.662 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.23 -3.93 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.743 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 28.6 m -103.12 -20.24 14.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.47 -27.05 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.39 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.942 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.703 HD21 ' OE2' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -61.02 -27.83 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.53 -62.89 4.67 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.507 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.1 Cg_endo -59.38 -39.99 71.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.431 2.087 . . . . 0.0 112.204 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.676 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -60.69 -28.98 69.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.86 -24.59 35.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -34.83 60.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -76.48 -62.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.639 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.9 tp -59.68 -29.17 67.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.79 -46.16 69.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.09 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 111.196 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.21 -61.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.674 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.59 -29.46 64.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.5 -26.86 51.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -96.29 38.18 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -127.5 -176.2 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.94 -3.85 46.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' ' 63' ' ' VAL . 22.8 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -72.6 -42.74 64.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -93.87 16.18 14.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.31 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 34.9 mtt180 -120.5 -55.73 2.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 54' ' ' TYR . 8.9 p -128.96 132.48 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.74 136.06 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.373 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.762 HG22 ' CE2' ' A' ' 47' ' ' TYR . 12.5 mm -89.29 117.23 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.87 130.57 50.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.001 0.429 . . . . 0.0 111.508 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 160.71 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 30' ' ' ILE . 9.1 p -168.12 149.73 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.32 145.33 37.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -79.54 51.62 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -137.67 15.13 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.61 -177.74 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.3 m-80 -127.27 165.7 19.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.88 35.23 23.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.194 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ASN . 27.4 t -131.48 94.03 27.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.15 79.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.318 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.08 106.39 15.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -108.41 113.81 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.82 160.12 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.6 -45.21 54.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.85 141.57 14.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.337 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.5 OUTLIER -37.3 -45.09 1.59 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 20.6 Cg_exo -62.53 78.49 0.1 Allowed 'Trans proline' 0 N--CA 1.429 -2.315 0 CA-C-N 119.292 0.783 . . . . 0.0 111.442 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.687 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -81.21 142.11 33.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.381 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 1.8 mp -132.91 107.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.358 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 30' ' ' ILE . 25.5 mmtt -103.38 124.48 48.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.414 ' CB ' ' HB ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -110.1 130.14 55.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.861 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 47.9 m-85 -132.81 93.56 23.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.33 147.98 23.44 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.577 2.185 . . . . 0.0 112.482 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.14 139.08 39.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.07 -38.04 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.173 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.59 57.98 1.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.0 0.429 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 -172.59 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.55 -10.04 45.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.9 pm0 -128.72 112.76 19.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.711 0.291 . . . . 0.0 110.704 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.28 111.14 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.443 2.095 . . . . 0.0 112.318 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 31.5 t -80.14 105.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -95.26 123.96 39.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.041 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.473 ' OH ' HD12 ' A' ' 108' ' ' LEU . 3.1 m-85 -69.35 -176.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.0 m -122.5 15.74 10.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.55 123.93 2.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.553 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.11 167.57 11.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.891 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.51 -66.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.509 HG21 ' OE1' ' A' ' 106' ' ' GLU . 11.2 m -128.6 154.37 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 46' ' ' LYS . 30.3 m -65.53 -28.67 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.314 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.509 ' OE1' HG21 ' A' ' 104' ' ' THR . 5.5 pt-20 -58.03 -38.81 76.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.977 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -72.89 -38.54 66.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.473 HD12 ' OH ' ' A' ' 99' ' ' TYR . 62.0 tp -60.43 -58.81 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.868 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.1 tt -51.43 -45.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.5 ' N ' HG23 ' A' ' 109' ' ' ILE . 3.2 tttt -57.5 -30.82 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -31.15 40.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 109' ' ' ILE . 27.0 mt -67.72 -28.89 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.65 -37.31 21.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -28.89 62.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.88 23.72 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.48 146.48 18.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -31.2 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 62' ' ' ARG . 5.5 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.24 -62.58 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.536 2.157 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 56.95 29.43 16.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.046 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.406 ' CA ' ' HB ' ' A' ' 9' ' ' VAL . . . 145.26 -27.88 1.83 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.546 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -22.31 42.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 2.2 tt0 -76.16 -29.86 57.9 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.062 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.492 ' N ' ' CD ' ' A' ' 8' ' ' PRO . . . 134.77 -43.03 1.29 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.319 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 7' ' ' GLY . 98.9 Cg_exo -43.9 -62.26 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.632 2.221 . . . . 0.0 112.921 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.839 HG13 ' HD3' ' A' ' 67' ' ' LYS . 25.9 t -85.19 126.15 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.854 0.359 . . . . 0.0 111.112 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 m -133.14 140.66 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.03 143.38 11.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.82 HG11 HD12 ' A' ' 30' ' ' ILE . 17.6 t -138.49 97.88 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.194 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.613 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.7 p -105.72 161.5 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.836 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.31 -36.57 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HG3' HG13 ' A' ' 13' ' ' VAL . 4.7 pttt -86.64 -7.5 58.27 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -111.91 -46.31 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.708 0.289 . . . . 0.0 111.572 -179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.788 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.8 -48.77 10.95 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.593 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.547 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -51.47 -34.23 34.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.754 0.311 . . . . 0.0 111.655 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.13 -59.2 2.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.801 HD11 HG13 ' A' ' 12' ' ' VAL . 12.9 pt -56.03 -47.31 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.0 m -63.25 -38.93 83.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.691 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 18' ' ' ASN . 81.7 mt -77.63 -8.95 58.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -72.51 105.35 4.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.827 0.346 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.874 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.1 p30 -79.3 -15.58 57.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.393 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.82 -29.9 68.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 111.076 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.558 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 25.3 tttt -142.22 150.68 41.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.074 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' O ' HG12 ' A' ' 64' ' ' VAL . 19.5 t0 -83.67 145.04 29.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.771 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.1 t -133.85 142.29 41.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.258 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.717 HD12 HD13 ' A' ' 65' ' ' ILE . 3.2 mt -125.96 103.83 7.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.82 HD12 HG11 ' A' ' 12' ' ' VAL . 8.8 tt -100.61 116.81 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.708 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -106.53 129.9 54.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.954 0.407 . . . . 0.0 111.143 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.886 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 28.7 m-85 -100.15 120.19 39.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.802 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.71 176.56 8.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.62 148.16 42.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.092 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.67 -45.14 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.541 2.161 . . . . 0.0 112.327 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.9 p90 -78.15 -3.5 42.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.312 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 17.9 t -50.2 -46.45 54.46 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.821 0.343 . . . . 0.0 111.319 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.65 -40.42 2.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.48 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -108.65 -3.12 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.719 0.295 . . . . 0.0 110.672 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 12.4 m -108.48 -19.98 13.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.039 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp -49.65 -28.19 5.58 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.873 0.368 . . . . 0.0 110.958 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.5 -27.8 37.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -33.26 72.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.849 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.624 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.98 -62.35 5.98 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.378 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.624 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 20.4 Cg_endo -60.9 -34.28 91.35 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.518 2.145 . . . . 0.0 112.272 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.61 -29.04 68.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.441 ' CE2' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -78.66 -28.53 45.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -70.77 -35.73 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.801 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.62 -55.45 8.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.582 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.0 tp -60.35 -28.68 68.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.21 -43.15 90.06 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.575 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.07 -30.01 62.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 111.118 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.64 -55.43 5.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -63.81 -32.66 74.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.882 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.11 74.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.22 -28.91 61.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.956 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -173.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.54 43.36 1.09 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -138.68 33.63 2.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.4 tptm -62.42 -43.45 98.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -94.48 16.16 16.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.82 -49.77 2.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.853 0.358 . . . . 0.0 110.916 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 54' ' ' TYR . 11.9 p -135.75 139.65 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.1 p -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.717 HD13 HD12 ' A' ' 29' ' ' LEU . 20.6 mm -85.86 106.23 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.977 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.77 134.39 52.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.289 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.839 ' HD3' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -114.51 153.16 30.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.806 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.748 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -168.16 150.35 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.36 146.13 26.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.592 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.886 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -88.11 48.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.95 0.405 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 p -137.47 20.66 2.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.21 -177.72 6.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.193 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.611 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -106.55 160.06 15.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.869 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 54.82 41.7 31.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.175 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.0 p -128.78 82.8 67.94 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.012 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.21 80.3 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.713 2.275 . . . . 0.0 112.344 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -125.92 93.4 3.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -88.47 118.18 27.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.601 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.744 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.76 160.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.546 -179.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -76.34 -48.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.215 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.73 141.2 14.32 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.638 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -42.75 -49.12 13.68 Favored Pre-proline 0 CA--C 1.485 -1.536 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -65.91 78.52 0.29 Allowed 'Trans proline' 0 N--CA 1.424 -2.572 0 CA-C-N 119.124 0.723 . . . . 0.0 111.176 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.744 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -101.1 143.06 31.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.089 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 ' OE1' ' A' ' 31' ' ' GLU . 3.2 mp -127.8 119.57 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -103.42 115.34 30.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.647 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -97.3 131.24 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.0 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.446 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 4.8 m-85 -132.7 93.48 24.09 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.618 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.39 147.98 47.88 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.427 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.874 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.13 115.85 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.899 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 106.1 -36.87 4.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.291 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.98 30.0 7.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.36 . . . . 0.0 111.012 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -172.18 2.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.815 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.53 -15.22 46.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.591 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.7 pm0 -128.85 112.67 18.83 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.717 0.294 . . . . 0.0 110.771 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.95 108.5 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.443 2.095 . . . . 0.0 112.157 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 21.5 t -80.14 105.88 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.983 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.67 126.9 36.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.045 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.475 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -73.26 -177.14 2.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.4 p -109.58 -26.96 9.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.7 133.52 1.73 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 169.83 9.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.78 0.324 . . . . 0.0 110.98 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -175.55 -42.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.091 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.513 HG22 ' H ' ' A' ' 106' ' ' GLU . 19.8 m -149.25 148.38 29.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.034 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.582 ' HB ' HD22 ' A' ' 50' ' ' LEU . 4.0 m -62.01 -27.91 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.415 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.513 ' H ' HG22 ' A' ' 104' ' ' THR . 18.7 pt-20 -58.11 -35.82 72.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.823 0.344 . . . . 0.0 110.938 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.57 -29.23 59.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 112' ' ' ILE . 60.7 tp -70.63 -51.5 27.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.52 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.3 tt -57.39 -45.94 85.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.497 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.5 tttp -58.54 -50.9 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.003 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.07 -52.23 65.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.647 HG12 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -50.83 -30.86 9.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.02 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.62 ' O ' ' HB2' ' A' ' 120' ' ' ALA . . . -75.82 -27.94 58.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.5 -38.0 22.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -92.04 -44.44 8.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.113 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.76 136.47 19.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.604 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -32.6 36.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -63.98 -31.19 72.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.13 29.63 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.001 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 113' ' ' ALA . . . -137.22 151.98 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.161 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.12 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.19 -45.92 36.08 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.564 2.176 . . . . 0.0 112.311 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.453 ' O ' HD12 ' A' ' 3' ' ' LEU . 1.5 pp -108.35 107.73 18.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.16 87.41 1.78 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -77.82 -39.26 44.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.822 0.344 . . . . 0.0 110.985 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.06 20.08 17.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.44 164.58 12.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.526 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 58.3 Cg_exo -51.87 -26.62 24.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.578 2.186 . . . . 0.0 112.376 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.439 HG11 ' HG2' ' A' ' 67' ' ' LYS . 4.3 t -62.82 147.8 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.075 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.9 m -100.28 144.38 29.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.72 143.52 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.2 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.794 HG13 HD11 ' A' ' 20' ' ' ILE . 1.5 t -118.21 100.87 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 14' ' ' ALA . 4.6 t -94.04 163.85 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.711 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.621 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -56.33 -39.5 72.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.837 0.351 . . . . 0.0 111.317 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -86.65 -7.69 58.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.656 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.82 -44.64 5.0 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 0.0 111.356 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.28 -49.91 63.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.357 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.485 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.9 -34.68 29.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.728 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -75.28 -59.32 2.79 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG13 ' A' ' 12' ' ' VAL . 13.3 pt -56.06 -46.94 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.3 m -64.69 -37.23 79.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.606 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 mt -76.66 -11.11 59.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.436 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.75 108.85 8.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.999 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.814 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 19.0 p-10 -79.33 -12.39 59.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.405 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.8 t -91.69 11.27 25.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.539 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -163.49 134.43 4.63 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.871 0.367 . . . . 0.0 111.096 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.75 139.87 32.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.656 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 20' ' ' ILE . 20.9 t -133.85 141.32 44.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.385 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.867 HD12 HD13 ' A' ' 65' ' ' ILE . 1.7 mt -124.72 103.31 8.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.692 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.769 HD11 HG11 ' A' ' 68' ' ' VAL . 6.9 tt -101.67 127.72 54.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 14.8 tm-20 -117.64 124.3 48.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.22 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.638 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 34.0 m-85 -95.18 118.74 32.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.833 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 13.4 p90 -139.76 174.71 10.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.77 145.36 30.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.11 -46.48 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.476 2.118 . . . . 0.0 112.337 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -78.02 -3.44 42.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.297 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 19.5 t -50.58 -47.19 58.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.784 0.326 . . . . 0.0 111.318 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.22 -39.84 2.73 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.574 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -110.14 -1.93 17.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.835 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 20.8 m -107.19 -22.86 12.47 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.094 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.45 -27.22 3.98 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.26 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.37 -28.75 41.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.758 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.1 OUTLIER -62.59 -29.93 70.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.869 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.89 -61.99 6.47 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 17.8 Cg_endo -60.12 -36.68 88.09 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.428 2.085 . . . . 0.0 112.399 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -65.45 -29.09 69.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -80.52 -26.4 38.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.34 -35.62 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.659 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -72.68 -53.76 10.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.806 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.846 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.4 tp -60.58 -27.84 68.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.69 52.58 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . . . -69.38 -27.97 65.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 111.266 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mp -76.35 -63.6 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -29.42 63.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.064 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.69 -34.84 72.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.138 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.32 -29.13 61.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.0 -173.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.06 30.94 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.991 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -130.98 30.18 4.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -72.91 -30.28 63.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.55 -29.88 33.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.21 -75.15 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.32 139.68 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.03 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.58 131.02 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.144 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.867 HD13 HD12 ' A' ' 29' ' ' LEU . 20.3 mm -81.77 120.56 33.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.712 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -129.3 126.65 39.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.959 0.409 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG2' HG11 ' A' ' 9' ' ' VAL . 3.8 pttp -106.13 155.8 19.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 30' ' ' ILE . 12.0 p -168.12 155.36 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' N ' HG22 ' A' ' 68' ' ' VAL . 0.4 OUTLIER -98.11 146.22 25.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.443 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -85.57 46.04 1.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.353 . . . . 0.0 111.278 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.57 20.6 2.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.52 -177.71 5.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.283 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.621 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.3 OUTLIER -95.91 158.44 15.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.827 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 2.4 t0 51.11 40.59 26.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.248 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.2 p -129.36 100.13 20.47 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.961 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -72.65 -73.5 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.637 2.225 . . . . 0.0 112.134 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 44.1 93.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.658 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.09 101.14 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.534 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.713 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.85 160.28 36.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.614 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.87 -43.58 12.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.451 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.57 141.14 16.75 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.945 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.616 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -47.3 -46.84 57.68 Favored Pre-proline 0 CA--C 1.485 -1.522 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.22 74.07 2.56 Favored 'Trans proline' 0 N--CA 1.422 -2.699 0 CA-C-N 119.422 0.829 . . . . 0.0 110.866 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.624 ' CG2' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -98.88 121.2 40.53 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.273 -1.331 . . . . 0.0 111.203 -178.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.574 HD11 ' CB ' ' A' ' 102' ' ' SER . 3.0 mp -102.47 116.9 46.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.48 ' NZ ' HG23 ' A' ' 98' ' ' THR . 4.6 tptt -103.34 122.23 44.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -105.8 133.5 50.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.091 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 40.8 m-85 -129.76 93.38 34.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.674 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.21 140.64 41.43 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.841 2.361 . . . . 0.0 112.271 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.01 115.85 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.62 -34.31 5.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.225 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.64 12.29 12.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.643 0.259 . . . . 0.0 111.343 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.13 -168.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.63 -17.78 42.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.421 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -128.77 130.58 23.48 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.563 0.22 . . . . 0.0 110.555 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.94 112.71 3.48 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.393 2.062 . . . . 0.0 112.439 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.2 t -80.01 105.86 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.948 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.48 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 0.3 OUTLIER -90.59 119.3 30.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.963 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.466 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.2 m-85 -66.33 -175.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -26.09 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.728 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 175.88 127.29 1.02 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.479 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.758 ' OG ' HD21 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -85.86 145.15 27.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -56.78 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 m -134.63 155.97 49.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.846 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -73.87 -27.02 21.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.331 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.23 -35.98 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.042 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.64 -31.03 57.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.942 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.748 ' CD2' HD11 ' A' ' 112' ' ' ILE . 1.1 tt -67.68 -51.38 50.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.941 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.933 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -58.98 -45.96 91.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.206 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 109' ' ' ILE . 13.3 ttmt -58.01 -33.89 69.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.11 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.91 -43.0 56.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.105 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.933 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.5 mt -56.36 -29.15 27.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.22 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' A' ' 119' ' ' LYS . . . -82.6 -37.05 25.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -72.17 -29.58 64.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -117.22 23.07 12.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.05 144.0 15.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.557 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -80.56 -29.75 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.809 0.337 . . . . 0.0 111.038 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -93.29 17.21 11.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.407 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 113' ' ' ALA . 0.3 OUTLIER -128.1 29.55 5.37 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.84 0.352 . . . . 0.0 110.88 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.32 119.94 39.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.14 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.034 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.24 172.69 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.577 2.185 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.87 -36.62 5.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.924 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 -30.84 9.37 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 t -61.26 -31.14 70.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 0.0 110.943 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -105.16 -29.86 10.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -141.5 24.0 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.474 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.756 ' HG2' ' HB2' ' A' ' 52' ' ' ALA . 2.7 Cg_exo -75.18 98.09 1.14 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.875 2.383 . . . . 0.0 111.977 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG13 ' HG2' ' A' ' 67' ' ' LYS . 28.8 t -144.58 141.51 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.4 m -116.4 121.65 42.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.25 143.36 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.741 HG13 HD11 ' A' ' 20' ' ' ILE . 0.9 OUTLIER -129.57 97.81 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.014 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 14' ' ' ALA . 6.6 t -99.4 162.7 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.696 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -52.04 -36.16 49.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.776 0.322 . . . . 0.0 111.456 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.84 -9.19 56.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.036 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -41.13 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.826 0.346 . . . . 0.0 111.556 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -58.47 -39.84 81.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.07 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -56.82 -38.81 73.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.92 -43.92 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.741 HD11 HG13 ' A' ' 12' ' ' VAL . 20.9 pt -66.8 -45.44 87.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 19.4 m -70.03 -36.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.595 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 18' ' ' ASN . 85.3 mt -76.83 -14.74 59.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.202 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.4 110.15 1.04 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.844 0.354 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.77 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 12.2 t70 -79.24 -12.29 59.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.405 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.6 p -106.62 14.91 26.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.375 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.18 141.85 19.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -98.69 127.5 44.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.692 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.735 HG22 ' CG1' ' A' ' 64' ' ' VAL . 38.4 t -133.91 147.55 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.925 0.393 . . . . 0.0 111.438 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -128.84 114.73 16.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.764 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.765 HD11 HG11 ' A' ' 68' ' ' VAL . 8.3 tt -105.03 118.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.203 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 6.9 tm-20 -109.31 131.54 54.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 75' ' ' VAL . 28.2 m-85 -103.36 126.1 50.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.982 0.42 . . . . 0.0 111.364 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.656 ' CE2' ' HB2' ' A' ' 44' ' ' ALA . 32.8 p90 -152.84 171.17 18.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.59 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.85 155.63 59.31 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.748 0.309 . . . . 0.0 111.23 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.423 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 27.2 Cg_endo -63.35 -56.88 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.55 2.167 . . . . 0.0 112.103 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p90 -61.91 -18.46 60.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.701 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 t -42.87 -39.97 2.74 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.563 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.72 -64.86 0.85 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.488 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.27 -69.13 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.806 0.336 . . . . 0.0 110.951 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 7.3 p -67.15 -13.64 62.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.446 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tttm -51.3 -27.38 9.32 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.896 0.379 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.46 -24.36 63.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 102' ' ' SER . 0.1 OUTLIER -61.05 -22.33 64.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.94 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . . . -66.73 -63.13 3.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.549 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 12.0 Cg_endo -56.24 -35.7 95.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -70.09 -25.8 63.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -77.42 -29.03 52.79 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.234 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 1.6 pt-20 -77.29 -31.15 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.36 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.33 -51.36 37.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.766 HD22 ' HB ' ' A' ' 105' ' ' VAL . 30.5 tp -70.25 -30.52 67.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.5 -50.66 63.21 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.313 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.756 ' HB2' ' HG2' ' A' ' 8' ' ' PRO . . . -66.62 -38.82 87.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 0.0 110.946 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.55 -60.34 3.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.797 ' CE1' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -56.55 -27.6 58.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.15 -33.06 33.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.217 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -77.18 -30.71 55.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.0 m -58.91 176.56 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.73 -10.84 60.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -95.96 38.17 1.19 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 111.005 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -30.35 65.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -105.71 16.22 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -116.48 -41.24 3.12 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.815 0.34 . . . . 0.0 110.861 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.797 HG11 ' CE1' ' A' ' 54' ' ' TYR . 14.3 p -126.55 150.23 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.735 ' CG1' HG22 ' A' ' 28' ' ' VAL . 11.7 p -138.88 122.32 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 111.28 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.608 HG22 ' CE2' ' A' ' 47' ' ' TYR . 15.1 mm -87.86 110.41 20.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.799 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -113.43 128.44 56.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.424 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -111.93 144.31 41.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.561 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.765 HG11 HD11 ' A' ' 30' ' ' ILE . 11.0 p -151.38 156.86 5.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.256 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.458 ' N ' HG22 ' A' ' 68' ' ' VAL . 20.8 m-20 -94.79 146.23 24.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.613 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.59 51.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 0.0 111.41 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 p -137.75 19.94 2.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.923 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -177.78 6.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 111.407 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.6 OUTLIER -118.39 153.15 34.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.834 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.1 t70 58.02 47.0 15.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.5 p -133.18 89.57 32.88 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.549 2.166 . . . . 0.0 112.077 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -112.22 84.91 2.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -88.06 109.72 20.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.499 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.864 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.77 160.17 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.597 -179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.29 -43.3 17.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.31 141.34 16.5 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.896 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -45.09 -45.96 28.97 Favored Pre-proline 0 CA--C 1.487 -1.472 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 37.3 Cg_endo -67.75 80.35 0.48 Allowed 'Trans proline' 0 N--CA 1.427 -2.435 0 CA-C-N 119.548 0.874 . . . . 0.0 111.435 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.864 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.8 OUTLIER -86.09 137.28 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.134 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 ' HB ' ' CD1' ' A' ' 99' ' ' TYR . 28.6 mt -130.93 109.53 16.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.774 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.547 ' HB2' HG23 ' A' ' 30' ' ' ILE . 10.1 mptt -103.38 119.36 38.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.844 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.06 128.1 53.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.014 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 11.3 m-85 -132.74 93.4 24.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.733 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.43 154.17 21.17 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.689 2.259 . . . . 0.0 112.595 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.77 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.16 117.66 19.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.05 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.98 -38.0 3.35 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.46 11.26 14.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.658 0.266 . . . . 0.0 111.486 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -173.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.796 0.332 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.2 -17.84 43.41 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.367 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -128.82 121.93 21.21 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 120.519 0.2 . . . . 0.0 110.636 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.17 107.64 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.324 2.016 . . . . 0.0 112.176 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.2 t -80.1 105.83 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.924 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.7 p -93.09 128.9 39.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.944 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB ' ' A' ' 85' ' ' ILE . 4.4 m-85 -69.54 176.82 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.6 -24.88 12.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.961 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -173.82 117.04 0.62 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 43' ' ' LEU . 25.7 p -76.65 145.86 38.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.815 0.341 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -148.19 -72.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.465 HG21 ' OE2' ' A' ' 106' ' ' GLU . 3.8 m -132.35 165.18 24.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.766 ' HB ' HD22 ' A' ' 50' ' ' LEU . 6.2 m -72.82 -29.06 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.43 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.465 ' OE2' HG21 ' A' ' 104' ' ' THR . 8.4 pt-20 -57.06 -31.36 65.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.951 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.04 -30.28 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tp -72.02 -49.99 32.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.925 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.542 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.5 tt -57.22 -46.38 84.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.091 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' N ' HG23 ' A' ' 109' ' ' ILE . 14.3 ttpt -63.13 -37.36 86.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.66 51.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 109' ' ' ILE . 3.8 mt -55.11 -29.83 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.083 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.08 -30.42 63.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -93.59 -26.43 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.247 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -116.14 23.0 12.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.148 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -134.53 138.8 10.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.519 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -6.29 58.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.584 0.231 . . . . 0.0 111.366 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CE1' ' HB3' ' A' ' 90' ' ' ALA . 3.2 m-85 -93.35 22.06 5.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.629 0.252 . . . . 0.0 111.323 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.14 -22.97 22.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.049 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 61.83 90.35 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.114 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.93 155.55 65.1 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.599 2.199 . . . . 0.0 112.292 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.52 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -61.34 -31.14 71.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.97 89.48 1.54 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -82.65 -59.68 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -76.49 -29.82 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.85 65.47 2.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.512 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.34 -27.84 40.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.582 2.188 . . . . 0.0 112.253 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.549 HG13 ' HG2' ' A' ' 67' ' ' LYS . 23.3 t -91.65 130.32 40.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.18 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.9 m -111.01 127.65 55.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.66 143.39 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.197 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.7 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -133.25 97.83 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.5 t -105.26 167.64 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.857 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -51.54 -41.23 60.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.552 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -86.73 -7.65 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.934 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.54 -52.67 2.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.774 0.321 . . . . 0.0 111.492 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -49.23 -55.7 11.72 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.41 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.558 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -46.2 -34.95 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -73.66 -59.35 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.7 HD11 HG13 ' A' ' 12' ' ' VAL . 9.0 pt -55.9 -49.44 75.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.852 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' TYR . 33.1 m -56.53 -43.05 77.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.271 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.474 ' N ' HG23 ' A' ' 21' ' ' VAL . 85.0 mt -73.22 -12.63 60.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.413 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -58.75 96.24 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.862 0.363 . . . . 0.0 110.804 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.772 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 1.2 m-20 -68.1 -19.25 64.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.371 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.74 27.12 4.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.645 0.26 . . . . 0.0 111.279 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -176.94 145.1 0.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 0.0 111.152 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.09 143.96 26.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.585 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 20' ' ' ILE . 5.8 t -133.85 146.44 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.871 0.367 . . . . 0.0 111.467 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.802 HD12 HD13 ' A' ' 65' ' ' ILE . 1.9 mt -136.67 101.21 4.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.72 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.773 HD11 HG11 ' A' ' 68' ' ' VAL . 7.9 tt -102.36 119.11 50.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.201 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.691 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -108.19 131.33 54.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 25.5 m-85 -101.05 123.78 45.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.801 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 35.1 p90 -146.73 174.47 11.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.138 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.76 147.68 39.78 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.967 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.31 -42.11 4.18 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.622 2.215 . . . . 0.0 112.333 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.4 p90 -78.21 -3.44 42.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.392 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 32.2 t -51.43 -49.58 61.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -39.73 2.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.473 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -108.79 -3.2 17.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.752 0.311 . . . . 0.0 110.623 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 16.4 m -107.22 -20.78 13.18 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.09 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -49.55 -27.88 4.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.064 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.4 -28.78 41.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.823 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.691 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -62.97 -31.71 72.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.78 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.622 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -60.3 -62.32 6.16 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.447 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.622 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.7 Cg_endo -60.8 -37.32 79.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.466 2.111 . . . . 0.0 112.314 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -64.04 -29.2 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.78 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.51 -24.34 36.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.948 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -71.06 -35.63 72.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.644 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -52.99 9.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.753 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.889 HD22 ' HB ' ' A' ' 105' ' ' VAL . 38.0 tp -60.36 -29.12 68.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.809 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.21 -44.91 58.33 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.528 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.03 65.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.59 -57.56 3.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.4 ' CD2' HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -57.13 -45.9 83.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.013 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.38 -30.35 71.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -97.38 38.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.9 m -129.22 177.78 6.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -61.42 -21.31 64.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -95.29 38.24 1.15 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -74.8 -39.81 61.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.07 16.11 15.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.242 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.88 -51.56 2.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.806 0.336 . . . . 0.0 110.797 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.94 149.72 21.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.036 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.4 t -134.31 120.97 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.242 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.802 HD13 HD12 ' A' ' 29' ' ' LEU . 20.9 mm -83.74 106.18 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB1' HG22 ' A' ' 12' ' ' VAL . . . -110.17 127.84 55.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -112.07 140.51 46.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.657 179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 30' ' ' ILE . 12.1 p -157.11 153.9 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.31 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -95.5 146.2 24.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.493 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.579 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -76.3 55.88 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 111.345 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.7 p -137.65 20.52 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.983 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.3 -177.77 5.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.892 0.377 . . . . 0.0 111.339 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.657 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -116.52 154.66 30.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 58.09 62.08 2.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.057 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG11 ' CZ ' ' A' ' 32' ' ' PHE . 42.5 t -154.47 104.03 2.37 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.035 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.29 78.59 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.491 2.127 . . . . 0.0 112.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -104.38 74.2 1.16 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.208 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 pm0 -93.54 98.51 11.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.823 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.79 160.19 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.726 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -48.5 16.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.087 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.13 16.7 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.628 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.579 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -45.94 -44.91 36.86 Favored Pre-proline 0 CA--C 1.486 -1.49 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 7.6 Cg_exo -66.6 80.97 0.32 Allowed 'Trans proline' 0 N--CA 1.424 -2.57 0 CA-C-N 119.239 0.764 . . . . 0.0 111.327 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.823 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -102.95 142.92 33.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.211 -178.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 102' ' ' SER . 4.1 mp -126.36 117.95 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.802 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HB2' HG23 ' A' ' 30' ' ' ILE . 6.2 mmtt -103.28 112.11 24.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.62 131.48 43.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.174 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.468 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 34.4 m-85 -132.87 93.23 24.05 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.522 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.2 145.19 17.0 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.672 2.248 . . . . 0.0 112.664 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.78 124.04 27.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.99 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.64 -23.9 31.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.53 29.65 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.814 0.34 . . . . 0.0 111.069 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -165.27 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.824 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.24 -18.09 42.8 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.23 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -129.19 119.96 19.89 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.449 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.35 111.26 2.46 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.243 1.962 . . . . 0.0 112.058 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.01 105.84 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.897 0.38 . . . . 0.0 110.865 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.4 p -96.55 123.18 40.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.481 ' CB ' HD13 ' A' ' 85' ' ' ILE . 3.6 m-85 -74.14 178.75 4.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.914 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.1 m -118.41 15.83 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 136.08 123.0 2.24 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.543 ' HB2' HD11 ' A' ' 85' ' ' ILE . 5.8 t -100.96 155.29 18.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.877 0.37 . . . . 0.0 110.925 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mmt-85 -139.72 -47.05 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.635 HG21 ' OE1' ' A' ' 106' ' ' GLU . 3.9 m -143.87 152.26 40.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.985 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.889 ' HB ' HD22 ' A' ' 50' ' ' LEU . 19.2 m -62.35 -27.05 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.4 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.635 ' OE1' HG21 ' A' ' 104' ' ' THR . 3.4 pt-20 -57.05 -34.2 68.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.097 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.53 -30.68 59.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.992 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.595 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -70.7 -53.74 14.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.617 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -55.81 -45.49 79.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.252 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.501 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.8 mtmt -58.11 -39.83 79.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.011 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CB ' ' HH ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -66.4 -48.57 69.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 109' ' ' ILE . 6.7 mt -58.18 -23.2 21.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.289 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.43 33.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.123 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.56 -29.2 19.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.998 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.52 -30.99 14.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.22 136.14 20.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.51 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -78.43 -7.75 57.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.579 0.228 . . . . 0.0 111.355 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -93.42 22.13 5.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.645 0.259 . . . . 0.0 111.279 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.9 7.57 26.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.458 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 61.63 115.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.84 0.352 . . . . 0.0 111.168 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.064 179.983 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.46 -49.23 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.531 2.154 . . . . 0.0 112.257 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 3' ' ' LEU . 4.0 mm? 57.37 173.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.0 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.67 -31.09 4.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.432 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 m -72.33 -13.08 61.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.641 0.258 . . . . 0.0 111.286 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -93.77 20.17 7.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.659 0.266 . . . . 0.0 111.263 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 8' ' ' PRO . . . -49.69 -60.87 6.06 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.81 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 7' ' ' GLY . 24.7 Cg_endo -61.95 -27.2 79.54 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.52 2.147 . . . . 0.0 112.265 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.88 143.26 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.068 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.7 m -136.94 142.92 42.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -91.36 143.43 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.025 HG11 HD12 ' A' ' 30' ' ' ILE . 15.7 t -135.6 97.81 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.266 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.612 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.6 p -105.2 161.66 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.776 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -45.9 -35.59 4.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -86.61 -7.48 58.31 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.612 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -112.29 -47.6 3.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.701 0.286 . . . . 0.0 111.622 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.797 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -44.08 -49.06 8.98 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.644 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.473 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.11 -32.08 21.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -79.37 -59.39 2.78 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.843 HD11 HG13 ' A' ' 12' ' ' VAL . 20.3 pt -54.97 -38.36 45.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.797 HG22 ' O ' ' A' ' 17' ' ' TYR . 29.1 m -74.52 -37.99 45.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.698 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.06 -6.39 52.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.546 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.42 105.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.828 0.347 . . . . 0.0 110.927 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 11.5 p-10 -79.39 -12.39 59.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.418 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.22 28.05 8.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.205 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -172.88 131.45 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.881 0.372 . . . . 0.0 111.105 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 137.41 33.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.7 t -133.82 147.45 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.397 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -133.45 104.92 6.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.693 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.025 HD12 HG11 ' A' ' 12' ' ' VAL . 9.1 tt -100.65 129.29 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.993 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.718 ' OE2' HD11 ' A' ' 43' ' ' LEU . 0.8 OUTLIER -118.55 126.37 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.103 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 38.6 m-85 -97.1 117.91 32.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.792 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.444 ' CE1' ' HD2' ' A' ' 67' ' ' LYS . 11.9 p90 -134.91 174.33 10.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.71 145.76 32.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.86 -46.67 1.1 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.536 2.158 . . . . 0.0 112.329 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -78.91 -3.41 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 29.6 t -48.63 -46.78 40.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.765 0.317 . . . . 0.0 111.306 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.6 -36.92 3.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.595 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -114.83 -2.76 12.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.713 0.292 . . . . 0.0 110.791 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 25.6 m -105.06 -22.3 13.13 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.063 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -49.52 -27.99 4.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.045 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.51 -28.09 37.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.718 HD11 ' OE2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -60.77 -31.6 70.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.778 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.629 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -62.62 -62.68 5.27 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.629 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.5 Cg_endo -60.19 -36.55 88.0 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.436 2.09 . . . . 0.0 112.216 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.647 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -64.55 -29.23 70.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.745 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.45 ' CD2' ' HG3' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -81.24 -24.25 37.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -72.56 -33.27 66.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.619 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.71 -54.15 7.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.2 tp -60.58 -31.52 70.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.733 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.46 -42.47 81.57 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.55 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.11 -29.35 63.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.14 -59.58 2.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.408 ' CE1' HG13 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -57.88 -39.53 78.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.068 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.16 -29.61 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -97.1 36.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.8 t -113.1 -173.85 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -76.52 -18.22 58.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.271 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.13 35.8 1.53 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.783 0.325 . . . . 0.0 110.989 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -29.24 70.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.157 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -103.14 16.25 27.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.373 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -116.9 -74.64 0.6 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.81 0.338 . . . . 0.0 110.882 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' CG1' HD11 ' A' ' 29' ' ' LEU . 21.4 t -97.32 141.68 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.132 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -133.41 128.26 54.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.134 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.794 HD13 HD12 ' A' ' 29' ' ' LEU . 23.4 mm -83.47 111.0 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -113.51 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.169 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -106.8 151.95 24.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.784 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.808 HG11 HD11 ' A' ' 30' ' ' ILE . 11.4 p -168.14 156.03 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.224 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.449 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 m-20 -103.62 146.13 29.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.486 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -84.23 51.69 2.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.864 0.364 . . . . 0.0 111.21 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 p -137.63 20.61 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.4 -177.74 4.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.873 0.368 . . . . 0.0 111.201 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.673 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -107.63 164.05 12.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.702 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 55.66 31.58 17.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.991 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.68 HG22 ' OD1' ' A' ' 77' ' ' ASP . 8.3 p -132.13 101.95 14.74 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.82 -68.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.463 2.109 . . . . 0.0 112.206 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.68 ' OD1' HG22 ' A' ' 75' ' ' VAL . 5.9 p-10 42.12 83.43 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.715 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.12 102.84 15.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.669 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.79 160.22 37.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.581 -179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -84.44 -46.05 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.485 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.38 141.24 16.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.951 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -47.44 -46.23 58.07 Favored Pre-proline 0 CA--C 1.485 -1.521 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.18 71.59 3.59 Favored 'Trans proline' 0 N--CA 1.423 -2.672 0 CA-C-N 119.469 0.846 . . . . 0.0 110.973 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -92.13 142.87 27.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.181 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.561 HD12 ' CD2' ' A' ' 99' ' ' TYR . 7.9 mt -123.21 116.53 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.97 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -103.54 116.85 33.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.732 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.567 HD21 HG12 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -101.08 130.87 47.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.174 -179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.47 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 3.5 m-85 -132.82 93.36 23.92 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.708 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -78.21 142.96 19.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.653 2.235 . . . . 0.0 112.478 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.49 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -72.93 131.35 42.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.967 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.98 -36.56 3.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.265 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.65 2.78 16.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.634 0.254 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.02 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.69 -17.78 41.9 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.489 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.76 118.94 19.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.597 0.237 . . . . 0.0 110.644 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLN . 25.4 Cg_exo -62.33 111.01 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.36 2.04 . . . . 0.0 112.267 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 87' ' ' LEU . 25.8 t -80.13 105.78 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.886 0.374 . . . . 0.0 110.69 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.16 124.09 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.02 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.561 ' CD2' HD12 ' A' ' 85' ' ' ILE . 2.8 m-85 -81.08 -176.86 6.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.028 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.4 m -102.54 -25.5 13.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.685 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.07 140.24 2.88 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.544 ' OG ' HD21 ' A' ' 43' ' ' LEU . 6.0 t -95.21 145.11 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.963 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -145.22 -66.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 m -121.22 160.3 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.001 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.647 HG11 ' O ' ' A' ' 46' ' ' LYS . 10.3 m -76.95 -28.58 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.284 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.68 -33.43 75.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.977 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.57 -35.28 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 112' ' ' ILE . 53.0 tp -72.71 -46.69 52.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -57.16 -38.91 63.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.118 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.58 -49.81 71.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.47 -46.98 85.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 109' ' ' ILE . 18.8 mt -51.46 -41.03 25.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.176 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 119' ' ' LYS . . . -67.98 -30.06 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -75.05 -51.6 13.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -73.68 -43.9 58.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.85 138.57 49.38 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.513 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -80.58 -38.7 28.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -57.5 -29.58 64.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.03 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.497 ' HE2' ' HB2' ' A' ' 113' ' ' ALA . 0.7 OUTLIER -91.14 -22.99 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.01 -170.1 1.59 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.114 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.09 -179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.9 144.26 52.7 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.589 2.193 . . . . 0.0 112.376 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.01 -51.74 62.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.33 125.5 2.47 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.6 p -68.06 -30.36 69.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.327 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -97.79 20.13 12.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.168 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.38 -118.72 4.39 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.461 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.26 -56.69 2.65 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.419 2.079 . . . . 0.0 112.304 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -78.23 126.4 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.064 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.1 m -129.42 135.73 49.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.2 139.15 17.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.984 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.004 HG11 HD12 ' A' ' 30' ' ' ILE . 7.1 t -123.99 97.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 14' ' ' ALA . 2.8 t -96.54 166.46 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.679 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -53.15 -39.05 63.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.831 0.348 . . . . 0.0 111.31 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.82 -9.99 54.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.76 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.63 -47.19 4.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.77 0.319 . . . . 0.0 111.353 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.777 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -46.97 -50.56 18.86 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.395 -179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.501 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.67 -32.84 31.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.716 0.293 . . . . 0.0 111.545 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -75.25 -59.25 2.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.948 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.851 HD11 HG13 ' A' ' 12' ' ' VAL . 11.0 pt -56.37 -47.62 81.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 17' ' ' TYR . 28.0 m -62.74 -38.27 81.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.652 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 71.2 mt -77.32 -10.47 59.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.51 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -58.88 104.31 0.22 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 5.8 m-20 -79.35 -20.08 48.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.379 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -95.48 22.12 7.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.303 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -177.03 137.99 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.381 . . . . 0.0 111.048 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' O ' HG12 ' A' ' 64' ' ' VAL . 1.4 t0 -83.78 140.01 32.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.566 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.701 HG11 ' HB ' ' A' ' 20' ' ' ILE . 16.0 t -133.79 141.92 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.925 0.393 . . . . 0.0 111.462 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -128.25 118.94 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.711 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.004 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -111.66 123.62 67.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.765 ' OE1' HG23 ' A' ' 85' ' ' ILE . 0.8 OUTLIER -111.84 132.46 54.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.014 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.2 m-85 -101.98 129.5 48.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.829 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 41.5 p90 -152.11 173.36 15.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.037 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.7 145.93 32.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' CE3' ' A' ' 36' ' ' TRP . 44.5 Cg_endo -68.59 -42.08 5.43 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.45 2.1 . . . . 0.0 112.247 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' CE3' ' HG2' ' A' ' 35' ' ' PRO . 25.8 p90 -79.44 -3.47 46.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 16.7 t -53.8 -48.57 69.71 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.15 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 95.27 -42.2 2.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.415 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.68 -1.93 25.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.715 0.293 . . . . 0.0 110.674 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 13.3 m -110.06 -22.48 11.79 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.073 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.93 -27.34 3.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.246 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.47 -29.28 52.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.027 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.838 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -64.3 -30.9 71.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . . . -59.6 -62.0 6.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 44' ' ' ALA . 27.4 Cg_endo -62.45 -36.78 63.98 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.604 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.9 mttp -63.9 -29.16 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.94 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -82.16 -25.4 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.932 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -73.35 -36.31 66.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.779 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HG2' HD12 ' A' ' 53' ' ' LEU . 17.2 tt0 -73.52 -56.79 4.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.834 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.7 tp -60.39 -28.93 68.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.809 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.66 -50.62 53.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.09 -30.14 67.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.454 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.2 mt -70.63 -64.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.565 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.84 -31.04 66.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.02 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.34 -33.93 72.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.059 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.33 35.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -118.21 -176.35 3.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -66.35 -28.67 68.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.964 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -96.63 38.2 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.99 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -70.94 -37.47 72.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -95.18 16.25 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.29 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.424 ' HB3' ' CG ' ' A' ' 118' ' ' TYR . 5.9 mtt180 -110.77 -31.72 7.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.565 HG11 ' CE2' ' A' ' 54' ' ' TYR . 9.9 p -144.08 155.72 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.999 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 64' ' ' VAL . 12.1 p -135.28 123.18 38.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.259 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.499 HD13 HD12 ' A' ' 29' ' ' LEU . 19.8 mm -84.55 106.16 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.866 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -109.74 126.62 53.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.352 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.53 150.4 27.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.791 HG11 HD11 ' A' ' 30' ' ' ILE . 11.5 p -164.28 154.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.219 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 68' ' ' VAL . 44.1 m-20 -95.23 146.15 24.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.61 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -77.47 56.83 1.45 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 0.0 111.252 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.9 p -137.63 20.63 2.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.0 -177.72 6.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.254 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.8 OUTLIER -116.65 157.2 25.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 -179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 t70 55.52 48.49 18.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.051 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.637 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.1 p -131.82 93.19 28.26 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.006 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.28 79.23 0.8 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.592 2.195 . . . . 0.0 112.302 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 24.2 p-10 -114.02 117.61 31.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.23 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -119.62 107.44 13.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.804 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.8 160.06 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.604 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.26 -36.55 54.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.28 141.31 12.6 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.509 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -40.69 -44.28 4.84 Favored Pre-proline 0 CA--C 1.487 -1.455 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 15.8 Cg_exo -63.98 81.21 0.15 Allowed 'Trans proline' 0 N--CA 1.427 -2.399 0 CA-C-N 119.318 0.792 . . . . 0.0 111.382 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.804 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -91.17 142.32 27.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.388 -178.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.765 HG23 ' OE1' ' A' ' 31' ' ' GLU . 6.9 mt -132.87 107.81 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.425 ' HB2' HG23 ' A' ' 30' ' ' ILE . 4.4 mtpt -103.86 129.99 51.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.915 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -113.62 132.06 55.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.963 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 39.2 m-85 -130.26 93.42 33.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.503 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.5 142.2 36.2 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.542 2.161 . . . . 0.0 112.436 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.21 115.92 17.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 108.65 -21.6 27.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.6 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.44 47.47 1.78 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 0.0 111.512 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' NZ ' ' HA ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -89.39 -164.12 1.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.32 -17.95 42.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.557 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -129.01 112.42 18.55 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.675 0.274 . . . . 0.0 110.621 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.1 110.91 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.349 2.033 . . . . 0.0 112.106 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.0 t -80.01 105.76 10.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.05 130.95 40.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.942 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.574 ' CD2' HD12 ' A' ' 85' ' ' ILE . 4.2 m-85 -75.62 -178.06 3.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.023 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -106.69 -26.78 11.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -178.29 127.17 1.14 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.564 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.838 ' OG ' HD21 ' A' ' 43' ' ' LEU . 4.6 t -89.41 142.99 27.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.744 0.307 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 22.8 mtp180 -147.37 -77.31 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.47 HG21 ' OE1' ' A' ' 106' ' ' GLU . 5.6 m -115.46 155.89 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.834 ' HB ' HD22 ' A' ' 50' ' ' LEU . 7.0 m -69.24 -26.84 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.326 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.47 ' OE1' HG21 ' A' ' 104' ' ' THR . 4.6 pt-20 -57.45 -35.33 70.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.3 -29.17 61.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.67 ' HG ' HD11 ' A' ' 112' ' ' ILE . 19.8 tp -72.63 -51.05 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.096 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.656 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.2 tt -56.04 -45.62 80.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.201 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.482 ' N ' HG23 ' A' ' 109' ' ' ILE . 8.7 tttt -57.03 -48.97 77.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.04 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -52.24 66.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.67 HD11 ' HG ' ' A' ' 108' ' ' LEU . 15.3 mt -48.57 -34.52 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.19 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.79 -30.43 62.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.822 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -80.54 -46.29 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -81.25 -33.95 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.993 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.95 139.93 23.38 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.646 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 -26.73 37.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.778 0.323 . . . . 0.0 110.963 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' A' ' 62' ' ' ARG . 18.3 m-85 -54.58 -29.09 50.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.113 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -92.61 -22.97 19.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.09 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.42 100.57 6.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.085 -179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.489 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.22 132.77 45.2 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD12 ' O ' ' A' ' 1' ' ' GLY . 1.7 mp -130.7 -59.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.32 -135.65 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.506 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -65.18 -46.64 79.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.826 0.346 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -65.26 -29.52 70.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -57.56 119.96 18.93 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.67 -51.28 11.52 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.426 2.084 . . . . 0.0 112.316 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG12 ' HD3' ' A' ' 67' ' ' LYS . 6.0 m -66.49 121.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.065 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -119.86 129.64 54.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.75 143.36 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.126 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.59 HG13 HD11 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -134.65 97.83 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 16' ' ' ASN . 10.9 p -114.0 160.81 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.914 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -46.82 -34.4 5.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.051 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -86.79 -7.43 58.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.542 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -115.55 -51.61 2.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.16 -51.29 10.65 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.56 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.519 ' O ' HD12 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -48.14 -34.43 9.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -75.79 -59.2 2.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' O ' HG21 ' A' ' 28' ' ' VAL . 9.7 pt -54.69 -47.91 72.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.9 m -62.0 -44.96 99.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.493 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 18' ' ' ASN . 84.8 mt -69.06 -12.41 61.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.369 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.611 ' OD1' HG22 ' A' ' 25' ' ' THR . 1.1 t0 -72.13 103.15 3.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.833 0.349 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.786 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.8 p30 -79.33 -12.36 59.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.461 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.611 HG22 ' OD1' ' A' ' 23' ' ' ASP . 4.3 t -68.66 -28.81 67.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.709 0.29 . . . . 0.0 111.22 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.722 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 0.0 OUTLIER -143.45 159.4 42.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.798 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.727 HG21 ' O ' ' A' ' 20' ' ' ILE . 13.7 t -133.88 141.99 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.188 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.8 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.4 mt -127.53 142.38 51.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.698 HD11 HG11 ' A' ' 68' ' ' VAL . 11.4 tt -139.73 122.02 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' HD11 ' A' ' 43' ' ' LEU . 1.2 tp10 -110.94 143.94 40.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 31.8 m-85 -113.47 113.85 25.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.736 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 45.1 p90 -135.75 171.5 14.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.69 147.97 41.16 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -69.23 -43.83 2.84 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.494 2.129 . . . . 0.0 112.386 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -78.77 -3.39 44.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.477 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 39.2 t -50.21 -48.67 54.21 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.807 0.337 . . . . 0.0 111.312 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.3 -36.26 4.01 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.495 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -114.69 -4.59 12.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.349 . . . . 0.0 110.686 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 33' ' ' TYR . 22.5 m -104.08 -19.91 14.02 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.098 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -49.47 -28.05 4.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.045 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.41 44.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.575 HD21 ' OG ' ' A' ' 102' ' ' SER . 0.2 OUTLIER -61.4 -30.72 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.623 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -61.77 -62.8 5.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.623 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.8 Cg_endo -60.69 -35.32 89.89 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.418 2.079 . . . . 0.0 112.149 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 105' ' ' VAL . 18.1 mmtm -65.75 -28.98 69.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.802 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -79.23 -27.77 42.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -72.22 -31.46 65.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.818 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -75.49 -60.2 2.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD22 ' HB ' ' A' ' 105' ' ' VAL . 32.4 tp -58.82 -30.42 67.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.06 -41.94 79.13 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.537 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.12 -32.68 69.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.84 -57.15 4.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.12 -29.93 67.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.958 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.98 -30.12 58.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -74.26 -31.31 62.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.892 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.418 ' HB3' ' CD2' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -59.71 -173.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.16 42.21 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 57' ' ' SER . 29.9 m-85 -119.48 37.08 4.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -62.1 -46.87 87.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -101.15 16.21 26.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.293 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -110.77 -53.55 2.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.826 0.346 . . . . 0.0 110.869 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.89 152.27 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.21 126.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.535 HG22 ' CE2' ' A' ' 47' ' ' TYR . 14.0 mm -82.97 113.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.95 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 29' ' ' LEU . . . -113.6 126.72 55.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.237 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.546 ' HD3' HG12 ' A' ' 9' ' ' VAL . 7.6 ptmt -109.42 134.56 51.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.734 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.698 HG11 HD11 ' A' ' 30' ' ' ILE . 10.0 p -144.6 158.2 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.271 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.49 ' N ' HG22 ' A' ' 68' ' ' VAL . 1.1 p30 -100.98 146.3 27.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.502 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -83.09 47.65 1.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.283 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 p -137.68 20.61 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.821 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -88.92 -177.76 5.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.302 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.528 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -110.16 157.13 19.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.934 -179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 t70 56.11 40.18 30.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.9 p -124.17 78.12 59.96 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.94 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.89 79.02 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.578 2.185 . . . . 0.0 112.263 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -127.44 88.93 2.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.089 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -86.16 118.95 25.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.609 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.783 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -136.54 160.06 37.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.467 -179.611 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.94 -44.34 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.773 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.96 141.3 13.39 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.952 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.7 OUTLIER -46.44 -45.96 45.84 Favored Pre-proline 0 CA--C 1.486 -1.481 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -179.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.46 72.06 3.02 Favored 'Trans proline' 0 N--CA 1.424 -2.602 0 CA-C-N 119.444 0.837 . . . . 0.0 111.152 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.783 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -87.0 142.97 27.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.371 -1.286 . . . . 0.0 111.249 -178.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.591 HD12 ' CD2' ' A' ' 99' ' ' TYR . 10.0 mt -126.58 111.7 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.617 ' HB2' HG23 ' A' ' 30' ' ' ILE . 31.4 mttp -103.45 127.29 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -109.38 136.52 48.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.04 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.455 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 27.8 m-85 -132.67 93.56 24.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.703 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.09 144.96 38.63 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.568 2.179 . . . . 0.0 112.436 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -77.89 118.87 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -36.1 4.18 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.377 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -124.12 16.67 9.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.711 0.291 . . . . 0.0 111.378 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -173.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.866 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.4 -14.77 47.02 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.543 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -128.44 112.95 19.52 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.593 0.235 . . . . 0.0 110.681 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.23 118.56 5.67 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.377 2.051 . . . . 0.0 112.356 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.13 105.99 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 109.47 17.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.1 m-85 -64.43 -176.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.034 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 12.8 p -116.43 15.78 15.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.931 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.42 131.53 3.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.575 ' OG ' HD21 ' A' ' 43' ' ' LEU . 3.4 t -89.93 162.93 15.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -159.78 -67.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.09 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 m -131.34 156.55 45.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 46' ' ' LYS . 31.5 m -68.41 -30.63 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.255 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -59.82 -34.19 72.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.014 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -76.63 -29.3 56.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.844 HD23 HD11 ' A' ' 112' ' ' ILE . 0.5 OUTLIER -72.45 -50.25 27.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.092 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.726 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.8 tt -58.94 -45.89 91.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' N ' HG23 ' A' ' 109' ' ' ILE . 6.8 ttpt -58.32 -41.43 84.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.121 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.98 -46.93 76.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.844 HD11 HD23 ' A' ' 108' ' ' LEU . 14.2 mt -54.05 -30.14 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.401 ' HA ' ' CB ' ' A' ' 119' ' ' LYS . . . -79.85 -30.6 40.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.04 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -80.03 -28.72 39.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.77 22.2 13.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.025 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -108.42 147.96 16.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -80.54 -31.97 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -76.47 -32.36 58.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.959 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' CB ' ' HA ' ' A' ' 113' ' ' ALA . 2.1 mptp? -92.99 -23.05 18.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.57 161.38 39.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.123 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.114 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.31 -177.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.59 2.194 . . . . 0.0 112.255 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 3' ' ' LEU . 7.5 tp -94.34 -50.71 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.21 -43.39 1.68 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.526 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 m -76.41 -31.25 57.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.907 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -95.24 -29.77 14.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -103.86 91.05 0.78 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.55 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.91 -25.34 28.03 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.536 2.157 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.6 m -57.36 144.6 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.19 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -118.56 144.24 46.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.94 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.9 t -80.37 143.36 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.853 HG11 HD12 ' A' ' 30' ' ' ILE . 21.8 t -144.12 97.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.255 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 16' ' ' ASN . 9.9 p -103.37 161.01 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.649 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.514 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -47.32 -33.56 5.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.67 -7.59 58.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.573 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.8 OUTLIER -113.73 -46.26 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 0.0 111.627 -179.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.787 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -43.59 -47.93 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.674 -179.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.48 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -51.03 -33.1 23.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.727 0.299 . . . . 0.0 111.769 -179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -59.24 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.816 HD11 HG13 ' A' ' 12' ' ' VAL . 11.4 pt -56.1 -46.89 81.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 17' ' ' TYR . 22.4 m -65.08 -38.72 83.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.662 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.94 -9.67 58.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.431 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -69.49 104.32 2.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.855 0.36 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.785 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 4.5 p-10 -79.27 -12.37 59.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.4 p -68.75 -44.27 74.12 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.773 0.32 . . . . 0.0 111.08 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.734 ' C ' ' HB2' ' A' ' 90' ' ' ALA . 27.3 mttm -127.73 166.13 18.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.068 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -91.44 148.21 22.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.754 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 20' ' ' ILE . 21.2 t -133.84 145.92 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.248 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 65' ' ' ILE . 6.6 mt -130.5 98.17 4.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.853 HD12 HG11 ' A' ' 12' ' ' VAL . 8.1 tt -102.34 117.04 47.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.755 ' OE1' HD11 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -107.93 127.25 53.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.501 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 29.0 m-85 -93.45 119.83 33.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.611 ' HB3' HD13 ' A' ' 43' ' ' LEU . 15.0 p90 -136.96 174.17 10.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.818 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . . . -143.85 144.42 26.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.07 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.26 -45.03 2.04 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.422 2.082 . . . . 0.0 112.124 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -3.88 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.132 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 34' ' ' ALA . 32.5 t -52.38 -49.97 63.35 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.45 -39.52 2.8 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.312 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -108.03 -2.29 19.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 18.1 m -108.93 -21.17 12.77 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.265 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -27.18 6.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.82 0.343 . . . . 0.0 111.042 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.53 -22.98 43.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.663 HD11 ' HG2' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -59.22 -29.43 67.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -65.3 -62.71 4.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.483 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.3 Cg_endo -59.01 -26.56 82.07 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.571 2.181 . . . . 0.0 112.356 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.591 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.7 OUTLIER -78.56 -28.94 46.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.118 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.47 ' CD2' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -79.26 -30.03 42.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.161 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 45' ' ' PRO . 10.9 pt-20 -74.98 -38.28 61.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 0.0 110.531 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -64.05 -53.66 46.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.665 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.821 HD22 ' HB ' ' A' ' 105' ' ' VAL . 24.0 tp -64.8 -32.92 74.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.655 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.15 97.4 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.6 65.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.43 -57.63 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.79 69.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.45 -24.23 57.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.24 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -95.48 37.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.4 m -126.48 -173.73 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.789 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 37.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.964 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -138.68 30.02 2.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.57 -31.28 72.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -94.05 16.28 14.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.232 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -113.29 -63.87 1.39 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 29' ' ' LEU . 19.7 t -122.7 155.84 28.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.046 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.423 ' N ' HG12 ' A' ' 63' ' ' VAL . 11.8 p -141.37 128.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.162 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.958 HD13 HD12 ' A' ' 29' ' ' LEU . 24.2 mm -83.96 118.59 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.984 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.584 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -129.93 132.42 46.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.361 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -102.32 160.65 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.664 HG11 HD11 ' A' ' 30' ' ' ILE . 14.4 p -167.98 158.44 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.288 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' N ' HG22 ' A' ' 68' ' ' VAL . 2.7 m-20 -105.58 146.14 30.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.553 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HB3' ' HE1' ' A' ' 82' ' ' PHE . . . -90.48 44.48 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.21 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 p -137.6 20.76 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -83.93 -177.73 6.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 111.2 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.54 142.65 33.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.748 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 63.37 51.52 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.91 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -138.03 86.25 18.01 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.42 79.89 1.11 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.635 2.223 . . . . 0.0 112.323 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -110.31 105.69 14.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.076 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.29 105.06 14.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.571 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.67 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.1 OUTLIER -136.75 160.08 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.612 -179.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -69.43 -57.89 4.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.208 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.78 141.24 16.77 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.562 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.585 ' HE1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -43.19 -48.14 15.8 Favored Pre-proline 0 CA--C 1.484 -1.577 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -68.39 76.44 0.71 Allowed 'Trans proline' 0 N--CA 1.423 -2.652 0 CA-C-N 119.282 0.779 . . . . 0.0 110.785 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.67 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -97.39 139.88 32.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.24 -178.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.865 HD12 ' CD2' ' A' ' 99' ' ' TYR . 6.8 mt -115.5 120.02 63.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.802 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.6 ' HB2' HG23 ' A' ' 30' ' ' ILE . 7.7 mttp -105.34 112.86 26.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.846 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.486 HD21 HG12 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -98.1 134.64 40.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.998 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.431 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 49.1 m-85 -132.71 93.5 24.01 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.718 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.45 133.37 20.62 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.605 2.204 . . . . 0.0 112.454 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.785 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -71.27 117.32 12.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.99 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.93 -35.72 4.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.32 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -121.38 17.61 11.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.734 0.302 . . . . 0.0 111.302 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -170.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.799 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.65 -17.84 41.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.492 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.6 pm0 -128.97 112.45 18.62 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.71 0.29 . . . . 0.0 110.636 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.84 117.39 4.86 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.442 2.095 . . . . 0.0 112.29 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.3 t -80.15 105.81 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.64 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.3 112.16 23.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.138 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.865 ' CD2' HD12 ' A' ' 85' ' ' ILE . 3.3 m-85 -66.32 -178.24 0.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.888 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.2 m -109.42 -24.99 10.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.839 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.01 132.02 1.29 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.276 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.54 ' CB ' HD11 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -145.3 161.74 38.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 0.0 111.15 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.36 26.41 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.14 146.87 14.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.971 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.821 ' HB ' HD22 ' A' ' 50' ' ' LEU . 11.9 m -77.8 -30.85 16.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.171 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.1 -36.78 78.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.12 -30.07 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.755 HD11 ' OE1' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -69.27 -53.54 19.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.977 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.901 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.0 tt -56.33 -45.83 81.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.189 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' N ' HG23 ' A' ' 109' ' ' ILE . 5.1 mttm -58.03 -44.42 87.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.074 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.22 -43.91 96.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.08 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.901 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.7 mt -56.35 -31.18 32.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.097 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.74 -30.4 51.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.027 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -77.99 -28.15 49.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.21 25.89 9.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.22 142.96 16.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? -80.54 -28.17 37.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 0.0 111.028 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -93.3 19.79 7.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.357 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 28.4 5.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.754 0.311 . . . . 0.0 111.023 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 57.31 92.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 179.962 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.653 ' O ' HD12 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.27 -42.33 0.72 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.635 2.223 . . . . 0.0 112.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.653 HD12 ' O ' ' A' ' 1' ' ' GLY . 4.3 mp 60.53 31.05 20.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.979 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 23.01 9.63 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.562 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.0 t -86.51 -50.67 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 0.0 110.9 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -100.02 20.12 15.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.75 -61.7 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.588 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.15 -30.14 20.9 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.578 2.185 . . . . 0.0 112.343 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.525 HG13 ' HG2' ' A' ' 67' ' ' LYS . 34.8 t -66.72 139.05 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.047 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -135.59 138.1 42.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.979 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.33 143.46 11.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.099 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.096 HG11 HD12 ' A' ' 30' ' ' ILE . 3.4 t -135.36 109.35 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.154 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.644 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.9 p -124.79 166.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 73' ' ' ASN . . . -44.14 -38.65 3.81 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' HG3' HG13 ' A' ' 13' ' ' VAL . 5.8 ptpt -86.63 -7.5 58.28 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.644 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -111.41 -52.64 2.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.717 0.294 . . . . 0.0 111.588 -179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.792 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -47.09 -52.55 14.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.437 -179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.23 -35.7 27.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.766 0.317 . . . . 0.0 111.795 -179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -75.87 -59.28 2.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.741 ' O ' HG21 ' A' ' 28' ' ' VAL . 13.3 pt -54.7 -47.0 73.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 17' ' ' TYR . 23.6 m -64.59 -37.91 81.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.626 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 mt -76.34 -9.74 58.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.407 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -69.78 103.45 2.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.828 0.347 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.868 ' O ' ' HB1' ' A' ' 90' ' ' ALA . 2.1 p30 -79.28 -12.47 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.379 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.5 p -94.53 19.65 9.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.659 0.266 . . . . 0.0 111.337 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -173.49 143.14 1.02 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.796 0.332 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.641 ' O ' HG12 ' A' ' 64' ' ' VAL . 0.3 OUTLIER -83.78 140.16 32.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 20' ' ' ILE . 16.2 t -133.43 137.6 52.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.834 HD12 HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -130.37 104.66 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.871 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.096 HD12 HG11 ' A' ' 12' ' ' VAL . 5.2 tt -105.23 130.38 56.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 10.6 tm-20 -122.55 118.23 27.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.944 0.402 . . . . 0.0 111.29 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.432 ' CD1' HG13 ' A' ' 68' ' ' VAL . 41.4 m-85 -88.25 125.44 34.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.632 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -143.26 164.46 30.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.2 148.5 57.4 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.93 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.62 -37.81 11.87 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.512 2.141 . . . . 0.0 112.435 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -3.47 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.0 t -52.46 -46.6 66.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.809 0.338 . . . . 0.0 111.27 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.88 -37.07 3.57 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.671 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -116.07 -6.51 11.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.692 0.282 . . . . 0.0 110.94 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.9 m -98.12 -20.38 17.36 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.951 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -49.48 -28.29 5.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.96 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.57 -26.8 29.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.803 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 102' ' ' SER . 0.2 OUTLIER -60.07 -31.33 69.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.765 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.631 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.33 -62.76 4.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.348 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.631 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 18.3 Cg_endo -59.62 -31.6 94.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.432 2.088 . . . . 0.0 112.225 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.619 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -71.11 -29.19 64.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.755 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -81.19 -25.85 36.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.823 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -71.37 -38.87 71.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -70.08 -50.63 39.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.622 HD22 ' HB ' ' A' ' 105' ' ' VAL . 26.4 tp -60.31 -35.22 75.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.617 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -64.02 -39.12 96.94 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.324 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.57 75.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.38 -52.81 14.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.737 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.438 ' CE1' ' HB ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -59.06 -29.43 67.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.789 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.23 -27.02 32.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.38 32.56 2.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.82 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.11 -173.64 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.756 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.26 22.68 4.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -138.77 28.44 2.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.837 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.1 -34.42 77.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -79.87 -29.39 39.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -56.38 7.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 29' ' ' LEU . 21.2 t -116.46 148.69 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 27' ' ' ASP . 11.5 p -134.48 122.1 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.834 HD13 HD12 ' A' ' 29' ' ' LEU . 22.9 mm -81.86 124.73 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.62 126.75 44.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HG2' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -109.56 139.79 44.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.775 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.858 HG11 HD11 ' A' ' 30' ' ' ILE . 11.1 p -154.26 151.73 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.216 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.23 146.26 26.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.409 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -74.59 51.2 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.417 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 p -137.76 20.56 2.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.15 -178.08 2.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.936 0.398 . . . . 0.0 111.369 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.803 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.9 OUTLIER -123.04 151.17 42.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.921 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.51 57.47 6.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.246 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 73' ' ' ASN . 36.1 t -144.44 93.89 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.995 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.71 78.29 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.527 2.151 . . . . 0.0 112.228 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -108.03 82.64 1.67 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.33 112.89 19.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.616 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.632 HG21 ' OG1' ' A' ' 84' ' ' THR . 0.2 OUTLIER -137.04 160.21 36.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.537 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -86.77 -29.47 22.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.874 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' C ' ' HD2' ' A' ' 83' ' ' PRO . . . -132.29 141.63 13.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.763 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.6 OUTLIER -42.17 -45.41 9.62 Favored Pre-proline 0 CA--C 1.488 -1.408 0 N-CA-C 115.555 1.687 . . . . 0.0 115.555 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 82' ' ' PHE . 36.0 Cg_endo -66.38 75.9 0.36 Allowed 'Trans proline' 0 N--CA 1.427 -2.393 0 CA-C-N 119.759 0.95 . . . . 0.0 111.605 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 79' ' ' ILE . 1.1 m -77.69 136.07 38.14 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.25 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.92 HD11 ' HB2' ' A' ' 102' ' ' SER . 6.3 mt -132.7 107.99 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.584 ' HB2' HG23 ' A' ' 30' ' ' ILE . 13.8 mttm -104.04 121.31 42.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -105.68 133.02 51.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.98 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.445 ' CG ' ' HB ' ' A' ' 21' ' ' VAL . 13.4 m-85 -132.75 93.35 24.19 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.802 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.85 145.45 19.98 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.574 2.182 . . . . 0.0 112.414 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.868 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -76.94 143.16 39.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.06 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 95.9 -37.34 3.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.349 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.27 13.24 7.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.622 0.249 . . . . 0.0 111.424 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.414 ' CE ' ' N ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -55.36 -173.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.44 -17.28 43.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.47 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -120.5 116.07 32.21 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.575 0.226 . . . . 0.0 110.622 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.5 114.95 3.99 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.366 2.044 . . . . 0.0 112.355 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -80.07 105.88 10.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.0 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -89.15 109.3 20.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.975 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.44 ' CG ' ' HB ' ' A' ' 85' ' ' ILE . 3.4 m-85 -68.55 -178.36 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 10.6 t -110.04 -28.9 8.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.685 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.36 143.51 4.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.499 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -108.35 -177.75 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.811 0.339 . . . . 0.0 111.006 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 179.6 -35.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.003 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 106' ' ' GLU . 5.2 m -148.64 148.6 30.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.622 ' HB ' HD22 ' A' ' 50' ' ' LEU . 10.5 m -67.1 -27.01 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.317 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 104' ' ' THR . 18.1 pt-20 -59.49 -35.19 73.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.967 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -76.34 -30.71 57.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.507 ' HG ' HD11 ' A' ' 112' ' ' ILE . 6.4 tp -69.74 -51.75 31.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.013 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.916 ' HA ' HD12 ' A' ' 112' ' ' ILE . 5.1 tt -57.95 -45.96 87.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.223 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 109' ' ' ILE . 58.9 tttt -58.1 -37.68 74.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.186 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -42.54 71.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.068 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 109' ' ' ILE . 9.4 mt -57.87 -28.85 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.114 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.467 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -83.95 -28.76 27.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.078 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.34 -28.13 42.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.97 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 23.61 11.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.039 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -126.24 124.32 5.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.57 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -67.5 -32.38 73.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.432 ' CE2' ' HB3' ' A' ' 90' ' ' ALA . 0.4 OUTLIER -60.99 -29.55 69.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.2 mmpp? -88.66 -22.97 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 60.59 87.3 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.111 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 113' ' ' ALA . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.249 -0.882 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.15 -38.63 71.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.612 2.208 . . . . 0.0 112.302 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.444 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.2 mm? -65.24 103.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' HG22 ' A' ' 9' ' ' VAL . . . 173.97 -93.11 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.577 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 m -79.46 -30.6 42.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.978 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -97.88 20.17 12.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.232 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.63 -99.05 0.88 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.666 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.72 -62.77 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.479 2.12 . . . . 0.0 112.455 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 4' ' ' GLY . 9.0 m -75.9 147.59 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.263 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.4 m -126.47 144.33 50.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -82.26 143.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.208 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.908 HG11 HD12 ' A' ' 30' ' ' ILE . 15.6 t -143.91 97.8 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' A' ' 16' ' ' ASN . 11.3 p -105.26 162.61 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.77 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.533 ' N ' HG22 ' A' ' 13' ' ' VAL . . . -45.81 -35.79 4.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -86.65 -7.54 58.23 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.601 ' HB2' HG12 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -111.8 -47.22 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 111.639 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.79 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -45.45 -48.59 13.8 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.518 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' N ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -50.98 -34.3 28.41 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -76.78 -59.31 2.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.753 HD11 HG13 ' A' ' 12' ' ' VAL . 16.3 pt -55.26 -46.43 78.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 17' ' ' TYR . 21.9 m -66.16 -38.27 81.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.631 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.6 mt -74.74 -10.35 59.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.39 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -57.7 105.06 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.911 0.386 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 25' ' ' THR . 25.5 p30 -79.29 -12.45 59.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.371 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.597 HG23 ' OD1' ' A' ' 24' ' ' ASP . 67.0 p -112.13 23.17 14.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.642 0.258 . . . . 0.0 111.291 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -167.13 130.32 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.66 136.23 34.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.84 146.31 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.142 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -126.94 107.65 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.932 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.908 HD12 HG11 ' A' ' 12' ' ' VAL . 6.3 tt -107.76 115.94 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.935 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.703 ' OE2' HD21 ' A' ' 43' ' ' LEU . 3.0 tt0 -111.18 122.12 47.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.556 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 35.3 m-85 -88.39 132.21 34.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' HD13 ' A' ' 43' ' ' LEU . 32.9 p90 -153.61 168.15 27.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.971 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.89 147.66 52.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.087 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.9 -45.13 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.575 2.183 . . . . 0.0 112.427 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 3.4 p90 -75.53 -5.06 43.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.396 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 38.9 t -50.09 -49.15 52.49 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.813 0.339 . . . . 0.0 111.365 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.8 -35.49 4.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.662 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -116.23 -3.93 11.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.755 0.312 . . . . 0.0 110.743 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 82' ' ' PHE . 28.6 m -103.12 -20.24 14.24 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.47 -27.05 3.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.39 61.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.942 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.703 HD21 ' OE2' ' A' ' 31' ' ' GLU . 0.5 OUTLIER -61.02 -27.83 68.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 45' ' ' PRO . . . -63.53 -62.89 4.67 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.507 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 44' ' ' ALA . 19.1 Cg_endo -59.38 -39.99 71.67 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.431 2.087 . . . . 0.0 112.204 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.676 ' O ' HG11 ' A' ' 105' ' ' VAL . 0.0 OUTLIER -60.69 -28.98 69.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.723 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -81.86 -24.59 35.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.983 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.45 -34.83 60.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.818 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -76.48 -62.5 1.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.639 HD22 ' HB ' ' A' ' 105' ' ' VAL . 34.9 tp -59.68 -29.17 67.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.79 -46.16 69.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.09 66.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.809 0.338 . . . . 0.0 111.196 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.21 -61.87 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.0 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.674 ' CE2' HG11 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -57.59 -29.46 64.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.102 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -77.5 -26.86 51.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -96.29 38.18 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -127.5 -176.2 3.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -78.94 -3.85 46.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.437 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' HB3' HG12 ' A' ' 63' ' ' VAL . 22.8 m-85 -96.91 38.19 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.841 0.353 . . . . 0.0 110.933 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -72.6 -42.74 64.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -93.87 16.18 14.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.31 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TYR . 34.9 mtt180 -120.5 -55.73 2.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.829 0.347 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.674 HG11 ' CE2' ' A' ' 54' ' ' TYR . 8.9 p -128.96 132.48 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 p -127.74 136.06 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.373 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.762 HG22 ' CE2' ' A' ' 47' ' ' TYR . 12.5 mm -89.29 117.23 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.824 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' CG2' ' A' ' 12' ' ' VAL . . . -126.87 130.57 50.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.001 0.429 . . . . 0.0 111.508 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -111.93 160.71 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.601 179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.787 HG11 HD11 ' A' ' 30' ' ' ILE . 9.1 p -168.12 149.73 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.32 145.33 37.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.473 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' PHE . . . -79.54 51.62 1.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.225 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -137.67 15.13 2.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.61 -177.74 2.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.917 0.389 . . . . 0.0 111.327 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.691 ' O ' HG23 ' A' ' 75' ' ' VAL . 1.3 m-80 -127.27 165.7 19.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.839 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.88 35.23 23.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.194 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ASN . 27.4 t -131.48 94.03 27.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.15 79.27 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.572 2.181 . . . . 0.0 112.318 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -112.08 106.39 15.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -108.41 113.81 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.683 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.689 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -136.82 160.12 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.464 -179.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -73.6 -45.21 54.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.649 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.85 141.57 14.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.337 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.5 OUTLIER -37.3 -45.09 1.59 Allowed Pre-proline 0 CA--C 1.488 -1.433 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 82' ' ' PHE . 20.6 Cg_exo -62.53 78.49 0.1 Allowed 'Trans proline' 0 N--CA 1.429 -2.315 0 CA-C-N 119.292 0.783 . . . . 0.0 111.442 -178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.687 ' OG1' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -81.21 142.11 33.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.381 -178.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.44 ' HB ' ' CG ' ' A' ' 99' ' ' TYR . 1.8 mp -132.91 107.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.358 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 30' ' ' ILE . 25.5 mmtt -103.38 124.48 48.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.128 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.414 ' CB ' ' HB ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -110.1 130.14 55.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.861 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.438 ' CD2' ' HB ' ' A' ' 21' ' ' VAL . 47.9 m-85 -132.81 93.56 23.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.835 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -78.33 147.98 23.44 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.577 2.185 . . . . 0.0 112.482 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 24' ' ' ASP . . . -78.14 139.08 39.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.07 -38.04 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.173 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -127.59 57.98 1.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.0 0.429 . . . . 0.0 110.579 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.01 -172.59 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.55 -10.04 45.5 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 1.9 pm0 -128.72 112.76 19.05 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.711 0.291 . . . . 0.0 110.704 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.28 111.14 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.443 2.095 . . . . 0.0 112.318 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 31.5 t -80.14 105.99 10.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.888 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.535 ' CG2' HG22 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -95.26 123.96 39.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.041 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.473 ' OH ' HD12 ' A' ' 108' ' ' LEU . 3.1 m-85 -69.35 -176.35 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 75.0 m -122.5 15.74 10.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.041 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 138.55 123.93 2.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.553 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.11 167.57 11.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 110.891 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.51 -66.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.509 HG21 ' OE1' ' A' ' 106' ' ' GLU . 11.2 m -128.6 154.37 46.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.974 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.676 HG11 ' O ' ' A' ' 46' ' ' LYS . 30.3 m -65.53 -28.67 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.314 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.509 ' OE1' HG21 ' A' ' 104' ' ' THR . 5.5 pt-20 -58.03 -38.81 76.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.977 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -72.89 -38.54 66.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.473 HD12 ' OH ' ' A' ' 99' ' ' TYR . 62.0 tp -60.43 -58.81 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.868 ' HA ' HD12 ' A' ' 112' ' ' ILE . 4.1 tt -51.43 -45.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.298 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.5 ' N ' HG23 ' A' ' 109' ' ' ILE . 3.2 tttt -57.5 -30.82 65.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.999 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.94 -31.15 40.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.036 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.868 HD12 ' HA ' ' A' ' 109' ' ' ILE . 27.0 mt -67.72 -28.89 43.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.181 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.65 -37.31 21.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.214 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.59 -28.89 62.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -117.88 23.72 11.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.05 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.48 146.48 18.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.505 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -31.2 37.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.434 ' CE2' ' HA ' ' A' ' 62' ' ' ARG . 5.5 m-85 -71.25 -28.17 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -93.35 -23.07 18.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -106.95 159.97 15.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.124 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.126 179.951 . . . . . . . . 0 0 . 1 stop_ save_